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The study of biology is partly an exercise in natural esthetics. We derive much of our pleasure 
as biologists from the continuing realization of how economical, elegant and intelligent are 
the accidents of evolution that have been maintained by selection. A virologist is among the 
luckiest of biologists because he can see into his chosen pet down to the details of all of its 
molecules. The virologist sees how an extreme parasite functions using just the most 
fundamental aspects of biological behavior. 
 
DAVID BALTIMORE (Nobel Lecture, December 12, 1975) 
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Résumé : 
 
Les adénovirus sont le fil conducteur du travail présenté dans ce rapport. Une partie 
importante est dédiée à une particule « pseudo-virale » non pathogène appelée le dodécaèdre 
de l’Ad3. Plusieurs aspects sont abordés dans ce mémoire. Nous verrons tour à tour, des 
aspects de virologie fondamentale tels que les mécanismes d’entrée des virus dans les 
cellules, des aspects structuraux avec l’étude de ces complexes par cryomicroscopie ou encore 
des aspects d’applications biotechnologiques. L’adénovirus est un bon exemple montrant que 
les connaissances dérivant d’un organisme aussi petit dépassent largement le simple cadre de 
la particule mais viennent s’intégrer dans le contexte général du fonctionnement cellulaire. 
L’étude de ces particules hyperspécialisées dans l’attachement et la pénétration des cellules 
permet non seulement d’approfondir les connaissances mais ouvre également des perspectives 
biotechnologiques notamment dans le domaine de la vectorisation de molécules 
thérapeutiques.
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FONCTIONS 
 
 Rédacteur de projet 
Dans le cadre de la valorisation de mes projets de recherches, j’ai soumis en 2001 une 
demande de financement à la région Rhône-Alpes. Ce projet « Emergence 2001 » 
visant à développer des vecteurs de transfert de protéines dans les cellules humaines a 
été retenu à hauteur du financement demandé (150.000 F, 23000?).  
 
 Rapporteur pour des journaux scientifiques 
Je suis régulièrement sollicité comme « rapporteur » pour deux prestigieux journaux 
de thérapie génique : « Journal of Gene Medicine » et « Gene Therapy » . 
 
 Membre de la commission de spécialistes de l’UFR de Biologie de l’UJF 
Depuis 2003, je suis membre nommé de la commission de spécialistes de l’UFR de 
Biologie (sections 64 à 69 du CNU) de l’Université Joseph Fourier de Grenoble. 
 
Porteur de projets                    
J’ai porté le projet « Virologie et applications au domaine des biotechnologies 
médicales » dans le cadre de la fête de la science 2004 et 2005. Ce projet consistait en 
une journée porte ouverte de l’Institut de Biologie Structurale avec des animations 
interactives avec le grand public autour des moyens d’étude en virologie et les 
applications virales en thérapie génique. 
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 16
PREAMBULE 
 
 Dans l’exposé suivant, je ferai ressortir les principales découvertes issues de mon 
travail de recherche. Les détails opératoires ne seront pas mentionnés ceux-ci étant 
accessibles dans les publications. Il en est de même pour la bibliographie qui sera limitée à un 
minimum de références essentielles pour la compréhension du rapport. La plupart de mes 
articles décrits dans ce mémoire sont donnés en annexe du document. 
 
 Le fil conducteur des recherches est l’adénovirus. Celui-ci sera vu sous des aspects 
purement fondamentaux comme l’étude de ses protéines de structure, la recherche de 
partenaires cellulaires ou encore l’étude des mécanismes d’endocytose mais également sous 
des aspects d’utilisations biotechnologiques en tant que vecteur de transfert. Si la plupart des 
recherches sur l’adénovirus humain utilisent les modèles des sérotype 2 ou 5, notre modèle 
d’étude repose essentiellement sur une particule originale associée à l’adénovirus de sérotype 
3 : le dodécaèdre de l’adénovirus.  
 
 Le plan du rapport s’attachera à mettre en valeur d’une part les recherches 
« fondamentales », et d’autre part les aspects « applications » et ne suivra donc pas toujours la 
chronologie des découvertes.  
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  Généralités 
   - Généralités sur les adénovirus 
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  Formation des dodécaèdres      
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   - Expression des dodécaèdres au cours du cycle viral 
   
  Propriétés biologiques des dodécaèdres     
   - Les dodécaèdres entrent dans les cellules 
   - Le dodécaèdre base 
   - La base du penton interagit avec les héparanes sulfate 
   - Survie des dodécaèdres dans les cellules 
 
  Vectorologie         
   - Régulation de l’expression d’un transgène dans le contexte des Rads 
   - Vectorisation d’ADN par les dodécaèdres 
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   - Localisation structurale des sites d’interaction des HS sur les Dds 
   - Détermination du rôle respectif des HS et des intégrines  
   - Compréhension du rôle biologique des dodécaèdres 
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GENERALITES 
 
 Généralités sur les adénovirus 
 
 Les adénovirus ont été identifiés en 1953 à partir d’amygdales d’enfants infectés 
(Rowe et al., 1953). Les adénovirus peuvent infecter les mammifères (Mastadénovirus), les 
oiseaux (Aviadenovirus) et animaux à sang froid classés chez les Atadénovirus ou les 
Siadénovirus (Davison, Benko, and Harrach, 2003). Chez l’homme, la cinquantaine de 
sérotypes répertoriés est divisée en six sous-groupes de A à F, selon des critères 
biochimiques, génétiques et structuraux. Les sérotypes les plus étudiés sont l’adénovirus de 
sérotype 2 (Ad2) et l’adénovirus de sérotype 5 (Ad5 : utilisé en thérapie génique) appartenant 
au sous-groupe C. L’Ad3, objet de mes travaux appartient au sous-groupe B.  
 D’un point de vue structural, les adénovirus sont des virus icosaédriques à ADN dont 
les facettes triangulaires sont composées d’une protéine trimérique appelée l’hexon (240 
copies). Une protéine pentamérique, la base du penton, compose les sommets de l’icosaèdre et 
interagit de façon non-covalente avec une protéine trimérique en forme d’antenne : la fibre. 
Le complexe formé de la base du penton et de la fibre est appelé : le penton. Si le domaine 
globulaire externe de la fibre appelé « domaine tête » est structuralement proche d’un 
sérotype à l’autre, la longueur de la partie allongée (la tige) varie suivant les sous-groupes. 
Cette variation vient du nombre de domaines structuraux répétés constituant cette tige (Green 
et al., 1983). Ainsi, la fibre de l’Ad3 contenant 9 éléments répétés présente une longueur 
d’environ 16 nm alors que celle de l’Ad2 qui en contient 22 présente une longueur d’environ 
37 nm (Ruigrok et al., 1990). 
 
 Les étapes précoces de l’infection 
 Lorsque j’ai commencé mon travail de recherche au cours de mon DEA en 1992, un 
certain nombre d’éléments essentiels de l’adénovirus n’était pas connus. Aucun récepteur 
adénoviral n’était identifié ce qui justifie le choix de nous être intéressé particulièrement à 
la fibre et à la base du penton . Depuis l’ores, de nombreux travaux ont éclairé les étapes 
précoces de l’internalisation des adénovirus. En 1993, deux publications ont décrit qu’une 
séquence « RGD » conservées dans la plupart des bases du penton des sérotypes adénoviraux 
humains (à l’exception du sous-groupe F : Ad40 et Ad41) était responsable de la 
reconnaissance des intégrines ?v?3 et ?v?5 et que cette interaction induisait l’internalisation 
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du virus (Belin and Boulanger, 1993; Wickham et al., 1993). Cette même année, le 
« déshabillage » progressif du virus à l’intérieur de la cellule et le transport de son génome 
vers le noyau ont été disséqués (Greber et al., 1993). Ce processus fait apparaître l’endocytose 
du virus par des vésicules à clathrine, un relargage très précoce de la fibre et de la base du 
penton (10 et 20 minutes respectivement) au cours de l’acidification de ces vésicules et une 
« endosomolyse » rapide permettant au génome viral d’aller vers les pores nucléaires via les 
microtubules en une quarantaine de minutes. Il est à noter que pour les adénovirus du sous-
groupe B comme l’Ad3, objet de mes études ou encore l’Ad7, ce mécanisme est très différent 
de celui du sous-groupe C comme l’Ad2 ou l’Ad5 (Fig 1). Ces adénovirus sont incapables de 
se libérer des endosomes et suivent la voie lysosomiale (Miyazawa et al., 1999). Cependant, si 
le temps nécessaire à ces sérotypes pour délivrer leur information génétique dans les noyaux 
est nettement supérieur (entre 2 et 8 heures), leur efficacité réplicative est comparable.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1 : Shéma présentant les chemins d’endocytose respectivement suivis par les 
adénovirus du sous-groupe C (Ad5) et du sous-groupe B (Ad7). D’après Miyazawa et al., 
1999. 
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 Les récepteurs adénoviraux  
 Malgré d’intenses recherches dans différents groupes, il aura fallu attendre 1997 pour 
voir l’identification des premiers récepteurs adénoviraux. C’est ainsi qu’il a été montré que le 
domaine ?2 du complexe majeur d’histocompatibilité de classe I (MHC-I) interagissait avec 
les domaines globulaires de la fibre de l’Ad5 (Hong et al., 1997). 
 Un autre récepteur commun au cocksackie virus et à l’adénovirus nommé CAR 
(Cocksakie and Adenovirus Receptor) a été identifié de façon concomitante (Bergelson et al., 
1997). Ce récepteur semble être commun à  la plupart des sérotypes humains à l’exception du 
sous-groupe B dont fait partie l’Ad3 (Roelvink et al., 1998). Ceci explique la différence de 
tropisme des sérotypes appartenant à ce sous-groupe ainsi que le changement de chemin 
intracellulaire décrit ci-dessus (confère Fig 1) (Miyazawa, Crystal, and Leopold, 2001; 
Miyazawa et al., 1999). 
 Plus récemment, un nouveau type de récepteur, les « héparane sulfate 
protéoglycanes » (HSPG) ont été décrits  pour l’Ad2 (Dechecchi et al., 2001; Dechecchi et al., 
2000). Cette reconnaissance est responsable de l’internalisation de 50% de l’Ad2 sur des 
cellules épithéliales en culture et n’est pas sensible à l’ajout de CAR soluble. L’interaction 
entre ces récepteurs portant des chaînes d’oligosaccharides fortement sulfatés et la fibre 
interviendrait non pas sur le domaine globulaire de celle-ci mais sur sa tige. La fibre de  l’Ad3 
possédant une tige plus petite et plus rigide (Wu et al., 2003) n’interagit pas avec les HSPG 
(Dechecchi et al., 2000). 
 Concernant plus spécifiquement le sous-groupe B, l’usage des récepteurs est plus 
complexe ce qui nécessite une sous-classification des sérotypes en B1 et B2. Les sérotypes 
appartenant à B1 reconnaissent un récepteur unique alors que ce du groupe  B2 reconnaissent 
ce même récepteur et un récepteur additionnel (Segerman et al., 2003a). Plusieurs groupes ont 
identifié de façon concomitante CD46 comme étant le récepteur de certains sérotypes du 
sous-groupe B (Gaggar, Shayakhmetov, and Lieber, 2003; Segerman et al., 2003b; Sirena et 
al., 2004). Une incertitude persiste pour l’Ad3 (sous groupe B1), car un travail lui attribue 
CD46 comme récepteur (Sirena et al., 2004), alors que d’autres travaux excluent la possibilité 
que CD46 soit le récepteur commun au groupe B1 (Marttila et al., 2005). Des molécules 
exprimées à la surface des lymphocytes B et des cellules dendritiques matures telles que 
CD80 et CD86 peuvent également servir de récepteurs pour le sous groupe B (Short et al., 
2004; Zhang and Bergelson, 2005). 
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 Les vecteurs adénoviraux 
 Du fait de leur facilité de production à haut titre et de leur grande efficacité de 
pénétration dans les cellules, les adénovirus sont des vecteurs de choix pour l’apport d’ADN à 
des fins biotechnologiques ou thérapeutiques. Je ne rentrerai pas dans le détail de leur 
production et dans les différentes générations d’adénovirus recombinants existantes, ces 
renseignements se trouvant dans la revue (Fender P, Gene Ther Mol Biol, 2004, en annexe). 
Brièvement, les vecteurs adénoviraux sont délètés d’une région précoce (E1) indispensable à 
la réplication du virus. Cette région est apportée en trans dans les cellules HEK-293 afin de 
permettre la production des adénovirus recombinants. La place libérée par cette région (et 
éventuellement par la région E3 non indispensable pour la réplication du virus sur des cultures 
cellulaires) permet l’apport du transgène. Des générations plus évoluées ont été élaborées en 
délétant la région précoce E4 ou en utilisant une région précoce E2 thermosensible. Ceci 
permettait non seulement de libérer de la place pour l’apport du transgène et surtout d’éviter 
l’apparition d’adénovirus compétants pour la réplication (RCA : replication competent 
adenovirus) qui polluaient les stocks d’adénovirus de première génération. Finalement, une 
dernière génération d’adénovirus dite « gutless » conservant uniquement les séquences ITR et 
la séquence d’encapsidation  et ne possédant aucune séquence codante du virus est apparue. 
Ces virus moins immunogènes permettent en théorie l’apport de transgène d’environ 30 kpb 
au lieu de 7 kpb pour les générations précédentes. 
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 Aperçu sur les dodécaèdres de l’adénovirus 
  
 Géométrie 
 D’un point de vue purement géométrique, un dodécaèdre est un solide composé de 12 
faces pentagonales et possédant 20 sommets. Il est intéressant de noter que ce solide est 
complémentaire de l’icosaèdre qui lui, est composé de 20 faces triangulaires et posséde 12 
sommets. Ces deux solides appartiennent aux solides de Platon (avec le cube, le tétraèdre et 
l’octaèdre) car leurs côtés sont isométriques, tous les angles sont égaux et ils sont inscriptibles 
dans une sphère. Le dodécaèdre et l’icosaèdre sont dits « dual » car il est possible de les 
inscrire l’un dans l’autre (Fig 2). Ces solides possèdent des axes de symétrie 2, 3 et 5. 
 
 Figure 2 : Dualité des icosaèdres et des dodécaèdres. Un dodécaèdre peut être inscrit 
dans un icosaèdre (à gauche) et réciproquement (au milieu). D’un point de vue symbolique l’ 
icosaèdre représente la terre inscrite dans l’univers dodécaèdrique. 
 
 Historique 
 La première mise en évidence des dodécaèdres adénoviraux date de 1966, une époque 
où la structure des adénovirus et de leurs constituants était peu connue. En purifiant les 
antigènes solubles produits lors de l'infection de cellules humaines par l'Ad3, Norrby  a 
observé des structures présentant une symétrie dodécaèdrique ressemblant à une étoile à cinq 
ou six branches: les dodécaèdres. Ces dodécaèdres étaient formés d'après l'auteur par des 
protéines ayant une structure tubulaire et autour desquelles étaient retrouvés cinq ou six points 
(Norrby, 1966). Ces structures tubulaires correspondent à ce que nous appelons aujourd'hui 
les bases du penton et les points correspondent aux domaines tête de la fibre. Dans ce travail, 
Norrby remarquait que les composants formant le dodécaèdre (les pentons) étaient 
normalement présents aux 12 sommets de la capside virale. 
 La purification de ces structures reposait sur les propriétés hémagglutinantes que 
possèdent les dodécaèdres. Lors d'une première étape de purification sur gradient de chlorure 
de césium, les virus entiers et défectifs étaient éliminés. Le matériel recueilli au dessus des 
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bandes virales était purifié lors d'une seconde étape par ultracentrifugation sur gradient de 
saccharose. L'activité hémagglutinante des différentes fractions du gradient de saccharose a 
permis de déterminer que cet antigène se retrouvait uniquement dans les fractions lourdes et 
qu’il semblait posséder un coefficient de sédimentation de 50-60 S. L'observation de ce 
matériel en microscopie électronique a permis à Norrby de définir une taille de 22,5 à 27,5 nm 
pour le coeur du dodécaèdre (les bases du penton) et de 40 à 50 nm entre deux "points" 
opposés (les domaines tête des fibres).  
 
 Sérotypes et dodécamérisation 
 Depuis cette première description, d'autres travaux ont permis de mettre en évidence la 
présence ou l'absence de dodécaèdres dans des cellules infectées par différents sérotypes 
d'adénovirus humains. Ainsi le sérotype 4 (Norrby and Wadell, 1967), le sérotype 7 (Neurath 
and Rubin, 1968), le sérotype 11 (Norrby, 1968) et les sérotypes 9 et 15 (Norrby et al., 1967) 
sont connus pour donner des structures dodécaèdriques lors de leur cycle d'infection alors que 
la présence de dodécaèdres n'a jamais pu être détectée pour les sérotypes 1, 2, 5 et 6 (Wadell 
and Norrby, 1969), le sérotype 12 (Norrby and Ankerst, 1969) et le sérotype 16 (Norrby and 
Skaaret, 1968) ou pour les adénovirus entériques (Ad40 et Ad41). 
 La formation de dodécaèdres ne semble pas être dépendante des sous-groupes 
d’adénovirus (tableau 1). Il est intéressant de noter que si aucun sérotype du sous groupe C ne 
produit naturellement de dodécaèdre, la structure de la base de l’Ad2 a été résolue à partir 
d’un cristal de bases du penton s’étant dodécamérisées au cours de la cristallogénèse (Zubieta 
et al., 2005).   
 
Sous-groupe Sérotypes 
A 12, 18, 31 
B 3, 7, 11, 14, 16, 21, 34, 35 
C 1, 2, 5 ,6 
D 8, 9, 10, 13, 15, 17, 19, 20, 22-30, 32, 33, 36-39, 42 
E 4 
F 40, 41 
 
Tableau 1 : Formation de dodécaèdres en fonction des sérotypes d’adénovirus. La formation 
de dodécaèdres a été observée pour les sérotypes indiqués en rouge alors que les sérotypes 
indiqués en bleu n’en forment pas. Pas de données pour les sérotypes indiqués en noir. 
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RECHERCHE 
 
 
 FORMATION DES DODÉCAÈDRES 
 Les dodécaèdres ont été observés pour la première fois en 1966 à partir de cellules 
infectées par l’Ad3.  Depuis l’ores, quelques travaux ont mentionné la présence ou non de 
dodécaèdres dans le lysat de cellules infectées. Une partie de mon travail mené depuis 1994 a 
été consacrée à l’identification structurale des éléments nécessaires à la formation des 
dodécaèdres et à la détermination de leurs fonctions.  
 
 Expression des dodécaèdres dans baculovirus : 
 Publication de référence : Fender et al., Nat Biotech 1997 
 En coexprimant la base du penton et la fibre de l’Ad3 dans le système de baculovirus 
nous avons purifié sur gradient de sucrose une particule dodécamèrique avec les fibres 
projetées vers l’exérieur. Cette particule à été nommée le dodécaèdre-fibre (DF) (Fender et 
al., 1997). L’expression simple de la base du penton de l’Ad3 à quant à elle permis de purifier 
une particule nommée le dodécaèdre-base (DB) (Fig 3). D’un point de vue structural, ceci 
démontre que l’information de dodécamérisation est contenue dans la base du penton et 
qu’aucun autre élément adénoviral n’est requis. L’expression de la base de l’Ad2 dans 
baculovirus (gracieusement donné par le groupe de Pierre Boulanger) nous a permis de 
confirmer que malgré une forte expression, les bases de ce sérotype ne pouvaient pas se 
dodécamèriser.  
 
                                  
 
 Figure 3 : Micrographies des différents dodécaèdres. Dodécaèdre composé 
uniquement de la base Ad3 (DB), dodécaèdre composé de la base et de la fibre Ad3 (DF), 
dodécaèdre chimérique composé de la base Ad3 et de la fibre Ad2 (DChim), et base 
pentamérique de l’Ad2. Les différentes photos ne sont pas présentées à la même échelle, la 
barre indique 30 nm. 
 
DB DF DChimi
 
Base Ad2 
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 Si l’interaction entre les bases pentamériques dépend des sérotypes, l’interaction base-
fibre semble plus universelle. En incubant la fibre « longue » de l’Ad2 avec des DB de l’Ad3 
nous avons pu obtenir des dodécaèdres chimériques. Réciproquement, l’incubation de la fibre 
courte de l’Ad3 avec des bases pentamériques de l’Ad2 permet l’obtention de penton 
chimérique. 
  En conclusion, nous pouvons dire que les interactions bases-fibres sont conservées 
entre plusieurs sérotypes. L’information de dodécamérisation est, quant à elle, contenue 
uniquement dans la base du penton de certains sérotypes. Aucun autre élément adénoviral 
n’est requis pour la formation des dodécaèdres. 
 
 Eléments structuraux de la formation des dodécaèdres 
 Publications de référence : Schoehn et al., EMBO 1996 – Fuschiotti et al., JMB 2006 
 Nous avons résolu pour la première fois la structure des DB et des DF par 
cryomicroscopie à 20A de résolution (Schoehn et al., 1996). Ceci nous a permis de montrer 
qu’une cavité d’environ 8,7 nm de diamètre (350 nm
3
) était présente dans les dodécaèdres. 
Ces particules sont donc des pseudovirus ne contenant aucune information génétique. De 
façon très intéressante, en présence de la fibre, une boucle de la base du penton contenant la 
séquence RGD se déplace de 15A vers l’extérieur de la structure. Il est donc envisageable que 
la reconnaissance des intégrines diffère entre le DB et le DF. 
 En 2004, la structure de la base du penton de l’Ad2 délétée de 49 acides aminés du 
côté N-terminal a été résolue par cristallographie aux rayonx X à 3,3A par le groupe de 
Stephen Cusack à l’EMBL de Grenoble (Zubieta et al., 2005). Etonnamment, cette base qui 
ne forme pas spontanément de dodécaèdres s’était dodécamérisée au cours de la 
cristallogénèse ce qui a permis l’identification des résidus impliquées dans la formation du 
complexe. En faisant correspondre cette structure cristallographique de la base Ad2 dans un 
modèle du dodécaèdre Ad3 obtenu par cryomicroscopie à 9A, nous avons pu mettre en 
évidence que l’architecture des dodécaèdres de l’Ad3 repose sur uniquement trois points de 
contact entre deux bases adjacentes. La séquence SDVS d’un pentamère « A » interagit avec 
son homologue sur un pentamère « B » voisin alors que la séquence NDFT du pentamère 
« A » interagit avec la séquence RSTR du pentamère « B » et que vice versa la séquence 
RSTR du pentamère « A » est en interaction avec la séquence NDFT du pentamère « B » (Fig 
4). 
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 En dehors de ces séquences d’interaction bien définies, nous avons montré qu’un 
clivage protéolytique joue sur la stabilité des dodécaèdres. Le monomère de la  base Ad3 est 
composé de 544 acides aminés. Nous avions identifié au cours de mon doctorat qu’une 
coupure protéolytique partielle était observée du côté N-terminal (E37-A38). Depuis l’ores, 
nous avons montré que cette coupure joue un rôle sur la stabilité des dodécaèdres, la forme 
tronquée donnant des dodécaèdres très stables alors que la forme non protéolysée résulte 
essentiellement en la production de bases pentamériques ou de dodécaèdres très instables 
(Fuschiotti et al., 2006). Cette observation s’explique par le positionnnement du côté N-
terminal de la base du penton dans la cavité du dodécaèdre. La « libération » des 37 premiers 
acides aminés de la base du penton sur les 60 monomères composant le dodécaèdre revient à 
enlever 2.220 résidues (244 kDa) au niveau de la cavité interne ce qui résulte en un moindre 
encombrement stérique et donc à une stabilisation du complexe. 
 Outre l’importance fondamentale des interactions « protéine-protéine », ces données 
structurales seront utiles à des fins biotechnologiques dans le domaine de la vectorisation. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4 : Structure des dodécaèdres par cryomicroscopie. Changement de la 
structure de la base du penton (en rouge) en présence de la fibre (A et B). Structure du 
dodécaèdre-base à 9A de résolution (C) et coupe transversale montrant la cavité interne (D). 
Points de contact entre deux bases de l’Ad3 permettant la formation des dodécèadres (E et 
F). La vue « par dessus » montre les interactions entre les séquences RSTR et NDFT 
(marquées 3), la vue « de côté » montre l’interaction entre deux séquences SDVS adjacentes 
(marquée 4). 
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 Expression des dodécaèdres au cours du cycle viral 
 Publication de référence : Fender et al., Virology 2005 
 L’étude des dodécaèdres peut se faire à partir de particules isolées produites dans un 
système d’expression tel que le baculovirus. Il n’en reste pas moins vrai que ces particules 
sont naturellement produites au cours du cycle viral de l’Ad3 et de quelques autres sérotypes 
adénoviraux (cf : tableau 1 page 23). Je me suis intéressé à leur production au cours du cycle 
infectieux du virus. Ce travail publié récemment (Fender et al., 2005) (en annexe) fait 
ressortir que la biosynthèse des monomères de la base du penton commence dans le 
cytoplasme des cellules 12 heures après infection. Ces polypeptides sont transportés 
rapidement dans le noyau où ils s’accumulent de façon diffuse alors que la traduction 
protéique continue dans le cytoplasme. Après 20 heures d’infection, il n’y a plus de 
néosynthèse dans le cytoplasme mais un arrangement du signal correspondant à la base du 
penton est observé le long de la membrane nucléaire côté interne. Il s’agit de dodécaèdres qui 
se sont assemblés dans le noyau. Il n’est malheureusement pas possible d’observer 
directement en microscopie électronique ces particules sur des coupes ultrafines de cellules 
infectées mais la corrélation de cette technique ultrastructurale avec la microscopie confocale 
fait apparaître une nette différenciation du signal dû aux bases dodécamérisées de celles 
présentent aux sommets des virus. Une quantification du nombre de dodécaèdres fait 
apparaître qu’en moyenne 7,5 10
5
 dodécaèdres sont produits par cellule. Ce nombre est bien 
supérieur au nombre de virions produits par cellule puisque nous avons estimé un ratio 
dodécaèdres/virion de l’ordre de 200. La fonction biologique des dodécaèdres n’est pas 
connue mais un tel excès suggère un rôle biologique important pour les dodécaèdres. (Cf : 
Compréhension du rôle biologique des dodécaèdres, page 39) 
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 PROPRIÉTÉS BIOLOGIQUES DES DODÉCAÈDRES 
 
 Les dodécaèdres entrent dans les cellules 
 Publications de référence : Fender et al., Nat Biotech 1997  
 Le dodécaèdre-fibre (DF) 
 Comme nous l’avons vu dans l’introduction, les éléments clefs de l’entrée virale sont 
la base du penton et la fibre présentes aux douze sommets de la capside. Il était donc 
important d’étudier si ces protéines conféraient des propriétés d’endocytose aux dodécaèdres. 
Nous avons très rapidement montré que le DF était capable de s’attacher à 4°C aux cellules en 
culture. En incubant ensuite ces cellules à une température permissive pour l’endocytose 
(37°C), nous avons observé une internalisation très rapide de ces particules (Fender et al., 
1997). En une dizaine de minutes seulement, la plupart des complexes se retrouvent autour du 
noyau mais ils ne semblent pas pénétrer dans celui-ci même après une heure d’incubation (Fig 
5).  
 
 
 
 
 
 
 
 
 
 Figure 5 : Etude de l’entrée des dodécaèdres dans les cellules. Les dodécaèdres 
incubés pendant une heure à 37°C sur des cellules HeLa sont détectés en bleu, le noyau est 
marqué en rouge. La coupe médiane d’une cellule montre la concentration des vésicules 
autour du noyau. La série Z de la même cellule consiste en la projection de 8 coupes focales 
de 0,5 μm partant du plan médian en allant vers le haut de la cellule et donne l’aspect 
tridimensionnel de cette cellule. 
 
 Par analogie au virus Ad3 ou Ad7 (Miyazawa et al., 1999) (Fig 1, page 19), il est 
concevable d’imaginer un mécanisme d’internalisation du DF par des vésicules d’endocytose. 
Dans un premier temps, la fibre reconnaît un récepteur à haute affinité ce qui facilite une 
interaction secondaire de la base du penton avec les intégrines. Cette dernière déclenche 
l’endocytose (Mathias, Galleno, and Nemerow, 1998; Wickham et al., 1993) et les petites 
 
Coupe médiane 
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vésicules ainsi obtenues fusionnent entre elles pour donner des endosomes tardifs qui se 
retrouvent près du noyau. 
 
 Le dodécaèdre-base (DB) 
 Les mécanismes d’internalisation en deux étapes avec la reconnaissance d’un 
récepteur d’attachement à haute affinité facilitant la reconnaissance d’un récepteur 
d’endocytose à plus basse affinité sont couramment observés chez les virus. Lorsque nous 
incubons des DB sur des cellules, nous observons une très forte internalisation de celui-ci 
montrant que la fibre n’est pas indispensable pour l’endocytose. Ceci suggére donc un 
mécanisme à une étape pour cette particule. En comparant l’efficacité d’entrée des DF et des 
DB, nous avons pu montrer que la fibre est très utile à faible concentration (0,3 nM) mais non 
indispensable à une concentration légèrement supérieure (3 nM) (Fender et al., 2003). A cette 
dernière concentration, l’internalisation du DB représente en effet 70% du signal obtenu pour 
le DF alors qu’il n’était que de 7% pour une concentration 10 fois moins élevée (Tableau 2). 
 
 
 
 Tableau 2 : Efficacité d’internalisation des DB et des DF sur les cellules HeLa à deux 
concentrations différentes. Les résultats sont exprimés en pourcentage relatif par rapport à la 
valeur maximale observée. 
 
 Il existe donc une interaction de la base du penton avec les cellules permettant 
l’internalisation des complexes. D’après la littérature disponible, nous pouvions imaginer un 
passage direct par les intégrines. Des travaux sur la base du penton de l’Ad2 ont également 
montré que celle-ci pénétrait efficacement dans les cellules et que contrairement à la base 
Ad3, elle pouvait même atteindre le noyau (Hong et al., 1999b). Les auteurs discutaient le 
possible rôle de récepteurs auxiliaires aux intégrines dans l’endocytose de cette protéine. 
Nous avons étudié cette possibilité et caractérisé ainsi le rôle des héparanes-sulafte dans 
l’internalisation de la base du penton.  
 
  
 0,3 nM 3 nM 
DB 7% 70% 
DF 83% 100% 
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 La base du penton interagit avec les héparanes sulfates  
 (Publications de référence : Vivès et al, Viorology 2004 – Lortat-Jacob et al., 
Virologie 2005 – Vivès et al., Curr Gene Ther 2006) 
 Les héparanes sulfates (HS) sont des chaînes de glycosaminoglycanes composées de la 
répétition d’un dissacharide sulfaté. Ces groupements peuvent être liés à un cœur protéique et 
forment alors un « protéoglycane ». De nombreux virus utilisent ces protéoglycanes et en 
particulier leurs chaînes d’HS pour s’attacher aux cellules (confère nos revues : (Vives, 
Lortat-Jacob, and Fender, 2006) et (Lortat-Jacob, Fende rand Vivès, 2005). Dans le cas de 
l’adénovirus, il a été montré que l’Ad2 et l’Ad5 utilisaient ces chaînes d’HS grâce à une 
interaction par les protéines « fibre ». L’Ad3, lui, n’utilise pas ces groupements HS pour son 
endocytose (Dechecchi et al., 2000).  
 De façon étonnante, nous avons pu mettre en évidence que les dodécaèdres se 
comportaient tout à fait différemment du virus dont ils sont issus. Nous avons ainsi montré 
qu’aussi bien les DF que les DB pouvaient se fixer à 4°C sur des cellules CHO exprimant des 
HS alors qu’ils ne se fixaient pas sur un clone de ces cellules n’exprimant pas d’HS à leur 
surface (Vives et al., 2004). Des caractérisations biochimiques par résonance plasmonique de 
surface, nous ont permis de confirmer que l’interaction se faisait par la base du penton  avec 
une affinité pour les HS de l’ordre du nanomolaire. La fibre ne joue aucun rôle positif ou 
négatif dans cette interaction puisque les affinités trouvées étaient identiques pour le DB et le 
DF.  
 Des expériences de compétition avec de l’héparine soluble sur des cellules HeLa ont 
permis de déterminer que l’internalisation des DB était strictement dépendante d’une 
interaction avec les HS cellulaires. Ce résultat indique que l’internalisation des DB n’est pas 
due à une interaction directe de la base avec les intégrines mais à un processus séquentiel 
commençant par la reconnaissance des HS. Dans le cas du DF, l’ajout d’héparine soluble ne 
bloque que partiellement l’internalisation de ces particules montrant que parallèlement aux 
interactions base du penton/HS coexiste un mécanisme de reconnaissance « classique » 
fibre/récepteur qui lui est indépendant des HS. 
 Un schéma récapitulatif de ces interactions est présentés avec de nouvelles données 
sur la figure 9, page 38 de la partie « projet en cours ». 
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 Survie des dodécaèdres dans les cellules 
 Publication de référence : non publié 
 Nous nous sommes intéressés au devenir intracellulaire des dodécaèdres dans les 
cellules et en particulier à leur survie. Pour cela, nous avons incubé des cellules HeLa pendant 
une heure avec des dodécaèdres et nous avons lysé ces cellules à différents temps pour 
quantifier la présence de la base ou de la fibre après immunotransfert en utilisant un anticorps 
reconnaissantces deux protéines. Une diminution du signal est observée avec le temps, avec 
en particulier, des sauts importants après 1, 4 et 6 heures (Figure 6). Aucun produit de 
protéolyse n’est observé que ce soit pour la base ou pour la fibre ce qui laisse à penser que la 
dégradation ne se fait pas par des coupures internes dans les polypeptides mais de façon 
processive et rapide. Ce mécanisme pourrait correspondre à une dégradation de type 
« protéasome ». Des expériences complémentaires en microscopie confocale nous ont permis 
de montrer que des signaux spécifiques des dodécaèdres étaient détectables autour du noyaux 
des cellules jusqu’à 8 heures d’incubation. Le signal est  à peine détectable après 24 heures 
dans les cellules dans ce type d’expérience (incubation pendant 1 heure avec les particules 
puis lavage) alors que le signal est très visibles à 24 heures si les dodécaèdres sont laissés 
dans le milieu pendant toute la durée de l’expérience (non montré). Ceci suggère un 
mécanisme de recyclage permanent des récepteurs à surface des cellules.  
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6 : Survie des dodécaèdres dans les cellules. En haut : les cellules HeLa 
incubées à 4°C avec le DF sont lavées puis incubées à 37°C pour les temps indiqués. Après 
lyse cellulaire, la présence de la base et de la fibre est détectée par western-blot (temps en 
minutes). En bas : immunodétection des dodécaèdres dans les cellules HeLa par microscopie 
confocale après 1, 8 ou 24 heures à 37°C. 
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 VECTOROLOGIE 
 Régulation de l’expression d’un transgène dans le contexte des adénovirus 
recombinants 
 Publications de référence : Fender et al., J. Gene Med 2002 – Fender. Gene Ther Mol 
Biol 2004  
 
 Ce travail a été réalisé au centre de recherche de Rhône-Poulenc Gencell à Vitry et en 
collaboration avec le laboratoire de génétique de la neurodégénerescence de l’Hôpital de la 
Pitié Salpétrière à Paris.  
 Le but de ce travail était de construire des adénovirus recombinants qui pourraient 
recevoir des accords d’essais cliniques chez l’homme dans le cas des maladies 
neurodégénératives. Ceci nécessitait de travailler avec des vecteurs adénoviraux incapables de 
se multiplier dans les cellules. Ces virus délétés des régions précoces E1-E3-E4 étaient dits de 
troisième génération (cf Fender. Gene Ther Mol Biol 2004). Un deuxième prérequis pour 
obtenir cette autorisation était de pouvoir contrôler l’expression du transgène et notamment de 
pouvoir arrêter facilement son expression. Pour cela, nous nous sommes tournés vers le 
système « Tet On » qui permet d’allumer un promoteur régulable par l’ajout de tétracycline 
(Gossen et al., 1995). Ce système nécessite deux éléments distincts : des régions opératrices 
(Op7) en amont d’un promoteur minimal (CMV* ou TK*) et un transactivateur qui n’est actif 
qu’après s’être lié à la tétracycline le « rtTA » (Fig 7). L’ajout de tétracycline permet donc 
d’activer l’expression du gène et le retrait de l’inducteur permet un retour à un niveau 
minimum d’expression.  
  
 
 
 
 
 
 
 
 
 Figure 7 : Principe du système « Tet On ». Ce système peut être appliqué avec une 
stratégie deux virus (en haut) ou virus unique (en bas). En présence de tétracycline le 
transactivateur peut se fixer sur les région opératrices et déclencher la transcription du 
transgène. 
 
Virus régulateur 
Virus opérateur 
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 Nous avons utilisé le gène reporteur de la luciférase que nous avons clonés en aval de 
deux promoteurs minimaux TK* et CMV* (promoteur de la Thymidine Kinase du virus 
Herpes Simplex et promoteur du Cytomégalovirus) précédés des régions opératrices Op7. Le 
transactivateur rtTA était pour sa part codé sous la dépendance d’un promoteur RSV entier 
(Rous Sarcoma Virus). Nous avons testé l’efficacité de régulation suivant une stratégie deux 
virus  (virus régulateur + virus opérateur) ou virus unique (opérateur et régulateur). 
 Plusieurs enseignements ont été tirés de cette étude (Fender et al., 2002) : 
 
 - En absence d’inducteur, le promoteur minimal Op7-TK* donne peu de bruit de fond 
ce qui n’est pas le cas du promoteur minimal Op7-CMV* qui donne une expression basale 50 
à 100 fois supérieure que ce soit sur des cultures cellulaires ou in vivo dans le cerveau de rat. 
 - La statégie « virus unique » donne de bons résultats. L’efficacité d’induction dépend 
du taux d’expression du transactivateur rtTA. Cette expression est variable d’un type 
cellulaire à un autre. La configuration choisie (Op7-TK* - luciférase/ RSV-rtTA) est optimum 
dans les cellules PC12 alors que dans les astrocytes primaires humains, le taux d’induction du 
virus unique de 80X peut atteindre 620X  lors de l’apport d’un excès de virus codant le rtTA. 
 - Il est possible d’allumer et d’éteindre à façon l’expression d’un gène en ajoutant ou 
en enlevant l’inducteur sur les cultures de cellules. 
 - Pour les expériences in vivo dans le striatum de rat ou dans le muscle de souris nous 
avons montré qu’il était possible avec la stratégie « virus unique » d’obtenir des taux 
d’induction de 8X à 32X en apportant la doxycycline (analogue de la tétracycline) dans l’eau 
de boisson des animaux. L’ajout de virus codant le rtTA était bénéfique en petite quantité car 
il permettait d’augmentait le taux d’induction alors qu’un excès de ce virus résultait en 
l’augmentation du bruit de fond en absence d’inducteur traduisant ainsi une fixation non 
contrôlée du transactivateur sur les régions opératrices.  
 
 
 Vectorisation d’ADN par les dodécaèdres 
 Publication de référence : Fender et al., Nat Biotech 1997 
 La grande efficacité d’internalisation des dodécaèdres les rend intéressants pour la 
vectorisation de molécules dans les cellules. Dépourvus de matériel génétique, les 
dodécaèdres ne pose pas les mêmes problèmes que les adénovirus recombinants d’un point de 
vue sûreté. Le volume de la cavité interne  par contre ne permet pas d’envisager son 
utilisation pour encapsider des acides nucléiques (Schoehn et al., 1996). Pour pallier ce 
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problème, nous avons élaboré un peptide bifonctionnel mimant la partie de la fibre de l’Ad3 
interagissant avec la base (les 20 résidues N-terminaux) que nous avons prolongé par 20 
lysines afin d’interagir avec les acides nucléiques. Ce peptide était capable d’interagir avec les 
DB mais également avec les DF car la fibre trimérique n’occupe que trois des cinq sites de 
liaison présents par base pentamérique. La partie polylysine quant à elle permettait d’attacher 
et de compacter l’ADN plasmidique.  
 Ce système nous a permis d’apporter  des plasmides codant la luciférase dans des 
cellules en culture. L’expression de la luciférase qui était détectée de 9 à 72 heures après 
incubation prouvait que le plasmide avait réussi à franchir les membranes plasmiques et 
nucléaires et que le gène de la luciférase (sous la dépendance d’un promoteur SV40) avait été 
correctement transcrit puis traduit. Un effet dose-réponse était observé en augmentant le 
nombre de particules par cellule. L’efficacité du DB était nettement supérieure à  celle du DF. 
Cette différence pouvait s’expliquer d’une part par le nombre de sites disponibles pour 
l’attachement du peptide sur le DB (12 fois 5 sites) contre (12 fois 2 sites demeurant libres) 
sur le DF, et d’autre part, par la gêne que provoque la fibre pour l’attachement des plasmides 
compactés.  
 
 Vectorisation de protéines par les dodécaèdres 
 Publications de référence : Fender et al., J. Virol  2003 – Fender. Gene Ther Mol Biol 
2004 -  Garcel et al., J. Gene Med 2006.  
 L’apport direct de protéines dans les cellules appelé également transduction de 
protéines est un champ émergent annexe à la thérapie génique. Il consiste à greffer une 
protéine d’intérêt incapable de franchir les barrières cellulaires à des protéines ou des peptides 
capables d’entrer dans les cellules. De façon intéressante, ces protéines ou peptides servant de 
vecteur sont souvent issus de protéines virales (ex : Tat de HIV ou VP22 de HSV ; confère la 
revue Fender - Gene Ther Mol Biol 2004) et entrent dans les cellules en utilisant une voie 
faisant intervenir les héparanes-sulfate (Console et al., 2003). Il était intéressant au vu de 
notre caractérisation des dodécaèdres d’explorer le potentiel de cette particule comme agent 
de transduction de protéines.  
 Dans un premier temps, nous avons élaboré des anticorps monoclonaux (MAbs) 
dirigés contre la base du penton. Nous avons sélectionné des clones capables de reconnaître 
aussi bien le DB que le DF et nous avons montré par microscopie électronique que ces 
anticorps décorés le pourtour des particules dodécaèdriques. L’incubation des complexes 
« dodécaèdre- MAbs » sur des cellules permettait une transduction rapide des anticorps qui 
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suivaient un chemin d’endocytose comparable à celui du dodécaèdre alors les anticorps seuls 
étaient incapables de pénétrer dans les cellules (Fender et al., 2003). Outre le fait que ces 
anticorps ne neutralisaient pas l’entrée des dodécaèdres, ce résultat apportait la preuve de 
principe de la transduction de protéines par nos vecteurs. L’efficacité du système est d’autant 
plus remarquable que les anticorps sont des protéines multimériques de grandes tailles (160 
kDa).  
 Dans un deuxième temps, nous avons voulu généraliser notre système pour apporter 
n’importe quelle protéine d’intérêt. Il fallait donc trouver un système universel d’attachement 
qui remplacerait les interactions « antigènes-anticorps » utilisées lors de notre précédente 
étude. Pour cela, nous nous  sommes penchés sur des résultats fondamentaux de notre 
laboratoire. La recherche de partenaires cellulaires de la base du penton en criblant une 
banque d’expression d’ADNc de poumons humains avec les dodécaèdres avait permis 
d’identifier plusieurs protéines qui possédaient toutes un point commun : des domaines WW 
(Galinier et al., 2002). Ces domaines structuraux WW sont composés d’environ 35 acides 
aminés et doivent leurs noms à deux résidus tryptophanes (W) conservés. Ils sont connus pour 
interagir avec des séquences complémentaires PPxY que l’on trouve conservées en deux 
exemplaires dans la séquence des bases du penton des différents sérotypes d’adénovirus.  
 Nous avons évalué l’utilisation de ces domaines WW pour greffer des protéines 
d’intérêt sur les dodécaèdres. Notre choix s’est porté sur une ubiquitine ligase (Nedd4) qui 
possède quatre domaines WW en tandem. Une caractérisation biochimique de ces domaines 
séparément ou en tandem nous a permis de conclure que, du fait d’une coopérativité 
d’interaction entre les domaines WW et les séquences PPxY, une construction contenant trois 
des quatres domaines (WW2,3,4) était optimale pour notre projet. Ce module WW2,3,4 peut 
être apporté en fusion N-terminale ou C-terminale avec des protéines d’intérêt ce qui permet 
leur attachement aussi bien au DB qu’au DF. Par microscopie confocale nous avons montré 
que la protéine d’intérêt était alors efficacement transduite dans les cellules ou elle colocalise 
avec le vecteur dodécaèdrique qui l’a délivrée (Garcel et al., 2006). Nous avons pu estimer 
qu’en moyenne 2. 10
7
 protéines d’intérêt avaient été vectorisées par cellule après une heure 
d’incubation, démontrant le fort potentiel de nos vecteurs dans le domaine de la transduction 
de protéines.  
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 PROJETS EN COURS ET A VENIR 
 
 Localisation structurale des sites d’interaction des HS sur les dodécaèdres 
 Nous cherchons à localiser les sites de fixation des HS sur la base de l’Ad3. Cette 
caractérisation devrait permettre d’apprendre d’une part s’il y a un ou plusieurs sites de 
fixation pour les HS par base pentamèrique et, d’autre part, si leur organisation ternaire dans 
le dodécaèdre facilite l’interaction. Ce dernier point pourrait en effet expliquer qu’il y ait une 
forte affinité des dodécaèdres pour les HS alors que le virus qui possède également douze 
base du penton est incapable d’interagir avec les HS (Dechecchi et al., 2000). 
 Un premier élément de réponse a été apporté par la microscopie électronique. En 
collaboration avec le Dr Guy Schoehn (IVMS-Grenoble), nous avons pu faire la 
reconstruction tridimensionnelle du DB avec un oligosaccharide d’HS composé de 8 
saccharides (dp8). Ce dp8 donne une densité supplémentaire sur la boucle des dodécaèdres 
contenant la séquence RGD (Fig 8). Il se trouve que l’analyse de la séquence primaire de la 
base Ad3 nous avait fait suspecté cette région du fait de la présence de nombreux résidus 
basiques à proximité de la séquence RGD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 8 : Reconstruction du DB incubé avec un oligosaccharide d’héparane sulfate 
de 8 unités (dp8). Les densités supplémentaires (2 sont représentées en rose) dues a cette 
oligosaccharide sont localisées sur la boucle contenant la  séquence RGD. 
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 Cette étude sera poursuivie avec des oligosaccharides de plus grandes tailles. En effet, 
nous avons pu montrer par immunofluorescence que, contrairement à de l’héparine soluble de 
grande taille, la préincubation d’un excès de dp8 avec le DB n’empêchait pas sa fixation sur 
des cellules HeLa. Cela suggère soit une compétition entre les HS cellulaires et le dp8, soit 
l’existence d’un autre site de fixation des HS sur le dodécaèdre. Des données de suivi de 
l’attachement des dodécaèdres sur les cellules par immunofluorecence montrent un effet 
compétiteur brutal pour des oligosaccharide dp14 (7 unités disaccharidiques) alors qu’un 
oligosaccharide dp12 (6 unités disaccharidiques) ne neutralise pas l’attachement et 
l’internalisation des particules (résumé sur la figure 9, page suivante). 
 Cette étude sera complétée par une analyse structurale par cristallographie aux rayons 
X (collaboration avec les Dr Stephen Cusack et Elena Seiradake – EMBL Grenoble). Nous 
avons produit un dodécaèdre dont la partie N-terminale (les 37 premiers résidus) a été délétée. 
Ce dodécaèdre plus stable (cf : page 26), sera co-cristalisé avec des oligosaccharides de 
différentes tailles afin d’analyser finement l’interaction dodécaèdre-HS. 
 
 
 Détermination du rôle respectif des héparanes sulfate et des intégrines dans 
 l’internalisation des dodécaèdres 
 
 Identification des protéoglycanes récepteurs 
 Il serait intéressant d’identifier le ou les protéoglycanes responsables de l’attachement 
des dodécaèdres à la surface des cellules. Du fait de la spécificité d’interaction avec les HS, il 
est envisageable que deux grandes familles de protéoglycanes soient impliquées dans cette 
reconnaissance : les syndécans (4 formes connues) et les glypicans (5 formes) connues. Nous 
avons montré par résonance plasmonique de surface (BIAcore) que certains anticorps 
monoclonaux que nous avions produits contre la base du penton de l’Ad3 ne neutralisaient 
pas les interactions dodécaèdres-HS. Ces MAbs nous serviront d’outils pour aller « pêcher » 
les complexes dodécaèdres - protéoglycanes obtenue en incubant nos particules pseudo-
virales avec des préparations de protéines membranaires. L’identification des protéoglycanes 
impliquées pourra alors se faire de manière indirecte par immunodétection ou de manière 
directe par séquençage en spectrométrie de masse (ms/ms) (collaboration avec le Dr Michel 
Jaquinod au CEA grenoble). 
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 Rôle des intégrines 
 Lors de nos précédents travaux (Vives et al., 2004), nous avions montré que les HS 
étaient primordiaux pour l’attachement des dodécaèdres,  en particulier pour le DB qui ne 
peut pas utiliser la voie d’attachement de la protéine fibre. Il restait à déterminer si 
l’interaction avec les HS était suffisante pour permettre son endocytose. Nous avons pu 
montrer que les intégrines étaient indispensables pour déclencher l’endocytose. Pour cela, 
nous avons réalisé une mutation ponctuelle (D331 en E331) dans la séquence de la base. Le 
dodécaèdre ainsi obtenu appelé « mutant RGE » est toujours capable de se fixer aux cellules 
exprimant des HS mais ne peut pas pénétrer dans celles-ci. Ce résultat montrant la nécessité 
d’une interaction base-intégrines pour déclencher l’endocytose a été confirmé par l’utilisation 
d’une drogue « S36578 » gracieusement fourni par les laboratoires Servier. Cette drogue ne 
gêne pas la fixation des particules (DB et DF non muté) sur les HS mais empêche leur 
internalisation (Fig 9).  
  
  
 
 
 
 
 
 
 
 
  
  
 
 Figure 9 : Mécanismes d’attachement et d’internalisation des dodécaèdres. La base 
du penton interagit avec les HS ce qui facilite l’interaction avec les intégrines. L’attachement 
peut être bloqué par l’ajout d’oligosaccharides de tailles égales ou supérieures  à quatorze 
unités saccharidiques (dp 14). En présence de la fibre un chemin indépendant des héparanes 
sulfate coexiste. Le bloquage des intégrines avec la drogue S36578 empêche aussi bien 
l’internalisation des DB et des DF. Le virus Ad3 n’interagit pas avec les HS. 
  
 L’incubation de dodécaèdres non mutés sur des cellules n’exprimant pas d’HS (CHO-
2241) a permis de montrer une fixation très faible mais spécifique à 4°C des dodécaèdres sur 
ces cellules. Cela suggère qu’une interaction directe entre les séquences RGD des 
dodécaèdres et les intégrines existe. Un ciblage des intégrines par nos vecteurs est donc 
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possible mais celui-ci nécessiterait l’abrogation complète des interactions avec les HS. Ce 
travail est en cours d’élaboration avec la création de dodécaèdres mutées dans certaines 
séquences basiques comme KQKR ou KFKAR. 
 
 
 
 Compréhension du rôle biologique des dodécaèdres 
 Nous avons apporté de nombreux éléments nouveaux sur les dodécaèdres que ce soit 
au niveau biologique ou structural. Une question virologique fondamentale demeure : quel 
rôle joue les dodécaèdres au cours du cycle viral ? En effet, il est difficile d’imaginer qu’une 
particule aussi intrigante ait été conservée au cours de l’évolution si elle n’apporte pas 
d’avantage sélectif au virus. Cette question est extrêmement complexe à aborder.  
 - Une approche pourrait consister à comparer la réplication de l’Ad3 type sauvage 
avec celle d’un Ad3 dont les bases seraient mutées afin de ne plus se dodécamériser. 
 - Une approche similaire pourrait se faire avec des bases se dodécamérisant mais ne 
pouvant plus interagir avec les HS. 
 Pour cela, nous pourrions utiliser des Ad3 recombinants qui ont été récemment décrits 
(Sirena et al., 2005). Ces mutations ne devraient pas affecter la production des virus ainsi 
modifiés. En effet, dans le contexte viral, les bases ne sont pas dodécamériques et elles 
n’interagissent pas avec les HS. Nous pourrions alors étudier l’effet des bases mutées sur 
différents points du cycle viral tels que l’efficacité de la réplication, leur localisation dans les 
cellules au cours du cycle réplicatif, leurs rôles dans la diffusion du virus. Ce dernier point est 
extrêmement intéressant puisqu’il a été montré que l’excès de la fibre Ad2 produit au cours de 
la réplication de ce virus interagissait avec le récepteur CAR qui est un composant des 
jonctions serrées. Ce mécanisme permettait une meilleure diffusion des virions à partir de la 
première cellule infectée (Walters et al., 2002). Par analogie, nous avons montré que la base 
Ad3 était produite en excès et qu’elle interagissait avec les intégrines et les HS qui sont des 
éléments fondateurs de la cohésion cellulaire. 
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 CONCLUSION 
 
 Les études que j’ai menées autour des adénovirus font intervenir différentes approches 
que sont la biologie structurale, la biologie cellulaire et les biotechnologies. Les virus peuvent 
être vus, tour à tour, comme des agents pathogènes, des agents thérapeutiques ou des outils de 
recherche fondamentale.  
 D’un point de vue structural, il est intrigant de remarquer qu’un virus icosaèdrique 
comme l’Ad3 produit au cours de sa réplication des particules dodécaèdriques qui sont les 
« dual » géométriques du virus. Si la production de particules pseudovirales (ou VLP : virus 
like particle) est fréquemment observée, le cas du dodécaèdre est particulier. En effet, les 
bases du penton n’interagissent pas naturellement entre elles au sein du virus alors qu’elles 
forment une particule hautement symétrique dans le cas du dodécaèdre. Cet assemblage 
confère de nouvelles propriétés à ces particules qui peuvent alors interagir fortement avec les 
héparanes sulfate et entrer dans les cellules par une voie que ne partage pas le virus. 
L’internalisation de ces particules dodécaèdriques est supérieure à l’adénovirus lui-même qui 
est pourtant à ce jour, un des modèles du genre dans ce domaine.  
 D’un point de vue vectorologie, il est intéressant d’utiliser les propriétés de ces 
particules. C’est ainsi que j’ai élaboré des systèmes permettant l’apport d’ADN plasmidique 
ou de protéines dans les cellules par l’intermédiaire des dodécaèdres. Pour ce faire, j’ai utilisé 
les connaissances fondamentales des interactions base du penton – fibre ou base du penton- 
domaines WW. La vectorologie consiste non seulement à créer des véhicules transportant des 
molécules dans les cellules, mais également à contrôler l’efficacité du système après transfert. 
La régulation de l’expression du transgène par le système « Tet On »  représente le deuxième 
volet de cette science récente.  
 En poursuivant mes recherches sur les adénovirus, j’espère pouvoir non seulement 
continuer le développement de nouveaux concepts biotechnologiques mais également 
améliorer les connaissances des interactions entre ces « nano-objets » biologiques et les 
cellules.   
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It was recently shown that co-expression of adenovirus
type 3 (Ad3) penton base and fibre in the baculovirus
system produces dodecahedral particles, as does the
expression of the penton base alone. The structure of
both of these dodecahedral particles, with and without
fibre, has been determined by cryoelectron microscopy
and 3-dimensional reconstruction techniques to a reso-
lution of 25 and 20 A, respectively. The general form
of the penton base resembles that of the base protein
in the recent reconstruction of adenovirus type 2. There
is a remarkable difference in the penton base structure
with and without the fibre. The five small protuberances
on the outer surface of each base move away from the
5-fold axis by -15 A when the fibre is present. These
protuberances are of relatively low density and most
probably represent a flexible loop possibly containing
the RGD site involved in integrin binding. The fibre is
apparently bound to the outer surface of the penton
base, rather than inserted into it. The fibre is flexible
and the shaft contains two distinct globular regions
26 A in diameter. The volume of the inner cavity of
the dodecahedron is 350 + 100 nm3. This small volume
precludes the use of the inner cavity to house genetic
information for gene therapy; however, the possibility
remains of linking the gene to the dodecahedron surface
in the hope that it will be internalized with the dodeca-
hedron.
Keywords: adenovirus 3/cryo-electron microscopy/
dodecahedron/gene therapy/3-D reconstruction
Introduction
Small dodecahedral particles were seen in adenovirus
type 3 (Ad3) preparations by electron microscopy as early
as 1964 (Norrby, 1964). These dodecahedron particles are
apparently an association of 12 Ad3 pentons. Recently,
the two penton proteins base and fibre of adenovirus 3 were
co-expressed in a baculovirus system and dodecahedral
particles formed spontaneously (Fender et al., 1997). This
observation has opened up interesting possibilities not
only for gene therapy (Fender et al., 1997), but also for
the study of the penton base-fibre interaction. Infection
by adenoviruses is unusual in that two cell recognition
sites appear to be involved (Philipson et al., 1968;
Wickham et al., 1993; Cuzange et al., 1994; Henry et al.,
1994; Louis et al., 1994). The first, on the knob of the
fibre, recognizes a cell receptor. The second, probably
involving an RGD sequence on the base, takes part
both in the attachment to an integrin and in the virus
internalization. The expressed dodecahedra are made of
the viral proteins responsible for the attachment and
internalization properties of the adenovirus.
Adenoviruses are non-enveloped double-stranded DNA
viruses which are responsible for conjunctivitis, rhino-
pharyngitis and enteric disease in humans (Horwitz, 1990).
They are of considerable use as model systems in molecular
biology and have been extensively studied. The ability of
the adenovirus to infect a wide range of cell types and
their relatively large DNA capacity have made them of
great interest as viral vectors in gene therapy (Fitzgerald
et al., 1983; Yoshimura et al., 1993; Yang et al., 1995).
The adenovirus capsid is .900 A in diameter with a
fibre protein protruding outwards from each of the 12
icosahedral vertices. The virion contains at least 11 proteins
(polypeptides II-IX, IVa, ,u, terminal) whose position and
role are becoming clearer (Stewart et al., 1991, 1993).
The major capsid proteins are 240 hexons and 12 pentons
at each of the 5-fold vertices. The pentons consist of a
pentameric base to which a trimeric fibre protein is
attached non-covalently. The fibre contains three regions:
the N-terminal tail which is attached to the base, a shaft
of serotype-dependent length and a globular C-terminal
knob. The amino acid sequence of the shaft contains a
repeat motif of -15 residues (Green et al., 1983; Stouten
et al., 1992). The length of the shaft ranges from six
repeating motifs in Ad3 to 22 in Ad2 and Ad5, i.e. from
120 to 330 A in length (Signiis et al., 1985; Devaux et al.,
1987; Ruigrok et al., 1990; Chroboczek et al., 1995). The
X-ray structures of the hexon of Ad2 (Roberts et al.,
1986) and the knob of Ad5 fibre protein are known (Xia
et al., 1994).
Stewart et al. determined the structure of the native
Ad2 virion to 35 A resolution (Stewart et al., 1991) and
then to 25 A resolution (Stewart et al., 1993) using
cryo-electron microscopy and three-dimensional (3-D)
reconstruction. They visualized the overall architecture of
the virion, including the penton base and roughly the first
88 A of the fibre at the same density level. The 330 A
long fibre of Ad2 is evidently very flexible and hence
cannot all be seen in the reconstruction. By combining
the cryo-electron microscope data with the X-ray structural
data on the hexon to generate difference maps, Stewart
et al. determined the form and location of six different
proteins in the Ad2 capsid. In particular, they located four
proteins involved in cementing and stabilizing the rather
complex Ad2 capsid.
In this paper, we present the cryo-electron microscopy
and 3-D reconstructions of the dodecahedron of the
expressed Ad3 penton both with and without the fibre.
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Fig. 1. Electron micrographs of frozen-hydrated Ad3 dodecahedra
without (A) and with (B) fibre. They are the more highly defocused
image pair used in the preliminary low-resolution reconstruction. The
defocus is -.3.5 gim. (C) and (D) Enlargements of Ad3 dodecahedra
seen down the 2-, 2-, 3- and 5-fold axis (from left to right).
(C) Frozen-hydrated without fibre. (D) Negatively stained in uranyl
acetate with fibre. Scale bars = 500 A
The small diameter of the Ad3 dodecahedron, compared
with the native virion, makes the Ad3 dodecahedron a
more difficult object for structural studies than the large
native virion, but the shortness of the AD3 fibre allows
visualization of its entire length. The aims of this study
were to determine the size of the inner cavity of the
dodecahedron because of its potential use as a gene carrier,
to visualize the attachment of the fibre to the base and to
determine whether structural changes occur on binding of
the fibre to the base.
Results and discussion
Cryo-electron microscopy of Ad3 dodecahedra
The electron microscope images of frozen-hydrated Ad3
dodecahedra reveal well-formed particles with a highly
textured surface (Figure 1). The knob, and in some cases
the fibre, is visible in high-defocus images and the
orientations of some of the particles in high-symmetry
orientations can be seen directly. The use of spun columns
to remove isolated monomers was more effective in the
case of dodecahedra without fibre than with fibre. Even
after two passages through spun columns, monomers are
visible in the background of the preparation with fibre. It
appears that the equilibrium dodecahedra-penton is
reached very rapidly and that the dodecahedra without
fibre is more stable under the conditions used here.
Reconstructed density of the Ad3 dodecahedra
The isosurface representations of the reconstructed Ad3
dodecahedron with and without fibre (Figure 2A and B)
reveal essentially the same external features as for the
penton base of Ad2 (Stewart et al., 1991, 1993). We
have used this similarity to choose the hand of our
reconstructions. Stewart et al. (1991) were able to deter-
mine the absolute hand of their reconstruction using
additional information on the X-ray structure of the hexon
and electron microscope data on a capsid dissociation
fragment of Ad2, called the group of nine hexons (Layer
et al., 1969; Nermut, 1984; Furcinetti et al., 1989). The
diameter of the base at its widest point is 95 A in both
the dodecahedron with and without fibre, cf. 112 A for
the Ad2 base. The base height, including the five low-
density protuberances, is roughly 124 A, cf. 124 A for
Ad2. The penton base appears hollow inside, but there is
no evidence of a 30 A hole in the base into which the
fibre is inserted, as was previously assumed (van Oostrum
et al., 1987; Ruigrok et al., 1990; Stewart et al., 1991).
However, there is probably a communicating hole between
the hollow interior of the base and the inner cavity of the
dodecahedron. The internal cavity of the dodecaheron is
8.87 nm in diameter so the volume is 350 ± 100 nm3. In
the dodecahedron, each penton base is bound to five
neighbouring pentons, whereas in the adenovirus each
penton is bound to five peripentonal hexons. The region
of the penton involved in penton-penton and penton-
hexon binding is roughly the same [Figure 3E and F, and
Stewart et al. (1993) Figure 3C].
As for the Ad2 penton, there are five small protuberances
on each penton base. The density in these protuberances
is only 50% of the maximum density in the rest of the
base (Figure 3). The contour threshold in Figure 3C has
been chosen so that the total enclosed volume estimated for
the dodecahedron equals the estimated volume, assuming a
protein density of 1.3 g/cm3 and a mol. wt of 430 kDa
per penton. In all other isodensity figures, a slightly
lower threshold has been used to show the low-density
protuberances. An explanation for the low density is that
the protuberances represent flexible loops. It will be
recalled that the highly immunogenic loop of viral protein 1
of foot-and-mouth disease virus (FMDV) is a highly
flexible loop which contains the RGD integrin receptor
site and is seen by X-rays as a zone of low density. The
structure of the FMDV serotype C 15 residue immunogenic
loop complexed with a neutralizing Fab is known
(Verdaguer et al., 1995) and may be fitted (with room to
spare) into the low-density protuberances of the Ad3
penton base (Figure 4). Mathias et al. (1994) used structure
prediction algorithms which predicted that the conserved
RGD sequence lies at the apex of two extended ax helices.
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Fig. 2. Stereo views of the isosurface representations of the Ad3 dodecahedron with fibre, viewed down a 2-fold axis (A) and without fibre (B).
Only the front half of the dodecahedra are represented. Scale bar = 50 A.
This and the hydrophobic nature of the residues flanking
the RGD sequence argue in favour of an exposed loop
structure. Thus, it is possible that the five protuberances
on each penton base each represent a flexible loop con-
taining the RGD site.
The X-ray structure of the AdS knob (Xia et al., 1994)
fits well in size the Ad3 reconstructed density (Figure 4).
The density of the knob has been 5-fold averaged so no
detailed fit is possible. Also, the question of how the
trimeric fibre binds to the pentameric base remains open.
In reconstructing the dodecahedra, icosahedral symmetry
is necessarily imposed. There is no obvious way of
reconstructing the fibre with the correct 3-fold symmetry.
The fibre-base interaction
The fibre has a total length of 13.6 nm (Figure 3), cf.
16.0 + 1.4 nm measured in negative stain (Ruigrok et al.,
1990). The tail of the fibre is spread out over a large area
of the base at least 4.0 nm in diameter. It interacts with
the outer surface of the base rather than being inserted
into a pre-existing hole. The fibre shaft has a distinctly
beaded appearance, as has been previously observed in
shadowed images of Ad2 fibre (Ruigrok et al., 1990) and
in the first 88 A of the reconstructed Ad2 fibre (Stewart
et al., 1991). In fact, there is good agreement between the
first 88 A of the reconstructed Ad2 fibre (Stewart et al.,
1991) and the total length of the Ad3 fibre shaft (without
the knob) which consists of two globular regions roughly
26 A in diameter and separated by 35 A. A beading pattern
with a spacing of 35 A was also observed in negatively
stained isolated fibres of Ad2 (Ruigrok et al., 1990). The
relationship between this beaded fibre structure and the
six hydrophobic repeating motifs in the fibre sequence
(Kidd et al., 1993) is not evident. There are apparently
three motifs per globular (bead) domain.
The reconstructed map for the dodecahedron without
fibre showed no change after about three cycles of refine-
ment. On the contrary, the reconstructed map for the
dodecahedron with fibre did not reach a completely stable
result, particularly for the fibre density. The fibre density
was more or less smeared out, as would be expected if
the fibre was flexing from a point half way along its
length. Stewart et al. (1991) observed a similar flexing of
the Ad2 fibre, which smeared out all but the 88 A of the
fibre closest to the capsid. The final map was chosen on
the basis of highest contrast in the fibre. The final
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Fig. 3. Sections through the origin of the reconstructed density maps
of the Ad3 dodecahedra with (A) and without (B) fibre, viewed down
a 2-fold axis. A section through the penton which passes through the
low-density protuberances on the dodecahedron with fibre (C) and
without fibre (D). The hatched region in (C) represents the additional
low-density protuberance visible when the threshold is lowered. The
grid spacing is 25 A. Isosurface representations of the Ad3
dodecahedron with fibre (E) and without fibre (F) viewed down a
2-fold axis. Only the back half of the dodecahedra are represented.
The dark regions in (E) and (F) represent cut surfaces.
Scale bar = 50 A.
Fig. 4. Fit of the X-ray structures of the RGD-containing loop of
FMDV (green) and the knob of Ad5 (red) to the cryo-electron
microscope reconstructed density of Ad3 dodecahedron (blue).
Scale bar = 50 A.
30
20
reconstruction of the dodecahedron without fibre was
made from 34 particles and included information to 20 A
resolution. The particle orientations were well dispersed
over the asymmetric unit triangle (Figure 5). The phase
residual went to 90° at roughly 20 A-1 and all the inverse
eigenvalues were <0.1. The final reconstruction of the
dodecahedron with fibre was made from 26 particles and
included information to 25 A resolution. The phase residual
went to 900 at 24 A-' and all the inverse eigenvalues
were <0.1.
Effect of fibre binding on the structure of the
penton base
Comparison of the reconstructions of the dodecahedron
with and without fibre (Figure 6) reveals remarkable
differences in the five protuberances on the penton base.
They move away from the 5-fold axis by =15 A when
the fibre is bound. If the assignment of these protuberances
to a flexible loop containing the RGD integrin binding
site is correct, it follows that the observed difference
probably has a functional significance for the entry of the
adenovirus into the cell.
Also, both density maps show the penton base to be
hollow inside, but there is no hole in the base at the
interface between the base and the fibre. The fibre is
10
0
-10
-20
-30
90 85 80 75
THETA
70
Fig. 5. Refined orientation parameters, 0 and of the 26 Ad3
dodecahedron with fibre (diamonds) used in the reconstruction shown
in Figure 2A and of the 34 Ad3 dodecahedron without fibre (+) used
in the reconstruction shown in Figure 2B.
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Fig. 6. Comparison of the reconstructed Ad3 penton with (blue) and
without (magenta) fibre. For better comparison, both reconstructions
'are restricted to 25 A resolution. Side view of one penton (A) and
corresponding sections through the axis of the fibre showing the
isodensity surfaces (B and C). Top view of one penton (D) and
corresponding sections perpendicular to the axis of the fibre showing
the isodensity surface through the low-density protrusions and through
the widest section of the base (E and F). Scale bar = 50 A.
apparently bound to the outer surface of the base. Given
the change in position of the protuberances on binding of
the fibre, there is clearly some rearrangement of the base.
The difference in the maps at the inner cavity cannot be
interpreted with certainty because the maps become less
reliable towards the centre. Also, while a correction has
been made to minimize the difference in contrast transfer
function (CTF) of the images used in these two reconstruc-
tions, only reconstructions of both dodecahedra from the
same image will completely eliminate all imaging-related
differences. However, differences in the CTF will essen-
tially cause differences in the size and not in the position
of density regions. The CTF correction made to the
reconstruction without fibre, for comparison with the
reconstruction with fibre, did not change the position of
the protuberance at all.
The inner cavity of the Ad3 dodecahedron
The volume of the inner cavity of the Ad3 dodecahedron
at 350 ± 100 nm3 is small compared with the Ad2 virion,
which has a volume of ~165 000 nm3 (Stewart et al.,
1991), and contains 36 000 bp. It follows that -80 bp can
fit into the Ad3 dodecahedron assuming the same DNA
packing density. This precludes the use of the inner cavity
of the dodecahedron to house genetic information for gene
therapy; however, the possibility remains of linking the
gene to the dodecahedron surface in the hope that it will
be internalized with the dodecahedron.
Materials and methods
Growth and purification of adenovirus 3 dodecahedra
Dodecahedra were prepared after the method of Fender et al. (1997)
using recombinant baculoviruses. Immediately prior to the preparation
of frozen-hydrated specimens for electron microscopy, excess monomers
were removed by passage through a Sepharose S300 spun column
(Pharmacia).
Preparation and observation of electron microscope
specimens
Negatively stained specimens of dodecahedron were prepared in uranyl
acetate by standard techniques as described in Hewat et al. (1992a) and
observed at 80 kV in a ZEISS IOC electron microscope.
Frozen-hydrated specimens were prepared on holey carbon films as
described by Hewat et al. (1992a). A 4 gl sample of the specimen was
applied to non-glow discharged holey carbon film on a 400 mesh copper
grid, blotted with filter paper for 1-2 s and rapidly plunged into liquid
ethane at -175°C. Specimens were observed at a temperature of close
to -180°C using a Gatan 626 cryo-holder in a Phillips CM200 operating
at 200 kV. Images were obtained under low-dose conditions (<10 e/A2)
at a nominal magnification of X27 500, and 1.2 and 3.5 tm under-
focus. The images were recorded on KODAK S0163 electron image
films and developed in full-strength D19 developer for 12 min at
room temperature. The magnification was calibrated in an independent
experiment using the 23 A pitch of tobacco mosaic virus.
Image analysis
Preliminary selection of micrographs for analysis was performed as
described previously (Hewat et al., 1992b). Defocus pairs were digitized
using an Optronics microdensitometer coupled to a PC, with a step size
of 12.5 gm, which corresponds to a pixel size of 4.55 A at the specimen,
taking into account the corrected microscope magnification of X28 500.
Particle image selection and pre-processing were performed on a Silicon
Graphics computer using the Semper 6 Plus image-analysis package.
Images were re-interpolated to a pixel size of 1.5 times the original so
that 128x 128 files could be used. The selected particles were masked,
normalized by subtracting the mean and any density gradient present,
and normalizing the standard deviation. The particle images further from
focus were pre-centred by cross-correlation with the radially averaged
summation of several particle images. The particle images closer to
focus had too little contrast for direct particle selection and centring.
They were therefore selected and centred by cross-correlation with their
high-defocus image pair.
Further image analysis was performed on a DEC Alpha using modified
versions of the MRC icosahedral programs and model-based programs
(Baker and Cheng, 1996) supplied by S.Fuller (Fuller et al., 1996). The
dodecahedron with fibre was the first to be analysed and the method of
common lines (Crowther, 1971) was used for the determination of
particle origins and orientations for the high-defocus image only. The
model-based programs were used for all subsequent orientation and
origin determinations. The reconstructed dodecahedron with fibre was
used as a starting model for the analysis of the dodecahedron without
fibre. In each case, the cycle of refinement consisted of: (i) determining
the origins and orientations for the high-defocus image using the model-
based approach; (ii) using the origins and orientations thus obtained to
refine the low-defocus image using cross common lines (Simplex
program); (iii) reconstructing an improved map from the low-defocus
image which is used as a model for determining the origins and
orientations for the high-defocus image in step (i). Using the low-
defocus reconstruction as a model for directly refining the low-defocus
data proved to be unsatisfactory. For the dodecahedron with fibre, the
fibre density was not included in the model for orientation determination
using the model-based programs, but it was included in the cross
common lines refinement. For the final reconstruction in each case
(Figure 2A and B), only particles from one negative were included and
no correction for the CTF was made.
The reconstructions of the dodecahedra with and without fibre were
made from micrographs with different defocus and hence different CTFs.
Thus, in order better to compare the density maps, the average radial
amplitude of the particle Fourier transforms for the reconstruction of
dodecahedron without fibre were forced to that of the dodecahedron
with fibre and the density map was recalculated to 25 A resolution. The
fibre density was not included in the comparison and the average radial
density was slightly smoothed. This was not a complete CTF correction,
just a minimal correction to bring the CTF of one reconstruction into
line with another.
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Isosurface representations of the reconstructed density were visualized
using Explorer on an SGI.
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Abstract
Background The ‘‘tet switch system’’ was originally described under the
tet-off configuration with its components encoded by two separate plasmids.
Since then, many virus vectors harbouring tet-off components have been
designed and their regulation by tetracycline is widely reported. On the
contrary, tet-on regulation by viral vectors is poorly documented.
Methods E1-E4-defective adenoviruses harbouring either rtTA or the
luciferase gene under a minimal inducible promoter (TK* or CMV*) or
both components in a single genome were produced. Using either a double
or a single virus strategy, induction of luciferase expression was investigated
in various cell lines, in mice muscle and in rat brain.
Results Over 400-fold induction can be reached with PC12 and NHA
cells using a double virus strategy. Comparison of the background activity
of different minimal inducible promoters revealed a significant difference
between TK* and CMV* promoters both with the cell culture and the in
vivo experiments. Interestingly, a single virus strategy permitted an induction
exceeding 600-fold with human astrocyte primary cells. Moreover, the E1-
E4-defective adenovirus-mediated tet-on system can be quickly switched
off and turned back on again. Depending on the cell line, the level of
rtTA derived by the single virus strategy differed, resulting in different
efficiencies. Experiments performed in rat striatum and mouse muscle
confirmed the importance of rtTA expression and minimal promoter used
on both doxycycline-independent expression and induction efficiency. Under
appropriated rtTA expression, a 32-fold induction is observed in mouse
muscle.
Conclusions In the recombinant adenovirus context, the CMV* but not
the TK* promoter is sensitive to transcriptional interference resulting in
high doxycycline-independent expression. By paying attention to the rtTA
expression, moderate and high induction can be obtained in vivo and in vitro
accordingly. Copyright  2002 John Wiley & Sons, Ltd.
Keywords E1-E4-defective adenovirus vectors; tet-on regulation; rtTA synthesis
Introduction
Gene therapy is a promising approach for the treatment of either innate
or acquired diseases and represents a major challenge for the new century.
Among vectors that are used to transfer DNA into cells, adenoviruses
Copyright  2002 John Wiley & Sons, Ltd.
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have several advantages, particularly in applications
concerning the central nervous system (CNS). Indeed,
adenoviruses can infect dividing as well as resting cells,
and gene transfer into the brain has been widely reported.
Moreover, adenovirus vectors transfect glial and neuronal
cells at the injection site and can also be transported
in a retrograde manner via axons to a projecting brain
area far away from this site [1]. This latter property
could be very useful for Parkinson’s disease (PD), as virus
injection into the striatum results in transgene expression
in both striatum and substantia nigra. The usefulness
of adenovirus vectors for PD has been demonstrated
using GDNF, a neurotrophic factor that prevents the
death of nigro-striatal dopaminergic neurons [2]. The
major limiting factor with first-generation adenovirus
vectors (E1-defective) is their immunogenicity that
triggers both inflammation and a cytotoxic response
against the transfected cell. It has been suggested that
this phenomenon leads in a few days to transgene
extinction due to cell death and the negative effects
of several cytokines on viral promoters [3]. As viral
proteins were nevertheless expressed in infected cells
with E1-defective adenovirus [4], deletion from the
adenovirus genome of other regions involved in the
replication process has been proposed. The E4 region
is crucial for virus replication and E1-E4-defective
adenoviruses were generated in a transcomplementing
cell line [5]. These recombinant adenoviruses were tested
for gene transfer in murine immunocompetent liver
and showed a prolonged transgene expression due to
lower viral protein expression and the absence of RCA
during production [6–8]. Interestingly, E1-E4-defective
adenoviruses have also been shown to be efficient for
gene therapy of brain diseases, as stereotaxic injection
in rat striatum was associated with an attenuated
immune response and prolonged transgene expression
(J. F. Dedieu, pers. commun.).
A very important feature of efficient gene therapy is the
control of transgene expression. If the use of tissue-specific
promoters permits the targeting of gene expression,
transgene regulation can only be obtained with artificial
systems. Among these, a tetracycline-derived, so-called
‘‘tet system’’, is widely used. This system exists in two
opposite configurations. The first, called ‘‘tet off’’, leads
to gene repression when tetracycline is added [9]. The
second, called ‘‘tet on’’, acts in the opposite way, since
tetracycline addition triggers gene expression [10]. Both
configurations are based on two separate elements:
(i) a tetracycline-responsive transactivator made from the
fusion protein between the tetracycline bacterial repressor
and the herpes virus VP16 transactivator (tTA or rtTA),
and (ii) a cluster of seven repeats of the tetracycline
operator (Op7) upstream from a minimal promoter
driving the targeted gene. Recently, an improved tet-
on system, in which a repressor element decreased the
background level in the absence of an inducer, has been
developed. In the absence of tetracycline, the silencer
domain of the KRAB protein fused with the tetracycline
repressor (tetR) binds the operator and decreases the
background activity of the minimal promoter. Tetracycline
addition triggers the release of this silencer protein
from operator sequences and permits the binding of
the rtTA transactivator, resulting in gene expression
activation [11].
Materials and methods
Cell lines
PC12 cells were maintained in RPMI 1640 medium
supplemented with 10% FCS and 5% horse serum. Normal
human astrocytes (NHA) were provided from Clonetics
and cultured in astrocyte growth medium following the
supplier’s protocol.
Construction of transcription units
Schuttle plasmids were generated by cloning transcription
units in pXL3234 (KnR plasmid) containing a multiple
cloning site between the left adenovirus ITR and
the pIX gene [12]. Minimal Op7.TK* promoter was
excised from pUHD10.7 (kindly given by Dr Bujard) by
SmaI-BglII digestion and ligated in the corresponding
sites of the luciferase-encoding plasmid pGl3 basic
(Promega). The Op7.TK*-luc transcription unit was
recovered by XmaI-BamHI digestion and ligated in AgeI-
BglII digested pXL3234 to generate the pXL3529 schuttle
plasmid. Minimal Op7.CMV* promoter was excised from
pUHD10.3 (kindly given by Dr Bujard) by XhoI-BglII
and ligated in the corresponding sites of pGl3 basic.
The Op7.CMV*-luc transcription unit was recovered by
XmaI-BamHI digestion and ligated in AgeI-BglII digested
pXL3234 to generate the pXL3530 schuttle plasmid.
The RSV-rtTA unit was constructed by the ligation of
the NheI-ScaI fragment of the rtTA encoding pXL3357
(Aventis) in corresponding sites of pXL3507 (Aventis),
thus generating the pXL3531 schuttle plasmid. For the
single Ad.TK*luc construction, the RSV-rtTA-luc-Op7.TK*
unit was generated by the ligation of the NotI-SalI
fragment of pXL3531 in the corresponding sites of
pXL3529 thus generating the pXL3532 schuttle plasmid.
For the single Ad-CMV*luc, the tetR-Krab was recovered
by BamHI-StuI digestion of pBabe [11] and ligated in
the corresponding sites of pRL.PGK (Aventis). Recovery
of the tetR.KRAB-IRES-rtTA-pPGK unit was obtained by
partial XbaI digestion. This fragment cloned in pXL3589
(Aventis) permitted recombination in the E3 region of the
adenoviral backbone.
Production of recombinant adenovirus
(RAds)
Recombinant adenoviruses were produced by ‘‘EDRAG’’
double recombination in E. coli [12]. Briefly, shuttle plas-
mids (KnR) containing the transcription units described
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
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above were transfected in an E. coli strain containing a
plasmid (tetR) harbouring the whole adenovirus genome
(except for the E1 region which was replaced with β-
gal and the E3 and E4 regions which were deleted). After
tetracycline and kanamycine selection, the presence of the
transgene in white colonies was determined by restriction
analysis. PacI sequences present at both extremities permit
lineation of the recombinant E1-E4-deleted adenovirus
genome; E1-E4-defective adenoviruses were produced by
transfecting the E1-E4 transcomplementing IGRP2 cells
as described previously [5]. Viral particles were purified
by CsCl banding and titration was determined by high-
performance liquid chromatography (HPLC) [13]. All the
experiments were performed using a unique viral stock
preparation.
In vitro RAd infection
One day before infection, 24-well plates were seeded with
105 PC12 cells or 5 × 104 normal human astrocyte cells
(NHAs).
Double virus strategy
Cells were infected with either Ad.TK*-luc or Ad.CMV*-
luc at 1000 vp/cell and co-infected with different
amounts of Ad.RSV-rtTA as indicated. Two days after
infection, luciferase expression in the presence of 1 µg/ml
doxycycline (Sigma) was determined.
Single virus strategy
Cells were infected at 1000 vp/cell with single Ad-
TK*luc. rtTA addition was performed by co-infecting
with increasing amounts of Ad.RSV-rtTA as indicated.
Reversibility of induction was monitored for 3 days with
PC12 for 1 µg/ml doxycycline removed on day 1 and re-
introduced on day 2. For NHA cells, luciferase expression
was monitored for 8 days. Doxycycline (1 µg/ml) was
added for the first 2 days, removed for the next 2 days,
re-introduced on day 4 and removed again on day 6.
Luciferase expression was determined in 10 µl of the
100 µl cell lysate (Promega cell lysis buffer) for 10 s in a
Berthold luminometer. The induction rate was calculated
by dividing the level of luciferase expression by the level
of background expression for each condition tested.
In vivo RAd infection
Young adult female Sprague-Dawley rats (Charles River
Breeding Laboratories) were stereotaxically injected in
the striatum (A = +1.2; L = +2.5) at three different
points (V = −5; −4.6 and −4.2) with 109 vp per injection
point (0.25 µl/min). Doxycycline (Sigma) was added at
1 mg/ml in drinking water. On the day indicated, the
rats were sacrificed and, after dissection, the striata were
lysed in 200 µl of cell lysis buffer (Promega). Luciferase
expression was determined in a volume of 20 µl for 10 s in
a Berthold luminometer. Results are given as an average
for a group of four animals and the error bar represents
the 95% confidence interval.
Single Ad.CMV*-luc was injected into mice Tibialis
cranialiswith increasing amounts of Ad.CMV-rtTA. On day
0, the mice were anesthetised with injections of xylazine
(3.6 mg/kg) and ketamine (120 mg/kg). Tibialis cranialis
muscle from the right leg was injected with 1 × 109 viral
particles of single Ad.CMV*luc alone in 30 µl of 20 mM
tris buffer at pH 8.4 in 10% glycerol or in association with
0.5 × 109; 1 × 109; 2 × 109; or 5 × 109 viral particles
of Ad.CMV-rtTA. Doxycycline (Sigma) was added at
1 mg/ml in drinking water. For the control, non-inducible
particles of adenovirus encoding luciferase driven by the
whole CMV promoter were injected alone. Four days
after the virus injection, animals were sacrificed. Muscles
were harvested in 1 ml lysis buffer (Promega) containing
protease inhibitors (Boehringer) and homogenised with
a Fastprep Bio101 apparatus (Savant) and centrifuged
for 10 min at 9000 g at 4 ◦C. Luciferase activity was
determined in a Berthold luminometer in 10 µl of
supernatant. Results are given as average of RLU/total
muscle for group of six mice and the error bar represents
the 95% confidence interval.
Results
Several E1-E4-deleted adenovirus vectors harbouring
the luciferase gene under the control of tetracycline-
inducible promoter and/or rtTA tetracycline-sensitive
transactivator have been constructed (Figure 1). Both the
double virus strategy and the single virus strategy were
tested.
Double virus strategy
The double virus strategy consists of using one virus
encoding the rtTA under the control of an RSV promoter
(Ad.RSV-rtTA) and a second virus encoding luciferase
under the control of an inducible TK* or CMV* promoter
(Ad.TK*luc and Ad.CMV*luc; Figure 1). An optimum
ratio between transactivator virus and inducible virus
was determined using this strategy. This parameter was
assessed on PC12 cells by adding a constant amount
of Ad.TK*luc or Ad.CMV*luc and a varying amount of
Ad.RSV-rtTA. The results clearly showed that rtTA was
the limiting factor for luciferase induction on PC12, as
a 400-fold induction was reached when rtTA-encoding
virus was added in 10-fold excess (Figure 2a). Moreover,
on PC12 cells, luciferase background expression was
two orders of magnitude less when the TK* promoter
was used instead of the CMV* promoter. More than
three orders of magnitude in luciferase expression
between uninduced Ad.TK*luc and induced Ad.CMV*luc
was obtained when these viruses were added with an
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
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Double virus strategy
Single virus strategy
Ad.CMV*-luc
Ad.CMV-rtTA
E1-E4 deleted regulatable adenoviruses
Single
Ad.TK*luc ITR rtTA pARSV luc TK* ITR
ITR pA CMV* pIXlucSingleAd.CMV*luc tetR-KRABpA IRES rtTA pPGK ITR
ITR pA CMV* pIXluc ITR
ITR pA pIXrtTACMV ITR
Ad.RSV-rtTA ITR pA pIXrtTARSV ITR
Ad.TK*-luc ITR pA TK* pIXluc ITR
Figure 1. Schematic representation of regulatable E1-E4-deleted adenovirus vectors. Transgenes were inserted into the E1 region
between the left ITR and the pIX protein of the adenovirus and into the E3 region for the vector harbouring the KRAB system [11].
Arrows indicate the direction of translation. (pA: SV40 polyadenylation sequence; CMV* and TK*: minimal CMV and TK promoter
under the control of seven tetracycline operator repeats; IRES: internal ribosome entry site of the encephalomyocarditis virus;
pPGK: phosphoglycerokinase promoter; ITR: inverted terminal repeat; luc: luciferase gene)
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Figure 2. Comparison of TK* and CMV* promoters. (a) PC12 cells were infected with either Ad.TK*-luc or Ad.CMV*-luc at 1000
vp/cell and co-infected with different amounts of Ad.RSV-rtTA as indicated. Two days after infection, luciferase expression was
determined and the induction rate in the presence of doxycycline (1 µg/ml) is shown. (b) Comparison of the level of luciferase
expression on PC12 cells co-infected with Ad.TK*-luc + Ad.RSV-rtTA or Ad.CMV*-luc + Ad-RSV-rtTA (1000 vp/cell for each virus) in
the presence or absence of inducer. (c) Luciferase background expression of Ad.TK*-luc and Ad.CMV*-luc (3 × 109 vp) co-injected
with equimolar amounts of Ad.RSV-rtA in rat striatum. Seven days after injection, luciferase expression in the absence of inducer
was determined in rat striata for a group of four animals
equimolar amount of Ad.RSV-rtTA (Figure 2b). Such
results are very interesting especially for ex vivo cell
engineering before transplantation. Features of the TK*
and CMV* inducible promoters were also investigated in
vivo and differences in background expression by these
promoters were confirmed in rat striatum. TK* promoter
exhibited a very low level of background expression
whereas CMV* promoter triggered a 50-fold increase in
leakage of luciferase expression (Figure 2c). This leakage
was not due to a non-specific binding of rtTA to the
minimal promoter in the absence of inducer, as the
background level of Ad.TK*luc or Ad.CMV*luc virus alone
was the same in the absence of the rtTA-encoding virus
(data not shown).
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
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Single virus strategy
For clinical trials, a single adenovirus harbouring both
rtTA and an inducible gene would be of great interest. Tet-
regulated gene expression has been successfully employed
in many mammalian cell cultures and transgenic
mice. Gene therapy applications, especially applications
concerning the regulated expression of neurotrophic
factors, potentially toxic when expressed at high dose,
are hampered by the residual basal activity in the non-
induced state. For this purpose we present two approaches
in which the expression of the transgene in non-induced
conditions is maximally minimised. The luciferase gene
was chosen as a reporter gene in this study for easy
quantitative analysis of the promoter regulation studies.
In the first approach, the minimal TK* promoter was
inserted downstream of the seven TetO sequences and
upstream of the reporter gene. As shown by the two
virus strategy experiments, the luciferase background
expression was much lower with this promoter than with
a CMV* promoter. The rtTA and luciferase genes were
cloned in a ‘‘head-to-head’’ configuration (single Ad.TK*-
luc; Figure 1) with the minimal promoter away from the
ITR region to avoid its transactivating effect [14].
In a second approach, activation by rtTA is combined
with repression in the non-induced state. For this purpose
the transactivator rtTA and the repressor are expressed
in the same cell on the same virus but are controlled
by the inducer in opposite ways. Indeed, the chimeric
repressor TetR-Krab [11] binds in the absence of inducer
to the tetracycline operator via its TetR domain and
silences the downstream minimal promoter via the
silencer Krab. Added inducer triggers both repressor
withdrawal from the operator and activation of the
promoter by binding of the rtTA to the operator. The
TetR-Krab system was added in a bicistronic configuration
with rtTA. This system, where both transregulators are
co-expressed as monocistronic constructs, was proved
to be efficient in mammalian cells where the basal
activity was significantly repressed by TetR-Krab without
significant reduction in the luciferase expression level
in the induced state [15]. The TetR-Krab transcriptional
unit is placed in the E3 region of the recombinant
adenovirus (Figure 1) far away from the operators
sequences in order to avoid silencing of its own promoter,
as repression by TetR-Krab is observable even when tet
operator sequences are placed more than 3 kb away
from the transcriptional initiation site of a eukaryotic
promoter [16]. In the single virus configuration, several
parameters could influence the efficiency of induction.
Among these the choice of the promoter encoding the
transactivator is critical. The RSV and the PGK promoters
were chosen since they permitted long-term expression
of transgene in E1-E4-defective adenovirus (J. F. Dedieu,
pers. commun.).
An inducer range assay showed that doxycycline at
1 µg/ml seemed to be the optimum concentration for
induction of single Ad.TK*luc on every cell line tested,
although high concentrations of doxycycline, unlike
minocycline, exhibited toxicity (data not shown). We
have determined the effect of the addition of Ad.RSV-
rtTA to the single Ad.TK*luc (Figure 3). With PC12 cells,
the addition of Ad.RSV-rtTA did not significantly increase
single Ad.TK*luc induction (around 15-fold for the single
virus alone). In contrast, with human astrocytes (NHAs),
the addition of Ad.RSV-rtTA to the single Ad.TK*luc virus
clearly changed the induction efficiency. In these cells, the
single virus alone permitted a 80-fold induction whereas
the addition of Ad.RSV-rtTA increased the induction rate
in a vp-dependent manner. When Ad.RSV-rtTA was used
in 10-fold excess, an induction rate as high as 620-
fold was reached representing an 8-fold increase in
protein expression when compared with that obtained
with single Ad.TK*luc alone. These data indicated that
single Ad.TK*luc was designed in a quasi optimal manner
for PC12 cells but the expression of rtTA by this virus in
human astrocytes was not sufficient to reach full induction
of the minimal promoter. Experiments performed on other
primary cell lines (HUVEC, SMC) exhibited the same
feature (data not shown). Interestingly, when rtTA was
expressed in excess, Ad.TK*-luc and single Ad-TK*luc
plateau at a comparable level with both NHA and PC12
cells. The weak and cell-specific difference in doxycycline-
independent luciferase activity observed between Ad.TK*-
luc and single Ad.TK*-luc is not dependent on rtTA
synthesis.
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Figure 3. Determination of rtTA expression with PC12 and human astrocyte cells. Cells were infected with 1000 vp/cell of
either Ad.TK*-luc or single Ad.TK*luc and co-infected with increasing amounts of Ad.RSV-rtTA. One day after infection, luciferase
expression was determined and the induction rate was calculated by dividing the level of luciferase expression in the presence (+)
of 1 µg/ml doxycycline by the expression level in the absence (−) of inducer
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Reversibility of induction
One important advantage of the tet switch system is
its reversibility. The time taken for induction, extinction
and re-induction of our regulatable adenovirus was
determined by adding or removing the inducer at different
stages for different periods of time. Luciferase expression
was tested daily with PC12 and NHA cells (Figure 4).
The time of induction and extinction differed by 1–2 days
between PC12-transformed cells and NHA primary cells
infected with single Ad.TK*-luc, but, in both cases, the
system was completely turned on and off. The longer
period of time observed for NHAs to return to background
levels could be due to the slower metabolism of these
cells, increasing the half-life of luciferase.
In vivo experiments
Recombinant adenoviruses encoding neurotrophic factors
have been described as good candidates for Parkinson’s
disease treatment [2]. To avoid side effects resulting
from an over-expression of the neurotrophic factor in
animals, a tight regulation of transgene expression is
required. In order to determine if the E1-E4-defective
adenovirus-mediated tet-on system can be used in the
striatum, the single Ad.TK*luc (Figure 5a) and the single
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Figure 4. Reversibility of induction of single Ad.TK*luc. PC12
or human astrocyte cells were infected with 1000 vp/cell of
single Ad.TK*luc. For PC12 cells, luciferase expression was
monitored for 3 days in the absence of inducer (empty triangles),
in the presence of 1 µg/ml doxycycline (empty squares) and for
1 µg/ml doxycycline removed on day 1 and re-introduced on
day 2 (dashed line). For NHA cells, luciferase expression was
monitored for 8 days. Doxycycline (1 µg/ml) was added and
withdrawn as indicated by the arrows. The induction rate is
calculated by dividing the level of luciferase expression by the
level of background expression of the virus in the absence of
inducer
Ad.CMV*-luc (Figure 5b) were stereotaxically injected
into rat brain. High background expression, but weak
induction, was observed in rat striatum with single
Ad.CMV*-luc suggesting that both rtTA and TetR-KRAB
were not sufficiently expressed. With the single Ad.TK*-
luc, the background expression in the absence of inducer
was very low and a 8-fold induction was observed at
day 4 in the presence of inducer. The level of luciferase
expression under induction slightly decreased at day 8
whereas background expression increased. The limited
induction rate observed in this experiment could be due
to an insufficient level of rtTA synthesis in vivo or to an
insufficient doxycycline concentration in the brain.
Experiments performed in mice muscle permitted the
investigation of the role of rtTA. As injection of the single
Ad.TK*-luc yielded no detectable luciferase expression
(data not shown), we investigated the behaviour of
single Ad.CMV*luc. In mice muscle (Figure 5c), the single
Ad.CMV*luc alone was weakly inducible (4×) whereas
the addition of small amounts of Ad.CMV-rtTA (ratio
1 : 2) led to a 32-fold induction of luciferase expression in
the presence of inducer. Interestingly, under doxycycline
induction, the intramuscular level of luciferase expression
reached a plateau whatever the amount of Ad.CMV-rtTA
virus co-injected with inducible virus. This result showed
that rtTA expression at a 1 : 2 ratio (Ad.CMV-rtTA/single
Ad.CMV*luc) was enough to saturate the tet-on system.
The increased background level demonstrated that over-
expression of the transactivator triggered promoter
activation in the absence of inducer and that tetR-KRAB
was not sufficiently expressed to thwart this phenomenon.
Under induction, luciferase expression at a 1 : 2 ratio was
comparable to that obtained by an adenovirus vector
encoding luciferase under a whole CMV promoter.
Discussion
The six different E1-E4-deleted adenovirus vectors
described in this study have highlighted the respective
roles of different components involved in the tet-on
regulation process. We have described the feature of a
tet-on system in adenovirus vectors, characterised the in
vitro and in vivo background expression according to the
minimal promoter used, and pointed out the effect of rtTA
synthesis on induction efficiency.
The choice of inducible minimal promoter is critical and
its use will depend on the applications required. It has
been reported by the Bujard laboratory that CMV* but
not TK* promoter was very sensitive to transcriptional
interference. The difference in doxycycline-independent
luciferase activity between the TK* and the CMV*
promoter in our study is likely due to the sensitivity of the
CMV* promoter to transcriptional interference in the E1-
E4 adenovirus landscape. The CMV* promoter triggering
a high background could be useful when constitutive
transgene expression is needed and the inducer could
be added only when over-expression is desired. This
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
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Figure 5. In vivo experiments. (a) Single Ad.TK*luc (3 × 109 vp) was stereotaxically injected into the striatum of Sprague-Dawley
rats. The animals (group of four) received either no inducer or 1 mg/ml doxycycline in their drinking water. On day 4 or 8, the rats
were sacrificed and luciferase expression was determined. (b) Ad.CMV*-luc or single Ad.CMV*-luc (3× 109 vp) was stereotaxically
injected into the striatum of Sprague-Dawley rats. The animals (group of four) received either no inducer or 1 mg/ml doxycycline
in their drinking water. On day 4, the rats were sacrificed and luciferase expression was determined. (c) Single Ad.CMV*luc
was injected in mice Tibialis cranialis with increasing amounts of Ad.CMV-rtTA virus. The animals received either no inducer or
1 mg/ml doxycycline in their drinking water. For the control, non-inducible particles of adenovirus encoding luciferase driven by
the whole CMV promoter were injected alone. Four days after the virus injection, animals were sacrificed and luciferase activity
was determined. Results are given as mean (group of six mice) and error bar represents the 95% confidence interval
approach could be used for secreted proteins such as
human antitrypsin or erythropoietin [17]. On the other
hand, the non-leaky TK* promoter could be used for toxic
protein expression (e.g apoptogenic proteins). Indeed, the
viral production process in the absence of inducer would
result in high vector yields and, after injection, the toxic
protein would be induced by addition of tetracycline.
Regulation of transgene expression by the tet switch
system has already been described in a single genome
with E1-defective adenoviruses, but only under the tet-off
configuration [18–21]. Moreover, previous studies have
already demonstrated the usefulness of tet-off tyrosine
hydroxylase regulatable adenovirus vectors either in ex
vivo strategies or after direct injection of the virus into the
brain [18,20]. For clinical trials, the tet-on system may be
more suitable as the transgene expression can be switched
off just by stopping inducer addition, thus making this
system safer. It has recently been reported that the
Ad-mediated tet-on system is ‘‘functionally inferior’’ to
the Ad tet-off system [22,23]. Nevertheless, we have
designed a single adenovirus mediated tet-on system,
optimal for specific cell lines. In other cell lines such
as human astrocyte cells, this single tet-on mediated
adenovirus alone permitted a 80-fold induction, whereas
a more than 600-fold induction was reached when
rtTA-encoding adenoviruses were added. This observation
indicated that rtTA synthesis differs according to the
cell lines and that the choice of the promoter used to
encode the transactivator is critical. Recently, it has been
demonstrated that a single Ad-mediated tet-off system
expressing the tTA under the control of cell-type-specific
promoters can be used in vivo [24]. Glial fibrillary acidic
protein (GFAP) and neuronal specific enolase (NSE)
promoters have permitted the expression and regulation
of the transgene only in restricted brain cells. Even if
the strength of these promoters is not as high as viral
promoters, we hypothesise that this strategy could be
adapted to an Ad-mediated tet-on system.
rtTA is less sensitive to doxycycline than tTA and
inducer concentration could be a limit for tet-on
regulation, especially in the brain. Nevertheless, it has
been previously reported that both tet-on and tet-
off configurations permitted the switching of transgene
expression in the hippocampus [23]. Moreover, since our
work was completed, a new generation of rtTAs more
sensitive to doxycycline has appeared, thus creating an
opportunity to overcome this potential limitation [25].
Using this novel generation of rtTAs, we can speculate that
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
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the 600-fold induction we obtained in human astrocyte
cells and the 32-fold induction we observed in mice
muscle could be improved and make possible the use
in gene therapy trials of a single adenovirus-mediated
tet-on system.
Acknowledgements
We warmly thank Badia Lamrihi-Kajout for technical assistance
with the animal work and Romain Vives for his help in the
redaction of this manuscript.
References
1. Bohn MC, Choi-Lundberg DL, Davidson BL, et al. Adenovirus-
mediated transgene expression in nonhuman primate brain.
Hum Gene Ther 1999; 10: 1175–1184.
2. Choi-Lundberg DL, Lin Q, Chang YN, et al. Dopaminergic
neurons protected from degeneration by GDNF gene therapy.
Science 1997; 275: 838–841.
3. Qin L, Ding Y, Pahud DR, et al. Adenovirus-mediated gene
transfer of viral interleukin-10 inhibits the immune response
to both alloantigen and adenoviral antigen. Hum Gene Ther
1997; 8: 1365–1374.
4. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral
antigens limits E1-deleted adenoviruses for gene therapy. Proc
Natl Acad Sci 1994; 91: 4407–4411.
5. Yeh P, Dedieu JF, Orsini C, et al. Efficient dual transcomplemen-
tation of adenovirus E1 and E4 regions from a 293-derived cell
line expressing a minimal E4 functional unit. J Virol 1996; 70:
559–565.
6. Wang Q, Greenburg G, Bunch D, et al. Persistent transgene
expression in mouse liver following in vivo gene transfer with
a delta E1/delta E4 adenovirus vector. Gene Ther 1997; 4:
393–400.
7. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with
E1 and E4 deletions for liver-directed gene therapy. J Virol 1996;
70: 8934–8943.
8. Dedieu JF, Vigne E, Mafhouz I, et al. Long term delivery into
the livers of immunocompetent mice with E1/E4 defective
adenoviruses. J Virol 1997; 71: 4626–4637.
9. Gossen M, Bujard H. Tight control of gene expression in
mammalian cells by tetracycline-responsive promoters. Proc Natl
Acad Sci 1992; 89: 5547–5551.
10. Gossen M, Freundlieb S, Bender G, et al. Transcriptional
activation by tetracyclines in mammalian cells. Science 1995;
268: 1766–1769.
11. Rossi F, Guicherit O, Spicher A, et al. Tetracycline-regulatable
factors with distinct dimerization domains allow reversible
growth inhibition by p16. Nat Med 1999; 20: 389–393.
12. Crouzet J, Naudin L, Orsini C, et al. Recombinational
construction in E. coli of infectious adenoviral genomes. Proc
Natl Acad Sci 1997; 94: 1414–1419.
13. Blanche F, Cameron B, Barbot A, et al. An improved anion-
exchange HPLC method for the detection and purification of
adenoviral particles. Gene Ther 2000; 7: 1055–1062.
14. Steinwaerder DS, Lieber A. Insulation from viral transcriptional
regulatory elements improves inducible transgene expression
from adenovirus vectors in vitro and in vivo. Gene Ther 2000; 7:
556–567.
15. Forster K, Helbl V, Lederer T, et al. Tetracycline-inducible
expression systems with reduced basal activity in mammalian
cells. Nucleic Acids Res 1999; 27: 708–710.
16. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible
silencing of eukaryotic promoters. Mol Cell Biol 1995; 15:
1907–1914.
17. Bohl D, Naffakh N, Heard JM. Long-term control of
erythropoietin secretion by doxycycline in mice transplanted
with engineered primary myoblasts. Nat Med 1997; 3: 299–305.
18. Corti O, Horellou P, Colin P, et al. Intracerebral tetracycline-
dependent regulation of gene expression in grafts of neural
precursors. Neuroreport 1996; 7: 1655–1659.
19. Ridet JL, Corti O, Pencalet P, et al. Toward autologous ex vivo
gene therapy for the central nervous system with human adult
astrocytes. Hum Gene Ther 1999; 10: 271–280.
20. Corti O, Sanchez-Capelo A, Colin P, et al. Long-term
doxycycline-controlled expression of human tyrosine
hydroxylase after direct adenovirus-mediated gene transfer to a
rat model of Parkinson’s disease. Proc Natl Acad Sci 1999; 96:
12 120–12 125.
21. Hu SX, Ji W, Zhou Y, et al. Development of an adenovirus vector
with tetracycline-regulatable human tumor necrosis factor alpha
gene expression. Cancer Res 1997; 57: 3339–3343.
22. Mizuguchi H, Hayakawa T. Characteristics of adenovirus-
mediated tetracycline-controllable expression system. Biochim
Biophys Acta 2001; 1568: 21–29.
23. Harding TC, Geddes BJ, Murphy D, et al. Switching transgene
expression in the brain using an adenoviral tetracycline-
regulatable system. Nat Biotechnol 1998; 6: 553–555.
24. Smith-Arica JR, Morelli AE, Larregina AT, et al. Cell-type-
specific and regulatable transgenesis in the adult brain:
adenovirus-encoded combined transcriptional targeting and
inducible transgene expression. Mol Ther 2000; 6: 579–587.
25. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence
space for tetracycline-dependent transcriptional activators:
novel mutations yield expanded range and sensitivity. Proc Natl
Acad Sci 2000; 14: 7963–7968.
Copyright  2002 John Wiley & Sons, Ltd. J Gene Med 2002; 4: 668–675.
JOURNAL OF VIROLOGY, Apr. 2003, p. 4960–4964 Vol. 77, No. 8
0022-538X/03/$08.000 DOI: 10.1128/JVI.77.8.4960–4964.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
NOTES
Adenovirus Dodecahedron Allows Large Multimeric Protein
Transduction in Human Cells
P. Fender,1* G. Schoehn,1,2 J. Foucaud-Gamen,3 E. Gout,1 A. Garcel,1 E. Drouet,3
and J. Chroboczek1
Institut de Biologie Structurale1 and Laboratoire Europe´en de Biologie Mole´culaire,2 38027 Grenoble, and
Faculte´ de Pharmacie, Domaine de la Merci, 38 La Tronche,3 France
Received 11 November 2002/Accepted 14 January 2003
Adenovirus dodecahedron is a virus-like particle composed of only two viral proteins of human adenovirus
serotype 3 that are responsible for virus attachment and internalization. We show here that this dodecameric
particle, devoid of genetic information, efficiently penetrates human cells and can deliver large multimeric
proteins such as immunoglobulins.
Human adenoviruses (Ads) are nonenveloped viruses re-
sponsible for respiratory, ocular, and enteric infections. Their
icosahedral capsid, containing the 36-kpb double-stranded
DNA genome, is composed of three major proteins: the hexon,
the penton (Pt) base, and the fiber. At the 12 vertices of the
capsid, the protruding fiber is noncovalently attached to the Pt
base, thus forming the Pt complex. It has been reported that
the fiber interacts with a high affinity with a primary receptor
and that the subsequent interaction of the Pt base RGD motif
with cellular integrins triggers endocytosis (17). A 42-kDa pro-
tein, called the coxsackievirus and Ad receptor (CAR), is rec-
ognized by at least one serotype of each of the six subgroups of
Ad except for the serotypes belonging to subgroup B (i.e.,
Ad3) (1, 12). Even though that Ad capsid is composed of at
least 11 proteins, it has been shown that Pt alone can penetrate
into human cell lines, thus making of this complex a potential
vector for DNA delivery (2, 5, 7, 8, 16). Remarkably, Ad3 but
not Ad5 Pt expressed in the baculovirus system led to the
formation of symmetric complexes of 12 Pts called dodecahe-
dron (Dd). We have previously shown that the non-CAR-
binding Ad3-Dd can be used as a gene transfer vector (2), and
we show here that this virus-like particle is also able to trans-
duce large multimeric proteins into human cells.
Dd internalization. Coexpression of Ad3 Pt base and fiber
proteins in the baculovirus system led to the formation of a
symmetric dodecameric particle (2, 14), Pt-Dd (Fig. 1a). This
complex results from the interaction between the pentameric
base proteins, as attested by the Dd formation upon expression
of base proteins alone (Bs-Dd; Fig. 1a). The respective roles of
the fiber and the Pt base protein in Ad3 Dd entry into HeLa
cells was assessed by immunofluorescence. HeLa cells grown in
a 96-multiwell plate (Falcon) at 2  104 cells per well were
incubated in 100 l of phosphate-buffered saline (PBS) with a
range of Dd concentrations. After 1 h at 37°C, cells were
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FIG. 1. Dd structure and function. (a) Negative-stain micrographs
of purified Bs-Dd and Pt-Dd. Views along the two-, three-, and five-
fold axes of Dds are shown. (b) Fluorescence quantification of Dd
entry into HeLa cells after 1 h of incubation at 37°C. Incoming Bs-Dd
or Pt-Dd was quantified by indirect immunofluorescence (at 485 and
535 nm) in permeabilized cells with an antibody directed against the
Ad3 Pt base protein and an FITC-conjugated secondary antibody.
4960
permeabilized, and the amount of Dd present in the cells was
estimated by using a rabbit polyclonal serum recognizing the
Ad3 Pt base, followed by incubation with a goat anti-rabbit
secondary fluorescein isothiocyanate (FITC)-labeled antibody
(Santa Cruz). After PBS washes, fluorescence quantification
was performed by using a plate reader fluorimeter (485 and
535 nm; Wallac). The antibody background was subtracted,
and the mean of three measurements is shown in Fig. 1b. The
Bs-Dd was capable of entering human cells, suggesting that a
direct interaction between the RGD motifs of the Pt base and
the cellular integrins or between the Pt base and another cel-
lular component (5) is sufficient for cell entry. However, the
presence of fiber in the Pt-Dd dramatically increased the level
of Dd entry, suggesting a more efficient two-step endocytosis
mediated by this protein.
MAb production and characterization. Monoclonal antibod-
ies (MAbs) have been produced against ion-exchange chroma-
tography-purified Bs-Dd according to the classical protocol
(6). Two retained hybridomas were analyzed by Western blot
and enzyme-linked immunosorbent assay (ELISA). The 5C12
hybridoma recognized both Bs-Dd and Pt-Dd only in their
native forms (as determined by ELISA), indicating that the
recognized epitopes are exposed on the Dd surface and that
the presence of the fiber does not interfere with MAbs binding
to the base protein. In contrast, the 5F5 clone, which was
strongly reactive toward the sodium dodecyl sulfate-denatured
base protein (detection of 0.1 ng of denaturated base in a
Western blot), recognized only weakly the native Dd by
ELISA.
Electron microscopy study of Bs-Dd–5C12 complex.
MAb-Dd complexes were obtained by incubation of purified
Dds with purified MAbs. After sucrose gradient (15 to 40%)
density centrifugation (4 h at 200,000  g in a TLS55 rotor
[Beckman]), 5C12 MAb was found at the bottom of the tube,
together with Dd, whereas the 5F5 MAb that is unable to
strongly bind native Dd remained in the upper part of the
gradient (data not shown). An aliquot of purified Bs-Dd–5C12
complex was applied to the carbon on mica and negatively
stained with 1% silicotungstate (pH 7.0) for electron micros-
copy (Fig. 2). Micrographs were obtained under low-dose con-
ditions by using a JEOL 1200 EX II microscope at 100 kV and
a nominal magnification of 40,000. The fuzzy outline and the
increased size of Bs-Dd–5C12 versus Bs-Dd alone suggest that
the particle is decorated by immunoglobulin G.
MAb entry into HeLa cells with Dd as a vector. In order to
find out whether MAbs can be delivered to the cell by Dd,
FIG. 2. Negative-stain electron microscopy of Bs-Dd (left panel) and Bs-Dd–5C12 complex (right panel). Proteins were purified by using a 15
to 40% sucrose density gradient, and a portion of the fractions corresponding to Bs-Dd or Bs-Dd–5C12 complexes was analyzed.
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Dd-MAb complexes (0.6 nM with respect to Dd) were incu-
bated for different times with living HeLa cells in a 96-multi-
well plate (Falcon) at 2  104 cells per well. After methanol
permeabilization, the level of MAb entry was determined by
using a fluorescent secondary antibody directed against the
mouse monoclonal antibody. After PBS washes, fluorescence
quantification was performed by using a plate reader fluorim-
eter (485 and 535 nm; Wallac). The antibody background was
subtracted, and the mean of three measurements is shown in
Fig. 3a. Bs-Dd permitted a limited transduction of 5C12 MAbs
with a maximum level obtained at 90 min, whereas Pt-Dd
permitted a very efficient transduction of 5C12 MAbs, with a
maximum reached after 20 min only. These results show that
the fiber in Pt-Dd improved considerably the protein transduc-
tion efficiency and also reduced the time needed by the Pt-Dd–
MAb complex to bind and enter the cells.
The approximate amount of MAbs and Pt-Dd present inside
the HeLa cell was determined by Western blot analysis. HeLa
cells grown in a 96-multiwell plate (Falcon) at 2  104 cells per
well were transduced for 1 h at 37°C with either 0.6 nM con-
centrations of Bs-Dd–5C12 or Pt-Dd–5C12 complexes or with
5C12 alone. After washes with PBS, cells were lysed in 100 l
of cell lysis buffer (Promega), and 10-l aliquots were boiled
and subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, together with known amounts of either puri-
fied Pt-Dd or 5C12 MAb. After transfer to a polyvinylidene
difluoride membrane, the blot was treated with either anti-
mouse horseradish peroxidase (HRP) antibody (visualization
of transduced 5C12) or anti-Pt base antibody and anti-rabbit
HRP antibody (visualization of internalized Dd). Estimation of
Dd and 5C12 present inside the cell was performed by band
scanning (Molecular Analyst; Bio-Rad), and the results were
scaled to the number of cells per well (Fig. 3b). About 6 ng of
Pt-Dd and 3 ng of 5C12 MAbs were found in 2  104 HeLa
cells, representing an average of 5  104 Pt-Dd and 5.7  105
MAbs per cell. This result indicates an average ratio of about
12 MAbs per Dd, suggesting a stoichiometric process of MAb
attachment to Dd. This experiment shows an efficient and
stable interaction of 5C12 MAb with Dd, as well as very effi-
cient cell transduction of attached MAbs. As expected, the
amount of Bs-Dd was much lower than that of Pt-Dd. Since we
determined by ELISA that equivalent amounts of 5C12 MAb
were bound to Bs-Dd and Pt-Dd (data not shown), the 10-fold-
smaller amount of antibody transduced by Bs-Dd is consistent
with the lower penetration efficiency of this particle (Fig. 3).
MAb localization upon transduction. MAb localization in
transduced cells was monitored by confocal microscopy. About
105 HeLa cells were incubated for different periods of time
with a 0.6 nM concentration of the Pt-Dd–5C12 complex. After
a given period of entry, cells were washed and permeabilized
and 5C12 MAb was detected by using an FITC-labeled sec-
ondary antibody (Fig. 4). Laser scanning confocal microscopy
was performed on an MRC600 (Bio-Rad). Incubation times as
short as 5 min were sufficient to detect some Pt-Dd–5C12
complexes bound to the plasma membrane and, after 10 min of
incubation, a green signal surrounding the cells was observed.
Consistent with the kinetic experiment (Fig. 3a), complex in-
ternalization began after 20 min (Fig. 4D). After 1 h of incu-
bation, MAbs were detected close to the nucleus, whereas a
control experiment performed with 5C12 antibody without Dd
gave no signal, thus attesting that MAbs delivery into the cells
is mediated by the Pt-Dd (Fig. 4E and A, respectively). More-
over, incubation of Dd with the 5F5 MAb (which was unable to
recognize native Dd) on a HeLa cell produced no signal as in
Fig. 4A, thus confirming that protein delivery occurs only when
the MAb is attached to Dd. A similar experiment of confocal
microscopy done with Bs-Dd–5C12 complexes confirmed the
weaker and delayed transduction of 5C12 in HeLa cells ob-
served in Fig. 3a (data not shown).
Activity of the transduced protein. It has been reported that
the cell entry of subgroup B Ads (i.e., Ad3 and Ad7) is differ-
ent from that of the subgroup C Ads (i.e., Ad2 and Ad5). The
major difference lies in the ability of subgroup C Ads to escape
endosomes, whereas subgroup B Ads accumulate in late en-
dosomes and to a small extent in lysosomes prior to their
cytosol escape (9, 10). It was therefore important to assess
whether the activity of the transduced protein is retained dur-
ing the trafficking process. For this, we developed an enzyme
delivery system. Purified Pt-Dd and Bs-Dd were biotinylated
with 1 mM Sulfo-NHS-LC-LC-biotin (Pierce). After removal
of the unbound biotin, a 0.6 nM concentration of biotinylated
Bs-Dd or Pt-Dd was incubated for 30 min in PBS with a 0 to 15
nM concentration of streptavidin conjugated to HRP (SptAv-
HRP; Jackson Laboratories). HeLa cells grown in a 96-multi-
well plate (2  104 cells per well) were then incubated with the
complexes and, after 1 h at 37°C, the cells were lysed in 100 l
of cell lysis buffer (Promega). The enzyme activity was deter-
mined by photometry at 492 nm after the addition of 100 l of
the colorimetric peroxidase substrate o-phenylenediamine (3
mg/ml; Sigma). Nonbiotinylated Dd incubated with 0 to 15 nM
of StpAv-HRP was used for background substraction. The
FIG. 3. 5C12 entry into HeLa cells. (a) Kinetic experiment. Bs-Dd–
5C12 or Pt-Dd–5C12 complexes (0.6 nM) were incubated with HeLa
cells for different times at 37°C. Transduced 5C12 antibody was quan-
tified in permeabilized cells by using a secondary anti-mouse FITC-
labeled antibody. Background signal raised by 5C12 antibody alone
was subtracted. (b) Dd and MAbs quantification. Lysis extract of HeLa
cells incubated for 1 h at 37°C with a 0.6 nM concentration of Pt-Dd–
5C12, Bs-Dd–5C12, or 5C12 without Dd was analyzed by Western blot
with either anti-Ad3 base serum and anti-rabbit HRP-labeled antibody
(recognition of internalized Dd) or anti-mouse HRP-labeled antibody
(recognition of transduced 5C12 MAb). Estimation of the amount of
protein was performed by comparison to a range of purified Dd or
5C12.
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experiment was performed in triplicate, and the results are
expressed as the mean of the values (Fig. 5). This experiment
shows an exogenous peroxidase activity in cells incubated with
biotinylated Dd–StpAv-HRP, thus demonstrating that enzyme
was delivered by biotinylated Dd and that at least a part of the
transduced proteins remained active 1 h after transduction.
During biotinylation of Pt-Dd, fiber protein is also biotinylated
which could, in part, neutralize its function, and it can possibly
explain the two- to threefold difference in transduction effi-
ciency of Pt-Dd and Bs-Dd in this experiment compared to the
10-fold difference observed with MAb delivery (Fig. 3).
MAb delivery into human cells by Dd shows that this particle
can act as a protein transduction vector. Protein transduction
technology represents an alternative to gene transfer technol-
ogy when no gene insertion into genome is required (3, 11, 15).
This technology may be appropriate for restricted applications;
it is also potentially a basis for an entirely new form of therapy
and may allow us to overcome some of the technical hurdles of
gene therapy. Protein transduction could be useful for the
efficient antigen loading of dendritric cells for a range of vac-
cination purposes, including anti-tumor immune therapy. In-
terestingly, both Dd and the Ad virion contain 12 Pts and
efficiently enter human cells. However, contrary to the com-
plete Ad capsid, the Dds are compact particles devoid of any
viral DNA. Consequently, Ad Dd might be a safe alternative
vector to use instead of the whole Ad. In order to deliver
proteins other than MAbs into the cells by Dd, a strategy
aiming to fuse the protein of interest to a single-chain antibody
derived from 5C12 can be considered. Moreover, it has been
recently observed that the two PPxY motifs present in the Ad
Pt base sequence interacted with WW domains of several pro-
teins (4). As reported for polyomavirus-like particle, in which
the WW domain has been inserted in order to target PPxY
motif (13), we can hypothesize that the fusion of therapeutic
protein to WW domains might permit its attachment to the
Dd, thus allowing its transduction into the target cell.
We thank R. Ruigrok for discussions and advice with the electron
microscopy study and R. H. Wade for help with the manuscript.
FIG. 4. MAb localization upon transduction into HeLa cells as determined by confocal microscopy. Pt-Dd–5C12 complexes (0.6 nM) were
incubated for different times at 37°C. Cells were washed, and transduced MAbs were detected by using a secondary FITC-labeled mouse antibody
(green signal). Cells nuclei were counterstained with propidium iodide (red signal).
FIG. 5. Biological activity of the transduced protein. Complexes
made of either biotinylated Dd (Bs-Dd* or Pt-Dd*), both at 0.6 nM,
and streptavidin-HRP (0 to 15 nM) were incubated with HeLa cells for
1 h at 37°C. Cells were lysed, and peroxidase activity was determined
at 492 nm by using the colorimetric peroxidase substrate o-phenylene-
diamine.
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Summary
Recombinant adenovirus (rAd) is one of the most frequently used vectors with 171 human gene therapy trials
involving 644 patients in 2002. Its success stems mainly from the capacity of rAd to efficiently penetrate various cell
lines or tissues and from the ease of producing large amounts of this vector on industrial scale. Recently, in parallel
to gene transfer by viral vectors, a new technology aiming to deliver proteins rather than genetic material in human
cells has emerged, using small vehicle peptides often derived from viral proteins. In the first part of this review, I
summarize the different types of rAd vectors used for gene transfer, their advantages and their limits. In the second
part, I summarize the main vectors used for direct protein delivery into human cells and I show how an amazing
nanoparticle called “adenovirus dodecahedron” can be used for this emerging therapeutic area.
I. DNA transfer
DNA transfer by adenovirus (Ad) can be achieved
using two different strategies. The first consists in
modifying the Ad genome in order to introduce a
transgene encoding the therapeutic protein, which will
then be delivered to target cells by virus penetration. Such
vectors are called: recombinant adenoviruses (rAd). The
second strategy using Ad capsid proteins as vectors allows
non-encapsidated plasmid DNA to be introduced into
cells.
A. Recombinant adenoviral vectors
Gene therapy is a promising approach for the
treatment of either innate or acquired diseases. Among
vectors that are used to transfer DNA into cells, Ads have
several advantages. They can infect dividing as well as
resting cells with high efficiency and can be easily
produced, purified and concentrated to high titres. In
addition, a sizeable part of the viral genome, non-essential
for virus development in cell cultures used for the vector
replication, can be removed, permitting the insertion of the
majority of various cDNAs encoding the therapeutic gene.
Numerous gene therapy trials have been performed, in
particular for cancer treatment, using different therapeutic
genes (tumor suppressor, thymidine kinase, cytokines…).
A co siderable effort has also been deployed in the area of
central nervous system diseases, as Ads infect non-
dividing cells and can be transported by the retrograde
route from the injection point to distant locations.
In the first generation of rAd vectors, the E1 region
involved in the initiation of the virus replication cycle is
deleted, in order to avoid formation of recombinant
replicative particles (RCA). The major limiting factor of
such vectors is immunogenicity, which triggers both
inflammation and a cytotoxic response against the
transfected cells. It has been observed that this
phenomenon results in transgene extinction a few days
post-application, due to cell death and to the negative viral
promoter regulation by some cytokines (Qin et al, 1996).
Surprisingly, viral proteins can be still expressed in cells
infected with E1-defective rAd (Yang et al, 1994).
Therefore, it has been proposed to delete from the
adenovirus genome additional regions involved in the
replication process. The E4 region is crucial for virus
replication and E1-E4-defective rAds were generated in a
transcomplementing cell lines (Yeh et al, 1996), where
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vectors are produced by double recombination in E. coli
(Crouzet et al, 1997; Figure 1). These rAds were tested
for gene transfer in murine immuno-competent liver and
showed a prolonged transgene expression due to lower
viral protein expression as well as the absence of RCA
during production (Gao et al, 1996, Dedieu et al, 1997,
Wang et al, 1997). Interestingly, E1-E4-defective rAds
have also been shown to be efficient for gene therapy of
brain diseases. The local injection (with a stereotaxic
pump) in rat striatum was associated with an attenuated
immune response and prolonged transgene expression (Do
Thi et al, 2004).
Recently, the elaboration of helper-dependent rAds
called gutless vectors represent a very promising
development area in gene therapy. Use of the helper Ad
encoding all adenoviral proteins made possible the
encapsidation of up to 30 000 base pairs transgenes in rAd
containing only the two inverted terminal repeats (ITRs)
and the encapsidation sequence (Y ) of the original virus.
In order to improve the yield of recombinant gutless vector
production, the helper virus encapsidation sequence has
been flanked by two loxP sequences permitting excision of
this sequence in the presence of the Cre recombinase.
Serial passages of both gutless rAd and helper virus in 293
cells expressing the Cre recombinase resulted in an
increased gutless rAd titre whereas the helper virus titre
remained constantly low, limiting rAd stock contamination
by this undesired particle (Parks et al, 1996). The resulting
gutless vectors harbouring no viral coding regions elicit no
cytotoxic immune response against Ad-infected cells, thus
permitting a prolonged expression of the transgene as
attested by a-antitrypsin expression in baboons for over 50
weeks (Morral et al, 1999).
B. Adenovirus pentons and dodecahedra
The use of recombinant adenovirus for gene therapy
has been tempered by strong immune responses that
develop to the virus and virus-infected cells. In addition,
notwithstanding that the rAd are replication-defective,
they introduce into the recipient cell together with the gene
of interest viral genes that might lead to fortuitous
recombination if the recipient is infected by wild-type
adenovirus. The use of an Ad structural complex called the
penton has been proposed as an alternative vector for
Figure 1: Principle of recombinant adenovirus production. Shuttle vector with the transgene cloned between the left ITR and the pIX
sequences of adenovirus is transfected in recombination competent E. coli containing the E1-/E4- adenovirus backbone. Selection with
Kanamycin (Kn) and Tetracyclin (Tet) results in the survival of a ß-galactosidase positive plasmid fusion. A second selection in presence
of Tet and sucrose (that confere sensitivity to SacB positive bacteria) lead to the selection of either b-Gal positive backbone (case A) or
the desired recombinant backbone (case B). After PacI digestion, the recombinant backbone is transfected in a E1, E4 complementing
cell line.
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human gene therapy. The penton is a complex of two
oligomeric proteins, a penton base and fiber. This complex
located on the 12 vertices of the Ad capsid (Figure 2) is
responsible for cell attachment, internalisation, and virus
escape into the cytoplasm. The penton retains many of the
advantages of adenovirus for gene transfer such as
efficiency of entry and wide a range of cell and tissue
targets. Because it consists of two proteins instead of at
least 11 contained in an Ad virion, it is potentially a safer
alternative to rAd. Interestingly, for some Ad serotypes
such as human adenovirus of serotype 3 (Ad3), twelve
pentons are capable of interacting together in a symmetric
manner thus forming a sub-viral nanoparticle called
dodecahedron (Dd) (Norrby et al, 1966). Expression of the
Ad3 penton base alone or its co-expression with fiber
protein using the baculovirus system leads respectively to
the formation of base-dodecahedron (Bs-Dd) and penton-
dodecahedron (Pt-Dd) (Figure 2). The Dds structures
solved by cryo-microscopy revealed that these particles
contain an internal cavity with a volume close to 100 nm3
(Schoehn et al, 1996).
Adenoviruses use primary receptors for high affinity
interaction with invaded cell. We have recently shown that
Ad3 dodecahedra recognize two types of receptors. The
first is the Ad3 receptor (Sirena et al, in press) and, in
addition, they have a capacity to strongly interact with cell
surface glycoaminoglycans (Vives et al, Virology in
press). This explains the remarkable penetration efficiency
of Dds observed for a wide spectrum of cells. It has been
proposed to use these particles as a gene transfer vector. In
theory, the Dds internal cavity can only accommodate
small oligonucleotides of about 100-mers. To overcome
this limitation and attach DNA externally to the particle, a
bi-functional peptide capable of interacting with both Dds
and plasmid DNA (thanks to a polylysine stretch) has been
designed, resulting in efficient gene expression in cells
transfected by this system (Fender et al, 1997). Under
certain conditions, this system permitted a gene expression
comp rable to that obtained with RAds in vitroand
superior to cells transfected with cationic lipids. Following
the same idea it has been reported that other penton base
serotypes like Ad7 can transfect cells in vitro in an
integrin-dependent manner. (Bal et al, 2000)
A modified version of this vector has been examined
using the non-dodecameric Ad5 penton base fused to
heregulin and a stretch of 10 lysines (HerPBK10). The
rationale for this idea was to conserve the endocytotic
properties of the Ad penton base (internalisation and
endosomolytic activity) together with the targeting of
HER-2/3 or HER2/4 heterodimeric receptors which are
over-expressed in certain aggressive breast cancers
(Medina-Kauwe et al, 2001).
II. Protein delivery
To date, direct protein delivery in the cell is mainly
based on the use of small protein or peptide vectors.
However, adenovirus capsid protein complexes can also
be engineered to become a novel protein transduction
vector.
Figure 2: Adenovirus pentons and dodecahedron. Diagram of the icosahedric adenovirus capsid (left). A non-covalent complex of the
fiber and the penton base protein called the penton (Pt) is found at each of the twelve virion vertices. The trimeric fibre is responsible for
primary receptor recognition and enables the interaction of the pentameric penton base with cellular integrins. Human Ad3 pentons are
capable of interacting together through the penton base and form a highly symmetric complex made of 12 units. The fibre is not required
for this process as attested by the formation of both penton dodecahedron (Pt-Dd) and base dodecahedron (Bs-Dd).
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A. Transduction peptides
A number of obstacles currently limit the
effectiveness of gene therapy. One of the most formidable
is the delivery of the desired genes to a sufficient number
of target cells to elicit a therapeutic response. Recently, a
series of virus-encoded and some regulatory proteins were
found to be able to cross biological membranes. For
example, peptides derived from the Drosophila
Antennapedia homeodomain are internalised by cells in
culture (Derossi et al, 1994) and transferred to cell nuclei
where they can directly and specifically interfere with
transcription (Le Roux et al, 1995, Derossi et al, 1996).
The HIV-1 Tat protein was reported to be rapidly taken up
by the cell in vitro where it can specifically transactivate
the HIV-LTR (Frankel and Pabo 1988, Green and
Loewenstein 1988). The Tat protein is composed of 86
amino acids and contains a highly basic region and a
cysteine-rich region. It was found that Tat-derived
peptides as short as 11 amino acids are sufficient for
transduction of proteins (Fawell et al, 1994, Nagahara et
al, 1998). The precise mechanism by which the 11-amino
acid transduction domain crosses lipid bilayers was for a
long time poorly understood but a recent study
demonstrated that Tat or Antenapedia peptide endocytosis
was promoted by interaction with cellular
glycosaminoglycans (Console et al, 2003). A Tat-
galactosidase fusion protein that was delivered efficiently
into brain tissue and skeletal muscle in vivo has been
generated recently (Schwarze et al, 1999). These findings
suggest that protein therapies may be successfully
developed provided that problems caused by immune
response and toxicity that might be associated with long-
term expression of novel proteins in v vo can be solved.
The herpes simplex virus type 1 tegument protein
VP22 was also reported to exhibit a unique property of
spreading between neighbouring cells. VP22 is a basic,
38-kDa phosphorylated protein encoded by the viral UL49
gene (Knopf and Kaerner 1980, Elliot and Meredith 1992).
The transport of VP22 occurs via a mechanism potentially
involving actin microfilaments. VP22 is exported from the
cytoplasm of expressing cells and imported into
neighbouring cells where it accumulates in the nucleus
(Elliot et al, 1997). These properties aroused interest in
VP22 as a delivery vehicle for therapeutic proteins (Dilber
et al, 1999). VP22-directed delivery of proteins could be
achieved either by transfection of genes encoding VP22
with a fused target protein gene, or by exogenous
application of a protein extract containing VP22-fusion
(Elliot et al, 1997).
However, the initial enthusiasm for results obtained
with these peptides is tempered by a recent controversy
whereby the nuclear homing of such fusion proteins was
shown to be an artefact occurring during cell
permeabilisation step (Lundberg and Johasson 2001).
B. Protein delivery using Ad
dodecahedron
We are convinced that the high endocytotic capacity
of adenoviruses can be used for direct protein delivery.
Sub-viral particles, dodecahedra, which retain the
endocytotic features of Ad and are devoid of genetic
material are ideal candidates for this purpose. The proof of
the principle of using Dds for protein delivery has been
made with a large multimeric protein (Fender et al, 2003).
In this study, a monoclonal antibody against the penton
base was shown to be efficiently delivered to cells by Dds.
On average about 5,7 105 Mabs was found per cell using
Pt-Dd vector while the efficiency of Bs-Dd in such
transfer was lower. In order to attach other proteins to Dd,
we are currently developing a system based on WW
domains. Indeed, WW domains were found to interact
with Ad penton base protein, which is a building block of
Dd (Galinier et al, 2003). These domains, containing a
linear sequence of about 35 amino-acids including two
conserved tryptohanes (W), are known to interact with
PPxY motifs in partner proteins (Sudol et al, 1995) and
two such motifs are conserved in penton base sequences.
In a novel study, we have shown that three WW domains
fused in tandem to any protein enable fusion protein
attachment to Dds and its subsequent delivery into human
cells (Figure 3, manuscript in preparation). The use of
WW domains as an adaptor to attach the protein of interest
to our particles makes of Dds a versatile vector for
proteins delivery. The efficiency of this new system is
surprisingly high with an average of 107 WW-fused
proteins imported per cell. Moreover, contrary to the
results obtained for Mabs delivery with Dd, a comparable
amount of protein is delivered by both Pt-Dd and Bs-Dd
showing that the WW domain does not neutralize our
vectors.
III. Conclusion
Its remarkable penetration efficacy has made
adenovirus one of the most used gene therapy vectors.
Several different types of rAds vectors have been
designed, helped by the available knowledge of Ad
genetics. The major problem with rAd vectors, their
immunogenicity, has been at least partially overcome with
the appearance of gutless rAd devoid of viral coding
sequences. The alternative approach that benefits from
virus endocytotic efficacy without the viral genome is to
use the adenovirus capsid protein responsible for viral
internalisation. Several studies have reported that the Ad
penton base alone or penton base-derived dodecameric
particle can be modified to attach plasmid DNA thus
leading to transgene expression in v tro.
Very recently, another therapeutic approach based on
direct protein delivery has appeared. Obviously, this kind
of approach cannot be used for applications, like
hereditary diseases, that require a sustained protein
activity. However, it can be used in a particular therapeutic
window where a temporary but massive protein delivery is
sufficient. Among the possible applications of protein
transduction, cancer therapy with toxins or apoptotic
proteins would be one of the major challenges. However,
the most promising uses for this new technology are ex
vivo applications. In this vein, the delivery of antigens to
prime dendritic cells for cancer vaccination or the delivery
of pro-proliferating proteins to expand primary cells in
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Figure 3: WW motifs can be use as a universal adaptor.  The protein to be delivered to the cell is fused with WW domains to permit its
attachment to the dodecahedron vector. The resulting complex is efficiently delivered into the cell as reflected by the green immuno-
fluorecence detection of the protein of interest in HeLa cells (nuclei are counterstained in red)
vitro before a safe re-injection to the patient could be
considered. Once again, Ad-derived vectors like the Ad3
dodecahedron could play an important role in this
restricted but valuable area.
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internalization of serotype 3 human adenovirus dodecahedron
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During adenovirus type 3 (Ad3) infection cycle, the penton (Pt) of the viral capsid, a noncovalent complex of fiber and penton base
proteins, is produced in large excess and self-assembles to form a highly organized dodecahedral structure, termed dodecahedron (Dd). The
physiological role of these particles is poorly understood, but we have recently reported that they can penetrate cells with high efficiency and
thus may constitute an attractive tool for gene or protein delivery approaches. Surprisingly, Dd displayed the ability to enter cells non-
permissive to Ad3, suggesting the existence of additional internalization modes. In this study, we show that Ad3 Dd binds to cell surface
heparan sulfate (HS) through high affinity interaction with the penton base. Furthermore, binding to HS was found to be the prerequisite for a
novel and Dd specific entry pathway that could not be used by Ad3. Overall, these data provide new insights in the possible role of Dd during
viral infection and potential therapeutic applications.
D 2004 Elsevier Inc. All rights reserved.Keywords: Heparan sulfate; Adenovirus dodecahedron; Receptor; Cell attachment; Internalization; VectorIntroduction
Heparan sulfate proteoglycans (HSPGs) are glycopro-
teins ubiquitously expressed at the surface of mammalian
cells and in extracellular matrices. During the past 15 years,
progress in the study of these molecules has highlighted
their central role in most biological processes including cell
proliferation, cell adhesion, chemoattraction, inflammation,
wound healing, coagulation, matrix assembly, embryo de-
velopment . . . (Delehedde et al., 2002; Esko and Selleck,
2002; Gallagher, 2001; Iozzo and San Antonio, 2001).
HSPG properties are mostly mediated by the O-linked
heparan sulfate (HS) polysaccharide chains present on the
protein core that bind and regulate a wide range of proteins
through motifs of specific saccharide sequence (Lindahl et
al., 1998). Binding of proteins to HS serves a range of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.01.015
Abbreviations: Ad, adenovirus; Bs-Dd, base-dodecahedron; CS-A,
chondroitin 4-O-sulfate; CS-C, chondroitin 6-O-sulfate; CAR, coxsack-
ievirus and adenovirus receptor; DS, dermatan sulfate; Dd, dodecahedron;
GAG, glycosaminoglycan; HS, heparan sulfate; HSPG, heparan sulfate
proteoglycan; Pt-Dd, penton dodecahedron.
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E-mail address: fender@ibs.fr (P. Fender).functional purposes, from simple immobilization and local-
ization to specific regulation of signal transduction, as
initially demonstrated for basic fibroblast growth factor
(bFGF) signaling (Lundin et al., 2000; Pye et al., 1998).
Besides its physiological functions, it is widely recognized
that HS binding properties can also be exploited by a great
number of pathogen microorganisms, particularly viruses,
for attachment to the host cell surface (Sawitzky, 1996;
Spillmann, 2001). Binding to HS is generally believed to
promote infectivity by increasing local concentration of
pathogens at the cell surface and thus favoring access to
specific entry receptors. Hence, HS can play the role of a
viral attachment receptor, as described for adenoviruses type
2 and 5 (Dechecchi et al., 2000, 2001), adeno-associated
parvovirus-2 (AAV-2) (Summerford and Samulski, 1998),
several members of the herpes virus family (Shukla and
Spear, 2001), Flavivirus including hepatitis C (Germi et al.,
2002) and Dengue (Chen et al., 1997) virus, Sindbis virus
(Byrnes and Griffin, 1998) or human T cell leukemia virus
type-1 (Q. Sattentau, personal communication). However,
several studies have recently highlighted a deeper role of HS
in infection mechanisms, for which a direct participation in
viral entry was demonstrated. This has been described at
least for herpes simplex virus-1 (HSV-1), for which viral
fusion with the cell membrane is triggered by the binding of
Fig. 1. Structure of Ad3 penton and Ad3 Dds. Schematic representation of
Ad3 penton (Pt), which comprises the pentameric penton base (Bs) and the
trimeric fiber. Self-association of Pt or Bs results in the formation of highly
organized dodecahedral complexes, termed, respectively, Pt-Dd and Bs-Dd.
The structure of Pt-Dd and Bs-Dd is represented schematically, along with
the respective electron microscopy pictures.
R.R. Vive`s et al. / Virology 321 (2004) 332–340 333the viral glycoprotein D to rather rare HS motifs, in
cooperation with other viral envelope proteins (Shukla et
al., 1999; Spear et al., 2000). Finally, HS expressed on
nonpermissive cells can capture, protect, and transmit
viruses such as HIV, with increased infectivity, to cells
permissive for the replication. This kind of novel class of
in-trans receptor may have a deep impact on the tropism and
dissemination of the virus in vivo (Bobardt et al., 2003).
Human adenoviruses (Ads) are a large family of non-
enveloped viruses responsible for respiratory, ocular, and
enteric infections. They share a common structural organi-
zation, in which the 36 kb dsDNA genome is concealed
within a 90-nm icosahedral capsid composed of three major
proteins: the trimeric hexon, the pentameric base, and the
trimeric fiber. The last two form a noncovalent complex
called the penton (Pt), which protrudes from each of the 12
vertices of the capsid (Ginsberg et al., 1966; Valentine and
Pereira, 1965).
Ad penton is the major structural element responsible for
viral attachment and entry into host cells. It has been
demonstrated that purified penton alone was able to enter
human epithelial cells (Fender et al., 1997; Hong et al.,
1999). The infection process involves a first interaction of
the fiber with a high affinity primary receptor that will
facilitate subsequent binding of the penton base to cellular
integrins and eventually trigger endocytosis (Mathias et al.,
1994; Wickham et al., 1993). For most Ads, a 42-kDa
protein of tight junctions, termed coxsackievirus and adeno-
virus receptor (CAR), is the primary receptor for infection
(Bergelson et al., 1997). Members of Ad subgroup B,
including adenovirus type 3 (Ad3), do not use CAR (Roel-
vink et al., 1998; Segerman et al., 2003). Recently, CD46 has
been identified as the primary receptor used by several
subgroup B Ads, but not Ad3 (Gaggar et al., 2003). How-
ever, this latter observation concerning Ad3 appears to be
challenged by a recent work from another group (Greber and
Hemmi, personal communication, manuscript submitted).
During Ad infectious cycle, free pentons are produced in
excess and released with the virus progeny. The physiolog-
ical relevance of this remains unclear, but a recent study
suggested that free penton proteins enhanced infectivity by
disturbing tight junctions and thus favored virus spreading
(Walters et al., 2002). In contrast with most Ads, expression
of Ad3 penton resulted in the formation of a highly
organized dodecahedral structure (49 nm in diameter), in
which the 12 penton base proteins interact with each other
(Fig. 1) (Schoehn et al., 1996). Although its physiological
role is not known, this complex, termed penton-dodecahe-
dron (Pt-Dd), displayed high efficiency ability to bind and
enter human epithelial cells, thus indicating that no other Ad
protein was required during early endocytosis.
We have recently demonstrated that Ad3 Pt-Dd could
constitute a good tool for gene or protein delivery (Fender et
al., 1997, 2003). However, potential applications require the
clarification of the mechanisms involved in cell attachment
and entry. Intriguingly, we found that the expression of Ad3penton base alone also yielded dodecahedral structures,
termed base-dodecahedron (Bs-Dd, see Fig. 1). These
smaller particles (28 nm in diameter) could also get into
human cells, though with lower efficiency than Pt-Dd,
indicating that the fiber plays an important role for cell
attachment or entry (Fender et al., 2003), but that the
existence of alternative internalization pathways had to be
considered. In this study, we provide evidence that HS is a
receptor involved in binding and entry of Dd into cells.Results
Ad3 Dds use cell surface GAGs for attachment to CHO cells
To study novel Dd internalization pathways, we first
investigated the ability of Ad3 Dd to bind to the surface of
Ad3 nonpermissive cells, that is, cells that would not
express Ad3 primary receptor. CHO-K1 cells were incubat-
ed with Pt-Dd at 4 jC and in presence of NaN3 to prevent
Dd internalization. After washing, bound dodecahedron was
detected by FACS analysis, using a set of anti-Dd primary
and FITC-conjugated secondary antibodies. No background
was observed for control assays performed in absence of
primary antibody (data not shown). Results showed that Pt-
Dd efficiently bound to CHO-K1 cell surface, as indicated
by a shift of the cell-associated fluorescence peak (Fig. 2A).
However, no Dd binding could be detected on CHO-2241
cells, a mutant clone defective in glycosaminoglycan (GAG)
synthesis, at both concentrations tested (Fig. 2B). These data
suggested that Dd interaction with the CHO cell surface
Fig. 2. FACScan analysis of Pt-Dd binding to CHO-K1 and CHO-2241
cells. CHO-K1 (A) and CHO-2241 (B) cells were incubated at 4 jC with 0,
25, or 120 nM of Pt-Dd (dotted, gray, and black lines, respectively),
followed by successive incubations with anti-Pt-Dd primary antibody and
FITC-conjugated secondary antibody. FL1-H: fluorescence intensity.
R.R. Vive`s et al. / Virology334involved GAGs, and that no other appropriate attachment
receptors were present on these cells. To confirm such
hypothesis, CHO-K1 and CHO-2241 cells were incubated
with FITC-labeled Dd and observed by laser confocal
microscopy (Fig. 3). On CHO-K1 cells, a green halo
resulting from bound Dd could be clearly seen at the cell
surface (Fig. 3A). In contrast, no cell-associated green
fluorescence could be distinguished on CHO-2241 cells,
indicating absence of Dd attachment. Interestingly, similar
observations were made for experiments performed with
FITC-labeled Bs-Dd. This indicated that Dd binding to
CHO cells was fiber independent. Such a mechanism is
distinct from the putative Ad3 primary attachment process,
which by analogy with subgroup C Ads, should require the
fiber. Finally, the involvement of GAGs suggested by the
above data was confirmed by competition assays with
exogenous heparin. Preincubation of Dd with the polysac-
charide before cell exposure indeed abrogated Dd attach-
ment, with a dramatic reduction observed at heparin
concentration as low as 0.01 Ag/ml (Fig. 3B).Ad3 Dd binding to GAGs is restricted to HS and heparin
The nature of cell surface GAGs actually involved in Dd
binding was then determined, using filter binding analysis.
Pt-Dd was incubated with biotinylated heparin (Hpb), after
which the reaction mixture was drawn through a nitrocel-
lulose membrane. Free Hpb was washed away, while Pt-Dd-
bound Hpb remained trapped on the membrane and was
detected by exposing the blots to peroxydase conjugated
extravidin, followed by ECL detection (Fig. 4). The absence
of signal for the negative control (Fig. 4, top lane, row 1)
confirmed that free heparin was not retained by the nitro-
cellulose membrane. In contrast, binding of Hpb to Pt-Dd
was clearly shown by a spot of strong density (Fig. 4, top
lane, row 3). The Pt-Dd/Hpb interaction could be inhibited
with an excess of non-biotinylated heparin or HS resulting,
respectively, in total or severe signal loss (Fig. 4, top lane,
rows 4 and 5, respectively). However, chondroitin 4-O-
sulfate (CS-A), Dermatan sulfate (DS), and chondroitin 6-
O-sulfate (CS-C) failed to compete with Hpb (Fig. 4, top
lane, rows 6–8), indicating that Dd GAG-binding properties
were restricted to heparin and HS. Experiments performed
with Bs-Dd yielded a similar binding pattern (Fig. 4, bottom
lane), with spots of equivalent intensity, thus further sup-
porting a location of the heparin/HS binding site on the base
protein of Ad3 Dd.
Ad3 Dds bind heparin with high affinity and form very
stable complexes
Ad3 Dd interaction with heparin was then studied, using
surface plasmon resonance (spr) analysis. For each sample,
a set of sensorgrams was obtained by injection of a range of
Pt-Dd or Bs-Dd concentrations (from 0 to 60 Ag/ml) over
both heparin-immobilized and negative control surfaces,
and on-line subtraction of the recorded signals (Figs. 5A
and 5B, respectively). Sensorgrams indicated potent inter-
action of both Pt-Dd and Bs-Dd to heparin, with significant
signal being observed even at the lowest concentration
tested (2.5 Ag/ml, i.e., 0.52 and 0.69 nM, for Pt-Dd and
Bs-Dd, respectively).
Preliminary kinetic analysis of the sensorgrams revealed
a complex binding process, which could not be fitted to any
obvious model of ligand–receptor interaction (data not
shown). This is in agreement with the complexity of the
Dd structure, in which the 12 penton bases, each composed
of 5 identical monomers, display 60 potential heparin
binding sites and thus could bind heparin in many different
ways. Such multivalency is likely to cause strong avidity.
Kinetic analysis of the sensorgram dissociation phases,
using the BIAevaluation 3.1 software, yielded apparent
dissociation rate constants (koff) of 5.6 10
5 and 9.3 105
s1 for Pt-Dd and Bs-Dd, respectively, indicating that Ad3
Dd formed highly stable complexes with heparin. To ana-
lyze the Dd–heparin interaction in more detail, we gener-
ated data in which the association phase was allowed to
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Fig. 3. Analysis of Dd binding to CHO-K1 and CHO-2241 cells by confocal microscopy. (A) CHO-K1 and CHO-2241 cells were incubated for 2 h at 4 jC
with 1 nM of FITC-labeled Pt-Dd or Bs-Dd (green signal). After permeabilization, cell nuclei were counter-stained with propidium iodide (red signal). (B)
Before CHO-K1 cell incubation, FITC-labeled Pt-Dd (1 nM) was pre-incubated with heparin (0, 0.01, or 0.1 Ag/ml) for 30 min at room temperature.
R.R. Vive`s et al. / Virology 321 (2004) 332–340 335proceed to equilibrium (20 min injections, Figs. 5A and 5B).
Equilibrium data were extracted from sensorgrams that
displayed a clear binding plateau, that is, for concentrationsFig. 4. GAG specificity of Dd interaction. Filter binding analysis of Dd/
GAG interaction. Pt-Dd/Bs-Dd were incubated with (rows 3–8) or without
(row 2) biotinylated heparin (Hpb), in absence (row 3) or presence of a 10-
fold excess of non-biotinylated competing GAG, including Hp, HS, CS-A,
DS, and CS-C (rows 4–8, respectively). Negative control (Hpb in absence
of Dd) is shown on the top lane, row 1.of 10 Ag/ml and above, and these were plotted according to
the Scatchard representation (Figs. 5C and 5D) to provide
an affinity value independently of the kinetic aspect of the
binding. This confirmed the high affinity of these interac-
tions, with calculated Kd values in the nanomolar range: 0.7
and 1.4 nM for Pt-Dd and Bs-Dd, respectively.
Cell surface HS is required for Ad3 Dd entry into CHO cells
Having highlighted the critical role of HS in Dd cell
attachment, we then investigated a possible involvement in
the cell internalization process. Here, incubation of CHO-
K1 cells with FITC-Dd was performed in PBS for 1 h at
37 jC to allow internalization. Cell observation by confo-
cal microscopy showed a very bright and punctuated
intracellular signal, indicating that both Pt-Dd and Bs-Dd
could efficiently enter CHO cells (Figs. 6A and 6B,
respectively), despite absence of Ad3 primary receptor.
Furthermore, Pt-Dd and Bs-Dd showed no difference in
the endocytosis efficiency, thus supporting that this process
Fig. 5. Analysis of Pt-Dd and Bs-Dd binding to heparin by spr. Sensorgrams were obtained by injections of Pt-Dd (A) and Bs-Dd (B) at 0, 2.5, 5, 10, 20,
30, 40 and 60 Ag/ml onto a heparin immobilized sensorchip. Data for which equilibrium was achieved were used for Scatchard analysis of the interaction
(C and D, respectively).
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heparin (10 Ag/ml) or cell treatment with chlorate that
blocks GAG sulfation totally abolished cell internalization
of both Pt-Dd (Figs. 6C and 6D, respectively) and Bs-Dd
(data not shown). These results demonstrate that Dd
binding to HS is a prerequisite for endocytosis of these
particles into CHO cells.Fig. 6. HS-dependent Dd entry into Ad3 nonpermissive CHO-K1 cells.
FITC-labeled Pt-Dd (A) and Bs-Dd (B) were incubated with HeLa cells for
1 h at 37 jC. After washing and fixation with 2% PFA, cells were observed
by laser confocal microscopy. Pt-Dd internalization was inhibited by either
pre-incubating Dd with 10 Ag/ml of heparin (C) or treating cells with
chlorate (D).
Fig. 7. Role of HS for Dd entry into Ad3 permissive HeLa cells. FITC-
labeled Dd (1 nM) was pre-incubated or not with 10 Ag/ml of heparin (Hp),
then incubated with HeLa cells at 37 jC. After washing and fixation with
2% PFA, cells were observed by laser confocal microscopy (A). Cell
fluorescence was quantified by photo-counting. The means of pixel
intensity were determined from 12 individual cells (B).
ology 321 (2004) 332–340 337HS constitutes an alternative pathway for Dd entry into Ad3
permissive HeLa cells
The role of HS in Dd cell attachment and internalization
was defined on CHO-K1 cells, which are not the natural
target of Ad3. To study this process in a more physiological
context, we repeated our direct fluorescence assays on Ad3
permissive HeLa cells. FITC-Dd were incubated with HeLa
cells for 1 h at 37 jC, before cell washing and fixation. In
agreement with our previous study (Fender et al., 2003),
results indicated that both Pt-Dd and Bs-Dd could enter
HeLa cells, with slightly lower yields for the latter (Fig. 7).
Addition of heparin resulted in a twofold reduction of Pt-Dd
endocytosis, and a complete abrogation of Bs-Dd entry, as
shown by cell fluorescence quantification (Fig. 7B). These
data support the existence on HeLa cells of a fiber-indepen-
dent, HS-mediated Dd internalization pathway, which is
exclusively used by Bs-Dd and accounts for about half of
Pt-Dd endocytosis.
R.R. Vive`s et al. / VirDiscussion
Due to its high ability to enter cells, Ad3-Dd has been
thoroughly studied as a putative vector for gene and protein
delivery. The advantage of such a structure is that it only
comprises two distinct proteins, the base and the fiber, and is
devoid of foreign nucleic acid. However, the mechanism of
Dd cell attachment and entry remains poorly understood. By
analogy with subgroup C adenoviruses, it is thought that
Ad3 fiber head binds to a cell surface primary receptor,
which will in turn facilitate interaction of Ad penton base
RGD motif with avh3 and avh5 integrins and trigger
subsequent endocytosis (Wickham et al., 1993). However,
our previous data had already suggested the existence of a
Ad3 primary receptor independent internalization pathway,
as fiber devoid Bs-Dd was still able to bind to and enter
cells, though to a lesser extent than Pt-Dd (Fender et al.,
2003). Here, we provide evidence of a novel Dd cell
attachment pathway, in which HS promotes binding and is
required for cell entry.
The present study first showed that both Bs-Dd and Pt-
Dd could bind to non-permissive CHO-K1 cells (Figs. 2 and
3). Interestingly, binding occurred with a similar efficiency
for both Dd forms, suggesting that the fiber was not
involved in this interaction. GAGs were identified as the
docking site, because Dd attachment to CHO-K1 cells could
be efficiently inhibited by competition with free heparin
(Fig. 3B) and that both Bs-Dd and Pt-Dd failed to bind to
GAG-deficient CHO-2241 cells (Fig. 3A). GAG-specific
requirements for Ad3 Dd cell attachment were then inves-
tigated by filter binding analysis (Fig. 4). Our results
indicated that both Bs-Dd and Pt-Dd bound to the biotiny-
lated heparin with similar efficiency, thus further supporting
the view that the base only participates to the binding.
Competition performed with non-biotinylated GAGs showedthat only heparin and HS could significantly inhibit the
interaction, although addition of CS-A, DS, or CS-C had no
effect. These results demonstrated that the base protein of Dd
specifically bound to HS amongst cell surface GAGs.
The Dd/heparin interaction was further characterized by
spr analysis. Injections of Pt-Dd and Bs-Dd on a heparin-
immobilized surface yielded sensorgrams with very similar
features, that is, a strong association with the polysaccha-
ride followed by a very slow dissociation phase (Fig. 5).
Due to the complexity of the binding reaction, we did not
attempt to fully describe the kinetic aspects of the interac-
tion. However, the very slow dissociation phase observed
indicated that the complexes formed were very stable. Kd
values could be deduced from Scatchard analysis of the data
obtained at the binding equilibrium. Pt-Dd and Bs-Dd
bound heparin with similar affinity (0.7 and 1.4 nM,
respectively). These particularly high affinities may result
from an avidity mechanism caused by the multiplicity of
HS binding sites present on the Dd. We recently reported
that the trimerization of the Ad2 fiber protein elicited a 25-
fold affinity increase for the CAR receptor, this being due to
an avidity effect (Lortat-Jacob et al., 2001). Such a phe-
nomenon has also been observed when comparing the
binding to heparin of HIV virions and isolated gp120
(unpublished observation). Moreover, the high affinity
values measured are consistent with the low heparin con-
centration (0.01 Ag/ml) needed to inhibit Dd cell attachment
(Fig. 3B). Interestingly, surface maximum occupancy of Pt-
Dd was half that of Bs-Dd (42 and 18 heparin chains per Pt-
Dd and Bs-Dd, respectively), this reflecting the radius
differences of Dd particles (49 nm versus 28 nm, see Fig.
1) that may limit the maximum density that could be bound
onto the heparin surface.
In addition to cell attachment, our data provided evidence
that Dd binding to HS was the prerequisite of a novel cell
internalization pathway. Such process involved interaction
of the polysaccharide with the penton base, as both Pt-Dd
and Bs-Dd failed to enter GAG-deficient CHO-2241 cells,
but could penetrate CHO-K1 cells with similar efficiency
(Fig. 6). HS requirement was further demonstrated by
blockage of Dd cell entry, using exogenous heparin, or cell
treatment with chlorate that prevents endogenous GAG
sulfation (Cardin and Weintraub, 1989). This HS-dependent
internalization pathway could be clearly distinguished from
the conventionally assumed Ad3 cell entry process that
required the binding of the fiber to the Ad3 primary
receptor, as shown by our results on Dd entry into Ad3
permissive HeLa cells (Fig. 7). On these cells, preincubation
of Dd with exogenous heparin completely abolished attach-
ment and entry of fiber devoid Bs-Dd, indicating an exclu-
sive use of the HS-dependent pathway, and significantly
reduced the internalization of Pt-Dd, which nevertheless
retained a partial ability to enter cells, most likely through
the Ad3 primary receptor pathway. The mechanisms by
which HS initiates Dd cell entry remain unclear. A first
hypothesis is that HS could facilitate the binding of Dd with
R.R. Vive`s et al. / Virology 321 (2004) 332–340338entry receptors, such as integrins. The structural basis of HS
interaction with the penton base has not been investigated
yet. However, analysis of the protein sequence revealed
several positively charged arginine and lysine residues
gathered in clusters typical of HS binding sites. Interesting-
ly, one of this cluster, K337QKR340, is found near the
R329GD331 sequence believed to interact with integrins.
The close proximity of these two putative binding sites
could suggest that HS and integrins may act in synergy to
trigger cell internalization. This would be in agreement with
our data showing that av integrins, which are expressed at
the surface of CHO-2241 cells, could not mediate Dd
attachment or entry on their own. Another hypothesis is
that HSPGs themselves could mediate internalization of Dd,
as observed for several ligands, including growth factors
and lipoproteins (Reiland and Rapraeger, 1993; Williams
and Fuki, 1997). Interestingly, work from Fuki et al. (1997)
reported that this endocytosis process could be triggered by
the clustering of HSPG transmembrane and cytoplasmic
domains. For Dd, HSPG clustering is likely to be favored by
the multiplicity of HS binding sites at their surface and thus
could permit efficient endocytosis of these particles.
In contrast to the high affinity binding of Ad3 Dd to HS,
the Ad3 virus does not interact with either heparin or HS
(Dechecchi et al., 2000 and unpublished data). Such a
discrepancy raises several questions from a structural and
a functional point of view. Pt-Dd and Ad3 viral capsid both
comprise 12 pentons protruding in a similar manner from
the particle. However, in the former, pentons directly
interact with each other, while they are separated by hexons
on the virus. It is possible that the HS binding site on the
penton base is located near the penton–hexon interface, and
thus the hexon on the virus partially or fully overlaps HS
binding residues. Alternatively, the HS binding site could be
created by the penton–penton interface that occurs on the
Dd. Such situation has been already described for several
dimerized chemokines, for which the HS binding site was
formed at the protein–protein interface (Lortat-Jacob et al.,
2002). Another hypothesis is that the negatively charged
hexon, which is the major component of the viral capsid, but
is not found on the Dd, may significantly influence the
surface electrostatic potential and thus prevent possible
interaction of the base with polyanionic HS. This is sup-
ported by data reporting that Ad endocytosis is sensitive to
the global charge of the capsid (Arcasoy et al., 1997;
Shayakhmetov and Lieber, 2000). Other Ads do use HS
for cell attachment. In particular, HS has been recently
described as an alternative receptor to CAR for wild-type
Ad2/Ad5 (Dechecchi et al., 2000, 2001). In this study, a
BBxB consensus motif (Humphries and Silbert, 1988)
within the Ad2 fiber shaft sequence was presented as a
putative HS binding site. This basic cluster is absent in the
Ad3 fiber, suggesting that Ad2 penton and Ad3 Dd interact
with HS through distinct binding sites. Pt-Dd is naturally
found during the Ad3 replication cycle and in vivo, large
amounts of Pt-Dd are released at the cell lysis (Norrby,1966). The physiological role of Dd during viral infection is
still unknown, but its ability to bind to HS, a molecule
involved in a huge array of biological functions, is likely to
be critical. It has been recently shown that the excess of
synthesized Ad2 fiber contributed to virus spreading by
disrupting the junctional integrity mediated by CAR (Wal-
ters et al., 2002). In addition, the base protein is also known
to trigger cell detachment (Boudin et al., 1979), supporting
further the ability of penton components to interfere with
cell adhesion processes. As HS participates to cell cohesion,
its interaction with Ad3 Dd may also be involved in the
weakening of cell–cell contacts and contribute to the viral
dissemination.
In this study, we have identified HS as a major attach-
ment receptor for Ad3 Dd to the cell surface, and as a trigger
for endocytosis through a novel, fiber-independent pathway.
Our data highlighted a major divergence between Ad3 and
Ad3 Dd cell entry mechanisms that may have an important
physiological significance. Clarifying the structural and
functional features involved in Ad3 Dd/HS interaction will
constitute a major challenge for the understanding of the
role played by these particles during viral infection, and for
a potential use, as a gene/protein delivery vector.Material and methods
BIAcore 3000, B1 sensorchip, amine coupling kit, and
HBS-EP buffer were purchased from BIAcore AB. FACS-
can is from Becton Dickinson. EMEM and Ham’s F12
medium were from Gibco. Heparin of 9 kDa was a generous
gift from Maurice Petitou (Sanofi-Synthe´labo). Heparin of 6
kDa and chondroitins sulfate were supplied by Sigma.
MRC-600 laser scanning confocal microscope was pur-
chased from BioRad. Tissue culture reagents were from
Gibco Lifesciences.
Cell culture
Chinese Hamster Ovary (CHO) cell lines K1 (GAG
positive, American Type Culture Collection [ATCC] code
CCL-61) and 2241 (GAG negative, pgsB-618, ATCC code
CRL-2241) were obtained from the European Collection of
Cultured Cells. Cells were cultured at 37 jC, under 5% CO2
atmosphere, in Ham’s F12 (for CHO cells) or EMEM (for
HeLa cells), supplemented with 10% fetal calf serum (FCS),
penicillin (50 IU/ml), and streptomycin (50 Ag/ml). Chlorate
treatment was performed by incubation of trypsinized cells
for 36 h in EMEM, 2% FCS, 30 mM sodium chlorate
(Cardin and Weintraub, 1989).
Production, purification, and labeling of Ad3 Dd
Both Pt-Bs and Bs-Dd were expressed using the baculo-
virus system. Particles were purified by sucrose density
gradient, as previously described (Fender et al., 1997). Dd
R.R. Vive`s et al. / Virology(300 nM) were fluorescently labeled by incubation with 1
mM FITC, in 20 mM HEPES, pH 8, for 3 h at 4 jC. Free
FITC was removed by dialysis against 20 mM HEPES, 150
mM NaCl, pH 8.
Flow cytometry analysis
Cells (2  106/ml) in FACS buffer (PBS, 1% BSA,
0.02% azide, 1 mM EDTA) were incubated with Pt-Dd (25
and 120 nM) for 45 min at 4 jC. After washing with FACS
buffer, cells were incubated with primary anti-Dd Ab (1/
1000, 1 h at 4 jC in FACS buffer, followed by washing),
then with FITC-conjugated secondary antibody (1/200, 1
h at 4 jC in FACS buffer, followed by washing), and
analyzed by flow cytometry.
Filter binding assay
The interaction of Ad3 Dd with heparin was analyzed by
filter binding assay (Sadir et al., 2001). Ad3 Pt-Dd and Bs-
Dd (100 ng) were co-incubated with biotinylated heparin
(0.05 Ag/ml) in 200 Al of Tris-buffered saline (TBS) for 45
min at room temperature. In competition assays, a 10-fold
excess of non-biotinylated GAGs (0.5 Ag/ml) was also
added. Samples were then drawn through a nitrocellulose
membrane using a vacuum-assisted dot-blot apparatus. The
membrane was washed twice with 200 Al of TBS and
blocked with 5% dry milk in TBS containing 0.05% Tween
20. Protein-bound biotinylated heparin was revealed by
incubation of the membrane with extravidin peroxydase
(0.5 Ag/ml) and enhanced chemiluminescence (ECL) detec-
tion reagents, followed by autoradiography.
Heparin/Dd interaction analysis by surface plasmon
resonance
Heparin (9 kDa) was biotinylated and immobilized on a
B1 BIAcore sensorchip, as described before (Vives et al.,
2002). Briefly, two flowcells were prepared by sequential
injections of EDC/NHS, streptavidin, and ethanolamine.
One of these flowcells served as negative control, while
biotinylated heparin was injected on the other one, to get an
immobilization level of 80–90 response units (RU). All spr
experiments were performed, using HBS-EP buffer (10 mM
HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% surfactant
P20, pH 7.4), at a flow rate of 10 Al/min. Interaction assays
involved 20 min injections of different dodecahedron con-
centrations (ranging from 0 to 60 Ag/ml) over the heparin and
negative control surfaces, followed by a 10-min washing
step with HBS-EP buffer to allow dissociation of the com-
plexes formed. At the end of each cycle, the heparin surface
was regenerated by sequential injections of 0.05% SDS (1
min) and 2 M NaCl (2.5 min). Sensorgrams shown corre-
spond to on-line subtraction of the negative control to the
heparin surface signal. Data from sensorgrams that reached
binding equilibrium were used for Scatchard analysis.Confocal microscopy
Cells grown overnight on coverslips (about 105 cells/
slide) and washed in PBS were incubated with either FITC-
labeled Pt-Dd or Bs-Dd (1 nM) for 2 h at 4 jC. For heparin
competition assays, Dd were first incubated for 30 min at
RT with 0.01 or 0.1 Ag/ml of 6 kDa heparin. Cells were then
permeabilized with cold methanol for 10 min at 20 jC and
cell nuclei counter-stained with propidium iodide (5 Ag/ml).
For internalization assays, cells were incubated with either
Pt-Dd or Bs-Dd (1 nM) in PBS for 1 h at 37 jC. After PBS
washes, cells were fixed with 2% paraformaldehyde. Cover-
slips were then mounted for observation on a microscope
slide with 1,4-diazabicyclo-octane.
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Adenovirus penton is a non-covalent complex composed of the penton base and fiber proteins, localized at the twelve vertices of the
icosahedral virus capsid. In cells infected by adenovirus serotype 3 (Ad3), penton is found not only in the virus capsid but also self-assembled
in dodecahedra formed through interactions between the twelve penton bases. In this study, the intracellular trafficking of penton proteins
from the cytoplasm to the nucleus has been followed, and the nuclear re-arrangement induced by viral infection has been observed by
electron microscopy of ultrathin sections. The amount of dodecahedra has been assessed in relation to the number of Ad3 infectious virions
produced during the Ad3 replication cycle. It appears that dodecahedra are produced in a large excess over viral infectious particles and that
they are located intranuclearly along the nuclear membrane of Ad3-infected cells at late times of infection.
D 2005 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Ad3; Dodecahedron; Nuclear localization; Ultrathin sections; QuantificationIntroduction
Human adenoviruses (Ads) are non-enveloped viruses
causing respiratory, ocular, and enteric infections. Their
icosahedral capsid, containing the 36 kpb dsDNA genome,
is composed of three major proteins, the hexon, the penton
base, and the fiber. At the twelve vertices of the capsid, the
protruding fiber together with the penton base embedded in
the capsid form a complex called penton (Pt). Ad penton is
the major structural element responsible for viral attachment
and entry into host cells. Interestingly, in some Ad
serotypes, penton proteins (penton base and fiber) are
over-expressed during replicative cycle and can be purified
from Ad-infected cell either separately or in form of penton
complex (Boulanger and Puvion, 1973). Pentons in the
complete virion are separated by hexon proteins but
amazingly, in some serotypes, pentons can self-assemble0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.030
* Corresponding author. Fax: +33 4 38 78 54 94.
E-mail address: fender@ibs.fr (P. Fender).into dodecameric particles called adenovirus dodecahedra
(Ad-Dd). This has been reported for the first time for Ad3-
infected cells (Norrby, 1966) and later the presence of Ad-
Dd has been observed for other Ad serotypes. Ad-Dd can be
also obtained by the penton expression in the baculovirus
system thus demonstrating that other adenoviral compo-
nents are not required for dodecahedra formation (Fender
et al., 1997). The structure of these particles has been solved
by cryo-electromicroscopy (Schoehn et al., 1996) and it has
been reported that Ad-Dd enters human cells with a high
efficiency, likely through interaction of the fiber with the
Ad3 primary receptor (CD46) (Gaggar et al., 2003; Sirena
et al., 2004), but also through direct interaction of the
penton base with heparan sulphate (Vives et al., 2004).
Despite all these functional and structural data, the
formation, the localization, and the quantification of Ad3-
Dd produced during the adenoviral replicative cycle are not
well established. Here, we report the kinetics and the site of
penton synthesis in Ad3-infected cells. In addition, we
present the data concerning the amount of Ad-Dd produced
in comparison with the infectious virus and we provide05) 167 – 173
Rapid Communication168information on the respective nuclear localization of Ad3
and Ad-Dd.Results
Penton synthesis during the Ad3 replicative cycle
For the determination of the kinetics of penton synthesis
during the Ad3 replicative cycle, HeLa cells were infected
with Ad3 at MOI 1 for different periods of time. Infected
cells were lysed and analyzed by Western blot using an anti-
Pt-Dd serum that recognized SDS-denatured penton base
and fiber proteins. Although the anti-Pt-Dd serum is able to
detect less that 1 ng of protein, neither fiber nor penton base
protein could be detected before 12 h of infection (Fig. 1A).
As expected for late viral proteins, the penton synthesis
started at 12 h p.i. as attested by the detection of the
monomeric forms of the penton base at 60 kDa and a faint
signal for the fiber at 35 kDa. Penton protein expression
increased rapidly between 12 and 24 h and seemed to
stabilize after 24 h.Fig. 1. Kinetics and localization of penton proteins in Ad3-infected HeLa cells. (A
with anti-Pt-Dd serum recognizing both monomeric penton base and monomeric
infected cells; Pt-Dd—purified penton dodecahedron expressed in the bac
immunofluorescence. Ad3-infected HeLa cells were permeabilized at indicated t
in green with a FITC-conjugated antibody while the nuclei are counterstained in r
exposure settings on MRC600 (Bio-Rad) LASER confocal microscopy.Cellular localization of pentons during the Ad3 replication
cycle
The expression and localization of penton proteins in
Ad3-infected cells were studied by confocal microscopy
using anti-Pt-Dd serum and anti-rabbit FITC-labeled secon-
dary antibody while nuclei were counterstained in red by
propidium iodide (Fig. 1B). At 12 h p.i., penton proteins
were observed solely in the cytoplasm of Ad3-infected cells
indicating entry into the late stage of the Ad replication
cycle. Interestingly, at this stage, no dodecahedra were
found in the heavy fractions of sucrose gradient density
suggesting that dodecamerization of penton does not take
place in the cytoplasm (data not shown). Four hours later
(16 h p.i.), although penton synthesis was still detectable in
the cytoplasm, the majority of the signal was observed in the
nucleus where the diffuse yellow signal reflected the co-
localization of penton proteins with the cellular DNA. At
24 h p.i., no detectable penton signal was seen in the
cytoplasm, indicating that Ad late proteins are not suffi-
ciently expressed to be detectable under these experimental
conditions. Interestingly, the diffuse green penton signal) Expression of penton base and fiber proteins monitored by Western blot
fiber. Time post-infection is shown on the figure. NI—lysate from non-
ulovirus system. (B) Localization of penton proteins, monitored by
imes of infection and incubated with anti-Pt-Dd. Penton proteins are seen
ed with propidium iodide. Picture acquisitions were performed at the same
Rapid Communication 169seen at 16 h in the nucleus was now punctated and
predominantly located at the nuclear membrane of the
infected cells (Fig. 1B, last panel). Taken together, these
results show that penton proteins are expressed in the
cytoplasm and transported to the nucleus where they tend to
localize close to the nuclear membrane later in infection.
Specific location of encapsidated and non-encapsidated
pentons in infected cell
At 24 h p.i., a complete cycle of adenovirus replication
has occurred yielding progeny virions in infected cells.
Penton can then be found either incorporated in the progeny
virions (encapsidated pentons) or can remain free in form of
dodecahedron (non-encapsidated pentons). To determine
whether the penton signal seen at the nuclear membrane is
due to the dodecahedron or to the virus, an immunofluo-
rescence study was performed using either anti-Pt-Dd or
anti-hexon antibodies. While the anti-Pt-Dd serum will
interact with both virions and dodecahedra, the latter
antibody will recognize virions but not the Dd. Interestingly,Fig. 2. Location of free and encapsidated penton complexes in Ad3-infected HeLa
Virions were detected with anti-hexon antibody (left panel) and dodecahedra wi
secondary antibody were observed by LASER confocal microscopy—scale bar:
(revealed in red with an anti-penton base antibody) and of the virus (in green reve
arrows indicate intranuclear inclusions of virus. The framed portion of the thin
Cytoplasm is denoted by letter c, and the nucleus by letter n. A dark intranuclear
The hexon signal observed in A (left panel) stems most likely from the intranuclear
is due predominantly to the condensed dark material seen in the ultrathin sectionthe signal raised with anti-hexon was also punctated but
arranged all over the infected cell nucleus (Fig. 2A, left
panel). Of note, a majority of hexon synthesized in the Ad3-
infected cells is used for the formation of 240 hexon
capsomers of virions since infection by Ad3 contrary to that
by Ad2 does not produce a large excess of free hexon
(White et al., 1969, Boulanger and Puvion, 1973). It seems
plausible that the weak intranuclear signal observed with
anti-Pt-Dd antibody (Fig. 2A, middle panel) is due to
encapsidated pentons whereas the bright perinuclear signal
raised by this antibody is likely emitted by non-encapsidated
pentons. To confirm this hypothesis, ultrathin sections of
Ad3-infected HeLa cell have been observed by electron
microscopy (Fig. 2B). As previously described for other Ad
serotypes (Henry et al., 1971), the Ad3 progeny viruses are
seen concentrated in form of nuclear inclusions, possibly
explaining the large punctate signal observed with the anti-
hexon antibody in the immunofluorescence study. It is
relevant that individual Dd with about 3-fold smaller
diameter than that of virus cannot be directly detected by
this technique. Nevertheless, the punctate signals observedcells at 24 h p.i. (A) Immunofluorescent detection of Ad3 virions and Pt-Dd.
th anti-Pt-Dd antibody (middle panel). Signal revealed with FITC-labeled
10 Am. Colored panel shows the respective localization of dodecahedron
aled with an anti-hexon antibody). (B) Ultrathin sections. On the left panel,
section presented in the left panel is shown blown-up in the right panel.
punctate signal lining the nuclear membrane can be seen on the right panel.
inclusions observed in B (right panel), while Pt-Dd signal in A (right panel)
along the nuclear membrane (B, right panel).
Rapid Communication170on Fig. 2A with anti-Pt-Dd (middle panel) can be correlated
with the dark punctate structures seen at the perinuclear
membrane space of infected cells nuclei on ultrathin
sections (Fig. 2B, right panel). It can be thus concluded
that a large excess of penton is synthesized during the Ad3
replicative cycle and that this non-encapsidated pentons
tends to accumulate in the nucleus lining the external side of
the nuclear membrane at late stage of infection.
Estimation of dodecahedra and infectious virus in
Ad3-infected cell
We have elaborated a strategy enabling both the
quantification of Dd and the titration of Ad3 to be performedFig. 3. Titration of infectious virus and quantification of Pt-Dd and total viral partic
A part of the lysate was centrifuged on a 15–40% sucrose gradient to recover Pt
serum. For this, aliquots of Pt-Dd produced during the Ad3 cycle were run on
baculovirus system and purified. For the infectious virus titration, Ad3 was puri
Results obtained in three independent experiments. Dodecahedron particle molecon the same batch of infected cells (Fig. 3). Lysate recovered
from HeLa cell infected for 24 h has been either subjected to
sucrose gradient ultracentrifugation to separate Dds from the
virus particles or applied to cesium chloride gradient to
purify Ad3 virions. As expected, Dd was localized in the
28–38% part of the sucrose gradient density with very low
contamination by virus particles as attested by electron
microscopy (below 0.5%, data not shown). These fractions
were then pooled and different volumes were run on SDS-
PAGE in the presence of known amounts of purified Dd,
and subjected to Western blot with anti-Pt-Dd serum. By
comparing the band intensity of our sample to that of the
purified Dd range, we found a total amount of 45 Ag of Dds
in the lysate of 107 cells meaning that, on average, 7.5  105les. (A) Principle: Ad-infected HeLa cells were lysed after 24 h of infection.
-Dd. Quantification of Dd was performed by Western blot using anti Pt-Dd
SDS-PAGE and compared to known amounts of Pt-Dd expressed in the
fied on a cesium chloride gradient and titrated by FFU determination. (B)
ular weight of 3.6106 Da was used in calculations.
Rapid Communication 171particles were found per cell. This amount is likely to be
underevaluated as some cells were not infected.
Infectious Ad3 particles were titrated by fluorescent
forming unit (FFU) determination. For this, adenoviruses
were purified from infected cell lysate by cesium chloride
gradient centrifugation in order to eliminate Dds and other
contaminants that could interfere with Ad3 infection.
Results of three independent experiments demonstrated that
a total of 1.4  106 FFU were present in the lysate. These
results show that there is a large excess of Dd over
infectious Ad3 particles in infected cells with an average
of 5.5  106 Dds per one infectious virus. Total viral
particles have also been assessed by Western blot by
comparing the penton base band displayed by the virus to
that of a range of known amounts of purified dodecahedron,
as described in Fig. 3. With a ratio of 26,000 non-infectious
viral particles per infectious virus, it has been calculated that
about 200-fold more Dds than total viral particles are found
in Ad3-infected cell, at 24 h p.i.Discussion
Adenovirus penton base is a major player not only in
adenovirus entry but also during the adenovirus replication
cycle. Indeed, even if it has been known for long time that
penton base has a critical role in viral endocytosis
(Wickham et al., 1993), another role for this protein has
been reported more recently. Due to their strictly
conserved PPxY sequence in their N-terminus, human
adenovirus penton bases interact with WW domain-
containing proteins such as the ubiquitin ligases family
(Galinier et al., 2002, Chroboczek et al., 2003). In our
study, we showed that neo-synthesized penton as a typical
late product appears in the cytoplasm of infected cell 12 h
p.i and its synthesis increases steadily until 24 h, as
reflected by the kinetic study (Fig. 1). During this period,
the penton is susceptible to interact with several
cytoplasmic protein partners including WW-containing
proteins before being transferred to the nucleus where
the virus assembly takes place. Interestingly, the diffuse
penton base signal seen inside the nucleus at 16 h p.i.
seems to become arranged along the nuclear membrane
8 h later. At 24 h p.i., one cycle of the virus replication
has been accomplished and thus virion progeny is already
present in the nucleus of infected cell (White et al., 1969;
Boudin et al., 1979).
It has been reported that a highly symmetric particle
made of twelve penton bases is produced in Ad3-infected
cells (Norrby, 1966). This particle, called adenovirus
dodecahedron (Dd), is well characterized from the structural
point of view (Schoehn et al., 1996; Zubieta et al., 2005) as
well as functionally (Fender et al., 1997; Vives et al., 2004)
but little is known about its formation. In this study, we
bring new elements showing that this particle is likely
assembled in the nucleus as no Dd can be recovered fromcell infected for 12 h when penton base is expressed in the
cell cytoplasm but not yet found in the nucleus (Fig. 1B).
Nuclear assembly of virus-like particles has already been
described for other viruses such AAV or polyomavirus
(Hoque et al., 1999; Johne and Muller, 2004).
Another point investigated in this work is the total
number of Ad-Dd produced per infected cell and how it
correlates with the virus titer. Surprisingly, Ad3 infection in
cell culture yielded very low titer of infectious virus. This
low number is somewhat in contradiction with the number
and the size of adenoviruses para-crystals (nuclear inclu-
sion) seen in the nucleus of Ad3-infected cells (Fig. 2B,
right panel). A ratio of about 26,000 non-infectious viral
particles per infectious particle has been determined. Such a
low yield of infectious Ad3 might suggest that the virion
maturation requires an additional step taking place during
normal cell lysis and which does not occur in freeze–thaw
cycles. However, whatever the number of defective and
infectious viruses, a massive amount of Dd is found in the
nucleus of Ad3-infected cell and we have investigated their
distribution. Remarkably, these complexes that at 16 h p.i.
are randomly spread all over the nucleus, are arranged inside
the nucleus along the nuclear membrane at 24 h p.i. This
distribution contrasts with the virion nuclear inclusions that
are found in different area of the nucleus as seen by
immunofluorescence with anti-hexon antibody and con-
firmed on infected cell ultrathin sections (Fig. 2). The
mechanism leading to such localization of Dd is not known
and unfortunately the size of the particle does not permit
obtaining precise details of their organization on ultrathin
sections.
The amount of dodecameric particles produced in
infected cell nuclei has been estimated. On average,
7.5  105 particles are found per infected cell representing
a ratio of 5.5  106 Dds per infectious virus. Such an
excess of pentons synthesized during the Ad3 replication
cycle strongly suggests that Dd has a role in virus strategy.
It is relevant that the Ad2 penton base protein is know to
triggers cell detachment (Boudin et al., 1979) and we have
reported that Ad3-Dd interacts with high affinity with
heparan sulfate that participates in cell cohesion (Vives et
al., 2004). It can be hypothesized that during cell lysis, the
release of massive amounts of Dd can affect cell cohesion
and/or that competition with virus for its receptor during
secondary infection contributes to virus escape and spread-
ing as reported for the Ad2 fiber (Walters et al., 2002).
With regards to our results, it can also be hypothesized that
Dd plays a role in the nucleus of infected cells. It could be
envisaged that Dd localizes with nuclear pore complex and
regulates nuclear import and export. Taken together, our
results show that only a low proportion of Ad3 penton
proteins migrating from cytoplasm to the nucleus is used
for virion formation while the major part self-assembles in
form of Dd and accumulates along the nuclear membrane
reinforcing the idea of the crucial role of this particle in the
Ad3 life cycle.
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Cells and virus
HeLa cells were cultured at 37 -C, under 5% CO2
atmosphere, in EMEM (BioWhittaker), supplemented with
10% fetal calf serum (FCS), penicillin (50 IU/ml), and
streptomycin (50 Ag/ml). Ad3 stock was purified from a
lysate of HeLa cells infected at MOI 1 for 48 h, by double
banding on CsCl gradient according to Kanegae et al.
(1994). This stock was dialyzed against Tris 20 mM pH
7.4–150 mM NaCl and stored in presence of 20% glycerol
at 20 -C.
Pt-Dd expression and detection
Pt-Dd was expressed in the baculovirus system and
purified on sucrose density gradient, as previously
described (Fender et al., 1997). Pt-Dds were detected by
Western blot using anti-Pt-Dd serum (diluted at 1/40,000
in PBS–0.1% Tween-20) and a subsequent incubation
with anti-rabbit HRP-conjugated antibody at 1/5000
(Jackson).
Virus titration and Dd quantification
HeLa cells grown in a 25-cm2 dish (about 107 cells) were
infected with Ad3 at MOI 1. At the indicated time after
infection, cells were washed with PBS and lysed by three
freeze/thaw cycles in 1 ml hypotonic buffer (Tris 20 mM pH
7.5–50 mM NaCl). The cell lysate was recovered after
5 min centrifugation at 400  g and one part was used for
titration of infectious virus while the other part was used for
Dd quantification (summarized in Fig. 3).
Ad3 titration
Titration of Ad3 infectious particles was performed by
immunofluorescence. Serial virus dilutions prepared in
250 Al of EMEM without serum were incubated for 1 h
with HeLa cells in a 24-multiwell plate (105 cells/well).
Then, 750 Al of EMEM containing 10% SVF was added
for an additional 23H. Cells were then washed with PBS
and permeabilized for 10 min with 250 Al of cold
methanol. After several PBS washes, the wells were
incubated for 1 h with 250 Al anti-Pt-Dd rabbit polyclonal
serum diluted at 1/1000 in PBS–0.1% Tween-20 for 1 h
and subsequently incubated for 1 h with FITC-labeled
goat anti-rabbit antibody (Jackson) diluted at 1/250 in the
same buffer. Green fluorescent cells were counted in
triplicate and the results were averaged and scaled in
order to obtain the titer of infectious particle in FFU/ml.
Total particles of adenovirus has been quantified by
Western blot, using an anti-Bs-Dd antibody (recognizing
Ad3 penton base). Penton base signal corresponding to
boiled viruses was compared to that of known amounts of
purified Bs-Dd.Dodecahedron quantification
Dodecahedron was purified from 100 Al cell lysate on a
15–40% sucrose gradient (prepared in 20 mM Tris, pH
7.4–150 mM NaCl–10% glycerol) by 4 h centrifugation at
200,000  g in a TLS-55 rotor (Beckman). Ten fractions
were collected from the top of the gradient. Fractions 6 to 9
containing purified dodecahedron (28–38% sucrose) were
pooled and analyzed by electron microscopy. Different
volumes of this pool were then boiled in the presence of
SDS and run on a 12% PAGE-SDS gel together with known
amounts of purified Pt-Dd. After electro-transfer on a PVDF
membrane, a Western blot was performed with anti Pt-Dd
serum as described above. The amount of Dd was assessed
by the comparison of band intensity and results were scaled
to the total cell number. Results are expressed as the mean
of three independent experiments.
Confocal microscopy
HeLa cells were grown overnight on glass coverslips
(about 105 cell/cm2) in EMEM medium supplement with
10% FCS at 37 -C under 5% CO2 atmosphere. Cells were
infected with Ad3 at MOI 1 in 250 Al EMEM without
serum. After 1 h at 37 -C, the inoculum was removed, cells
were washed, and 750 Al EMEM containing 10% FCS was
added. After different periods post-infection (p.i.), the
medium was removed, cells were rinsed with PBS and then
permeabilized with cold methanol for 10 min. Immuno-
fluorescence detection of penton was performed by incuba-
tion of coverslips with anti-Pt-Dd rabbit polyclonal serum at
1/1000 in 50 Al PBS–0.1% Tween-20 and a subsequent
incubation with FITC-labeled goat anti-rabbit antibody
(Jackson), diluted 1/250 in the same buffer. Cell nuclei
were counterstained with propidium iodide (5 Ag/ml). A
similar experiment was performed with mouse monoclonal
anti-Ad3 hexon antibody (Chemicon) at 1/100 and FITC-
labeled anti-mouse antibody. Localization of Dd and
adenoviruses in the same cell was performed by using an
anti-Bs-Dd rabbit polyclonal serum (recognizing only the
penton base) at 1/1000 and an anti-Ad3 hexon antibody at 1/
100. Penton base signal was revealed in red by rhodamine-
labeled anti-rabbit antibody and hexon signal in green by
FITC-labeled antibody. Laser scanning confocal microscopy
was performed on MRC600 (Bio-Rad).
Epon inclusion and thin sections of infected cells
HeLa cells grown in a Labtek chamber slide (Nunc) were
infected with Ad3 at MOI 1 for 24 h. Cells were fixed with
2.5% glutaraldehyde in 100 mMHEPES buffer pH 7.4, post-
fixed with 1% osmium tetraoxide and dehydrated with
ethanol. Ultrathin sections (80 nm) of infected cells embed-
ded in Epon were performed and collected on carbon-coated
grids. Grids were stained with saturated uranyl acetate in
50% ethanol and then with 1 M lead citrate. Observations
were made with Philips CM10 microscope at 80 kV.
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Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?
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Abstract: The attachment of viruses to the host cell surface is a critical stage that will largely condition cell permissivity
and productive infection. The understanding of such mechanisms is therefore essential for gene therapy applications in-
volving viruses, as this step will influence both targeting and delivery efficiency of the gene of interest. Viral attachment
depends upon the recognition and binding of viral envelope/capsid proteins to specific cellular receptors that can be from
very diverse origins. Amongst them are heparan sulphate proteoglycans (HSPGs), a family of glycoproteins which,
through the large binding properties of their heparan sulphate (HS) polysaccharide chains, serve as attachment receptor for
a great number of viruses. The aim of this review is to provide an update on the multiple roles of HSPGs during viral in-
fection, with a special focus on viruses used as gene delivery vectors. Consequences of HS binding for gene therapy ap-
plications will be assessed, as well as the various strategies that have been developed to potentiate the advantages or to
overcome the drawbacks resulting from viral vector interaction with HS.
Keywords: Proteoglycan, glycosaminoglycan, heparan sulphate, adenovirus, AAV, virus, viral vector, receptor, endocytosis,
targeting, gene therapy.
1. HEPARAN SULPHATE PROTEOGLYCAN (HSPG):
A MULTIFACETED MOLECULE AT THE CELL
SURFACE
1.1 Proteoglycans and Glycosaminoglycans
Proteoglycans (PGs) are ubiquitous glycoproteins, widely
distributed in animal tissues, that are involved in a multitude
of biological processes, including cell proliferation and dif-
ferentiation, embryo development, inflammation, migration,
chemoattraction, and viral attachment [Bernfield et al., 1999;
Delehedde et al.,  2002; Iozzo et al.,  2001; Liu et al.,  2002;
Perrimon et al.,  2000] . They are characterised by a protein
core, on which one or several glycosaminoglycan (GAG)-
type polysaccharide chains are covalently attached. PGs are
generally classified according to the nature of their polysac-
charide chains, their location and their function. PGs can first
be expressed in intracellular compartments. This is the case
of Serglycin that is found in mast cell secretory granules
released upon inflammation and that helps packaging their
protein content. PGs can also be extracellular (examples are
Perlecan, Aggrecan, Decorin…) and are then generally asso-
ciated with roles in the cohesion and remodelling of the ex-
tracellular matrix, or protein storage. Finally, a last class of
PGs are associated to the cell surface, where they provide
binding sites for a large number of proteins, have been
shown to participate to most cell processes and are exploited
by many pathogens for binding to the cell surface. These
PGs fall in two main families: syndecans, a four member
family of type I transmembrane proteins, and glypicans
(Glypican-1 to -6), which are extracellular proteins bound to
the cell surface by the mean of a phosphatidylinositol lipid
anchor (Fig. 1). In addition, proteins occasion-
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ally bearing GAG chains have been observed, including type
III Transforming Growth Factor b (TGFb) receptor, or cell
adhesion molecule CD44.
A number of evidence suggests that PG core protein di-
rectly participates to various cell functions [Yoneda et al.,
2003; Zimmermann et al.,  1999] . Syndecan protein core is
involved in the regulation of the cytoskeleton organisation
and formation of focal adhesion. Moreover, syndecan cyto-
plasmic domain can be phosphorylated and thus, may initiate
cascades of signalling events. However, it is widely recog-
nised that most of HSPGs’ large biological activities are
primarily due to the ability of their GAG chains to interact
with a wide range of protein ligands [Esko et al., 2002; Gal-
lagher, 2001; Lyon et al., 1998] . GAGs are a family of
highly sulphated (with the exception of hyaluronic acid),
complex polysaccharides. The structural basis of GAG sac-
charide backbone is a disaccharide unit, comprising a
hexosamine and an uronic acid, that can be variably sul-
phated (for review, see [Esko et al., 2001; Lindahl et al.,
1998] ). The nature of the hexosamine (glucosamine or ga-
lactosamine), uronic acid (glucuronic or iduronic acid) and
the degree of sulphation define the type of GAGs. For in-
stance, HS which is the major GAG species found at the cell
surface, is a polymer of glucosamine and glucuronic/iduronic
acid. In HS, sulphation occurs at C-2, C-6 and occasionally
C-3 of the amino sugar, and at C-2 of the uronic acid (mostly
iduronic acid) (Fig. 1). Remarkably, disaccharide unit sul-
phation does not occur uniformly along the chain. This is
particularly marked in HS, for which sulphation is mostly
restricted to specialised regions of the polysaccharide called
S domains. Consequently, HS features a unique molecular
organisation, with homogeneous, non or low sulphated re-
gions alternating with hypervariable highly sulphated S do-
mains. Within these domains are found motifs of precise
saccharide sequence and sulphation pattern that constitute
protein binding sites. On proteins, a positively charged area
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usually characterises the HS binding region. It often consists
of a BBXB or BBBXXB type sequence (where B stands for
a basic and X for any other amino acid), but can also include
conformational epitopes comprising distant amino acids
clusterised through the folding of the protein [Vives et al.,
2004a] . Interaction with HS can influence protein activity
through many ways. Binding of antithrombin III (AT-III) to
HS induces conformational changes that turn the protein into
an active form, able to bind and inhibit coagulation factor Xa
[Petitou et al., 2003] . HS can act as a template that brings
proteins together and directs formation of biologically active
complexes. A well-studied example of such mechanism is
that of HS binding independently both thrombin and AT-III
to favour their interactions [Petitou et al., 1999; Petitou et
al., 2001] . HS has been shown to induce chemokine dimeri-
sation, a process that may be critical for cell signalling and
formation of chemotactic gradients. HS can act as a
corepector for a number of growth factors, including fibro-
blast growth factors (FGFs), for which binding to the poly-
saccharide is necessary for induction of productive cell re-
sponse [Rapraeger et al., 1991; Yayon et al., 1991] . In con-
trast, HS can inhibit ligand-receptor recognition as for inter-
feron g [Sadir et al.,1998] . Finally, HS has been involved in
the storage and protection of proteins against proteolysis
[Sadir et al., 2004] .
1.2 Role of HSPGs in Viral Infection
1.2.1 PGs Serve as High Affinity Receptor
HS, because of its potent interactive properties and wide
tissue distribution, has been exploited as a prevalent source
of cell surface docking sites by a great number of pathogens
(for reviews, see [Rostand et al., 1997; Spillmann, 2001]).
These comprise parasites, such as Plasmodium falciparum
[Ancsin et al., 2004] or Toxoplasma gondii [Carruthers et al.,
2000] , bacteria, including Bordetella pertussis [Geuijen et
al., 1998] , Staphylococcus aureus [Fallgren et al., 2001] and
Helicobacter pylori [Utt et al.,1997] and many viruses, such
as Human Immunodeficiency Virus type 1 (HIV-1) [Patel et
al., 1993] , Herpes viruses [Shukla et al., 2001] , Dengue
virus [Chen et al., 1997] , Foot and Mouth Disease Virus
[Jackson et al., 1996] and adenoviruses [Dechecchi et al.,
2001; Dechecchi et al., 2000] . Binding to HS has usually
been associated with increased infectivity and studies
showed that many viruses could very easily adapt to the use
of HS, after a few passages on cells in culture [Klimstra et
al., 1998; Lee et al.,  2002] . Elimination of cell surface HS
using sulphation inhibitors (sodium chlorate) or HS degrad-
ing enzymes (heparinases) has been associated with in-
creased cell resistance to infection, resulting from a reduc-
tion in the virus ability to bind to the cell surface. HS has
thus been regarded as an ubiquitous virus attachment recep-
tor that facilitated concentrations at the cell surface and ac-
cess to specific entry receptors (Fig. 2a).
Such an implication has been well established in the case
of adenovirus. Human adenoviruses (Ads) are a large family
of non-enveloped viruses responsible for respiratory, ocular
and enteric infections. Their 36 kb dsDNA genome is con-
cealed within a 90 nm icosaedral capsid composed of three
major proteins : the trimeric hexon, the pentameric base and
the trimeric fibre. The last two form a non-covalent complex
called the penton, which protrudes from each of the 12 verti-
ces of the capsid [Ginsberg et al., 1966; Valentine et
al.,1965] (Fig. 3). The infection process involves a first in-
teraction of the fibre with a high affinity primary receptor,
that will facilitate subsequent binding of the penton base to
cellular integrins and eventually trigger endocytosis [Mathias
et al., 1998; Wickham et al., 1993] . It has been first demon-
strated that most adenovirus serotypes, including Ad5, use a
protein termed Coxsackievirus and Adenovirus Receptor
(CAR) as the primary receptor for infection [Bergelson et al.,
1997; Roelvink et al., 1998] . This interaction is mediated by
the distal globular “head-domain” of the fibre (Fig. 3). Re-
cently, Decchechi et al., reported that the adenovirus fibre
was also able to interact with HS and thus, that this sulphated
polysaccharide is another primary receptor for Ads. Indeed,
addition in the culture medium of a HS competitor, such as
heparin, reduced Ad2 and Ad5 binding by 50% [Dechecchi
et al., 2000] and a similar reduction was achieved by treating
cells with heparin lyases, but not chondroitin lyases. Moreo-
ver, whereas competition assays using soluble CAR only
lead to a 50% reduction of Ad5 binding on HS expressing
Fig. (1). Cell surface HSPGs.
Cell surface HSPGs are divided in two main families: transmem-
brane syndecans and GPI-anchored glypicans. HSPG main feature
is the presence, on the protein ectodomain, of HS chains. HS is
linear polysaccharide constituted by the repetition of a disaccharide
motif, comprising an uronic acid and a glucosamine, that can be
variably sulphated. Within the chain, oligosaccharide motifs of
precise sugar sequence and sulphation pattern constitute binding
sites for a multitude of proteins.
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Fig. (2). HSPGs and their roles in viral entry.
HSPGs play multiple roles during viral infection (a) PGs serve as high affinity primary receptor that enables virus docking and facilitates
subsequent interaction with specific entry receptors. (b) PGs can be involved in storage and protection of viruses at the surface of non-
permissive cells, and then mediate “in trans” infection by presenting these viruses to attachment and entry receptors on permissive cells. (c)
For some viruses, PGs can participate to both virus attachment and entry processes. (PG: Proteoglycan; R:receptor; Co-R: Co-receptor).
Fig. (3). Interaction of Adenovirus with its receptors: the French « ménage à trois ».
The trimeric fibre is composed of an elongated shaft and a globular head domain. The latter interacts with the CAR receptor, whereas the
shaft can bind to with HS. This primary attachment enables the subsequent interaction of the pentameric penton base with integrins that will
eventually trigger endocytosis. The fibre and penton base are located at each of the twelve vertices of the capsid.
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cells, full inhibition could be achieved on Raji GAG-
defective cells. Further work from the same group also dem-
onstrated that HS played the role of attachment receptor for
Ad2 and Ad5 on cells, such as CHO-K1, that do not express
CAR but exhibit HS on their surface [Dechecchi et al.,
2001]. Interestingly, they also showed that GAG expression
at the cell surface varied according to the degree of conflu-
ency and that sparse cells which expressed more HS on their
surface were more susceptible to Ad infection. Ad molecular
determinants involved in HS recognition have not been
identified yet, though the presence of a HS binding consen-
sus sequence has been highlighted within the shaft domain of
Ad-5 fibre. However, a recent study suggests that adenovi-
rus-HS interaction could be indirectly mediated by blood
factors such as the coagulation factor IX or the complement
component C4 binding protein. In this hypothesis, the blood
factor interacts in one hand with the adenovirus fibre head
and in the other hand with HS [Shayakhmetov et al., 2005] .
Whatever the mechanism, a virus–like particle produced in
great excess during the Ad3 replication cycle [Norrby, 1966]
could also interact with the polysaccharide. This particle
called penton-dodecahedron (Pt-Dd) is made of twelve pen-
ton bases interacting through their base in a symmetric man-
ner, with the fibre protruding outside. The formation of this
structure is only due to the penton base, as dodecahedron
lacking the fibre (Bs-Dd) could be produced in the baculovi-
rus system [Fender et al., 1997] . Interestingly, both Pt-Dd
and Bs-Dd interact with HS with an affinity in the nanomolar
range, indicating that the base protein is involved in HS
binding and that the fibre does not interfere with this process
[Vives et al., 2004b] . The functional aspects of both do-
decahedron production during the viral cycle, and strong
interaction with HS are unknown. However, as these parti-
cles can be utilised for protein transduction, their ability to
interact with HS is of large interest in this context (see para-
graph 2.3).
Another interesting example of HS-using viruses is that
of adenovirus associated virus (AAV). AAVs were discov-
ered associated to adenovirus infection [Blacklow et al.,
1968] . Their replication is dependent on a helper virus, such
as adenovirus or herpesvirus. However, AAVs can enter
cells on their own. Three different AAV-2 receptors have
been reported so far: HSPGs [Summerford et al., 1998] ; the
FGF receptor 1 (FGFR1) [Qing et al., 1999] and integrins
a vb 5 [Summerford et al.,  1999] , although the involvement
of this latter receptor has been challenged in other studies. In
any case, AAV-2 binding to HSPGs is critical for entry into
cells. Indeed, studies showed that relatively low concentra-
tions of soluble heparin (5 m g/ml) nearly completely inhib-
ited the binding of AAV-2 to HeLa cells, whereas other
GAGs such as dermatan sulphate, or chondroitin sulphate A
and C, had negligible effect on the virus binding
[Summerford et al.,1998] . In agreement with this, enzymatic
digestion of cells by heparin lyases reduced viral adsorption
on HeLa cells by 80%. Moreover, the use of CHO mutants
that do not express HSPG or express undersulphated GAGs
at their surfaces confirmed the role of HSPG as a primary
attachment receptor for AAV-2. Binding to GAGs involves
the VP capsid proteins, and may explain the broad tropism of
the virus.
For many viruses, the role of HS as a low specificity,
preliminary attachment receptor has been reported and
clearly documented, at least in cell culture. However, it
should be noted that HS-binding activity can emerge as a
result of virus adaptation to replication in cultured cells, in
which viral variants carrying substitutions of positively
charged instead of acid or neutral amino acids in the attach-
ment protein, have been selected. If this makes difficult the
extrapolation of the conclusions raised from laboratory
strains to primary isolates, this also indicates that viruses
have an advantage to attach cell through HS, a situation
likely to be the case for viral vectors that have been propa-
gated and amplified on cultured cells.
1.2.2 PGs are Involved in Virus Storage and Protection
Evidences have also indicated that HS could play more
intricate roles in the mechanisms of viral infection. It has
been recently observed that HIV-1 ability to bind to HS was
related to viral tropism. HIV-1 infection of a host cell is
based on the recognition of two distinct classes of cell sur-
face molecules: the primary receptor CD4 and a coreceptor,
mostly chemokine receptors CXCR4 and CCR5. The use of
one coreceptor or the other defines viral tropism: R5 strains
(using CCR5 as a coreceptor) preferentially infect monocytes
and macrophages, while CXCR4-using strains target CD4+
T-lymphocytes. The ability to bind to HS seems to be re-
stricted to X4 strains [Moulard et al., 2000] . Such tropism
specific property may explain physiological differences ob-
served in vivo. In particular, the preferential ‘trapping’ of X4
viruses onto cell surface HSPGs could lead to selective ex-
haustion of these viral phenotypes observed in the early stage
of the infection. Such a phenomenon may help to explain the
preferential transmission and early dominance of R5 viruses
over X4 viruses in vivo. In support to this, a study has re-
cently shown that non permissive endothelial cells could trap
HIV at their surface via interaction with their HS, store it for
several days without loss of infectivity (whereas free virus
would be rapidly inactivated) and transfer it to circulating T
lymphocytes through a mechanism of “in trans” infection
(Fig. 2b). Furthermore, another recent study has suggested
that HS interaction with HIV-1 envelope glycoprotein gp120
could interfere with gp120 binding to the virus coreceptors, a
process that is the prerequisite of virus-cell membrane fusion
[Vives et al., 2005] . Although the precise role of HS in the
regulation of HIV-1 entry remains unclear, these results
strongly suggest a participation of the polysaccharide in late,
post-binding events of the infection process.
1.2.3 PGs Participate to Both Virus Attachment and Entry
Processes
For other viruses, such as vaccinia virus and HSV-1, a
direct role of HS in cell entry mechanisms has already been
demonstrated. For the latter, HS is implicated at two distinct
stages of the infection. HS participates to cell attachment via
interactions with viral envelope glycoproteins gB and gC,
[Shukla et al., 1999] but is also one of the entry receptor
recognised by glycoprotein gD [Liu et al.,  2002] . More in-
terestingly, binding to gD was shown to be dependent upon
precise and rare saccharide motifs on the HS chains com-
prising a 3-O-sulphated glucosamine residue (Fig. 2c). This
finding suggests therefore the existence of two different
strategies for the use of HS by viruses: the traditionally rec-
ognised “low specificity” binding, for which abundance and
charge content of HS provide both efficient attachment and
Heparan Sulphate Proteoglycans and Viral Vectors Current Gene Therapy, 2006, Vol. 6, No. 1    39
large infection tropism, and an emerging “high specificity”
approach, in which viruses would bind to defined saccharide
epitopes involved in more critical steps of the infection and
enabling a cell targeting restricted to those expressing such
motifs. Better insights into this last strategy may of great
importance for both understanding viral infection mecha-
nisms and engineering new viral vectors for gene therapy
applications.
In this context, defining the molecular determinants of
HS interaction with viral proteins has become more and
more critical. Structural characterisation of protein/GAG
interactions still remains a challenging issue. Nevertheless,
great progress in the field can be mentioned and have in-
volved a number of innovative approaches. Structural deter-
minants of HS interaction with viral proteins, such as AAV-2
capsid protein [Kern et al., 2003], pseudorabbies gC
[Trybala et al., 1998] , HSV-1 gC [Mardberg et al.,  2001] ,
HIV gp120 [Moulard et al., 2000; Vives et al., 2005] , or
vaccinia virus A27L [Ho et al.,  2005] , have been clarified,
with the help of site directed mutagenesis or surface pasmon
resonance analysis. Identification of HS critical 3-O-sulphate
group for binding to HSV-1 gD glycoprotein (see above) was
first achieved, following the observation that expression of
specific HS 3-O-sulfotransferases involved in the biosynthe-
sis of the polysaccharide were associated with cell permis-
sivity to the virus [Shukla et al., 1999] . Later on, screening
of oligosaccharide libraries enabled the isolation and char-
acterisation of a HS structural motif binding to gD [Liu et
al., 2002] . In another interesting work, the full structure of
FMDV virus in complex with a heparin oligosaccharide was
elucidated by X-Ray crystallography [Fry et al., 1999] . Very
recently, a complex involving heparin and the Ross River
virus has been analysed by electron cryo-microspcopy
[Zhang et al., 2005] . These two studies provided detailed
mapping of the polysaccharide/virus interface.
2. TAMPERING WITH HS BINDING PROPERTIES
OF VIRAL VECTORS: APPLICATIONS IN GENE
THERAPY
In the context of gene therapy, interaction of recombinant
viruses with HS can be looked at with two opposite points of
view. On one hand, the large HS dependent hepatic tropism
reported for recombinant virus injected in preclinical trials
can be considered as a negative effect of this interaction.
Indeed, for in vivo experiments, the massive retention of
transfer vectors by the liver prevents an efficient targeting of
others organs or tumours. On the other hand, adapting viral
vectors to the use of HS can be beneficial to broaden the
tropism to cells that would not be permissive otherwise.
Such approach has been proved efficient in ex vivo experi-
ments or for direct injections into target tissues.
2.1 Targeting HSPGs: How to Broaden Gene Delivery
For several applications, the interaction of viral vectors
with HS is beneficial and it can even be desirable to artifi-
cially improve this interaction. Increasing the binding of
recombinant adenovirus (RAd) to the polysaccharide has
been successfully achieved by insertion of short, positively
charged HS binding motifs within the exposed region of the
capsid. It has been first elegantly reported that the suppres-
sion of the fibre stop codon led to the translation of the en-
coding mRNA polyA tail, resulting in the addition of a
polylysine sequence at the C-terminus (in the head domain)
of the fibre [Wickham et al., 1996] . Such kind of C-
terminus insertion has been improved further by the cloning
of a stretch of 7 lysines, downstream a flexible Glycine-
Serine arm (AdpK7) [Wickham et al., 1997] . On the basis of
the high-resolution structure of the fibre head domain [Xia et
al., 1994] , the polylysine stretch was also inserted within the
very exposed and flexible HI loop of this domain. However,
HS interaction resulting from this latter insertion appeared to
be slightly less efficient, compared to insertions at the fibre
C-terminus [Koizumi et al., 2003]. Nevertheless, whatever
the insertion site, these approaches consistently improved
vector entry, with yields varying amongst cell types. For
epithelial cells that are naturally easily infected by Ads, the
use of modified RAd harbouring HS binding motifs resulted
in a very modest increase of cell transduction (1 to 2 fold
increase). In contrast, entry efficiency was dramatically in-
creased for cells that are normally not permissive to wild
type Ads, including macrophages, smooth muscle cells or
endothelial cells. This increase was the result of RAd ability
to bind to HS, as AdpK7 entry into cells that do not express
the CAR receptor was totally abolished by cell treatment
with heparinase, whereas chondroitinase or neuraminidase
treatment had no effect.
Such strategy aiming at increasing cell transduction lev-
els is not restricted to ex vivo applications. It has been dem-
onstrated that Adpk7 could penetrate human glioblastoma
cells 70 times more efficiently than the unmodified Rad,
suggesting a possible use of this vector for direct injections
in tumours. In addition, primary endothelial cells, such as
HuVEC, that are known to be poorly infected by adenovirus,
are 50 times more sensitive to AdpK7. This latter observa-
tion suggests again potential therapeutical applications. Im-
proved targeting of endothelial cells could be of interest in
anti-angiogenic strategies, aiming at restricting tumour
growth and metastasis spreading, or in the prevention of
restenosis as the endothelium is lesioned during angioplasty.
Interestingly, cell entry efficacy could be further enhanced
by combining the addition of HS binding motifs with modi-
fications enabling recognition of other cell surface mole-
cules. It has indeed been reported that AdpK7 harbouring a
RGD peptide displayed an increased transduction efficiency
on human cervix carcinoma, both in cell culture assays and
in in vivo experiments [Rein et al., 2004] . Addition of HS
binding motifs has not been restricted to the fibre protein.
Another capsid protein, the minor pIX protein, has also been
engineered to comprise a polybasic sequence within their
ectodomain [Dmitriev et al.,2002]. Advantages are the
higher number of pIX trimers (80 copies versus 12 fibre
trimers) and their repartition at the virion facets, [Fabry et
al., 2005] . However, modification of this cimenting protein
was shown to partially disturb the stability of the virion ar-
chitecture.
Another aspect that may favour the development of viral
vectors with a tropism for HS is the recent observation that
HS may be responsible for HIV ability to cross the blood
brain barrier (BBB). Contrary to other retroviruses, HIV can
infect resting cells including, in particular, cells of the central
nervous system. Although this property has not been ex-
ploited yet in gene therapy, stereotaxic injections of HIV
have been widely reported [Blomer et al., 2002] . A study
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has recently shown that HSPGs were involved in HIV brain
invasion. Interaction of HS with basic domains of HIV
gp120 enables capture of the virus at the surface of CD4
negative endothelial cells and migration through the BBB
[Bobardt et al.,  2004] . This transcytosis process is not fully
understood, but cannot be inhibited by the natural ligands of
CXCR4 or CCR5 coreceptors (SDF-1a, RANTES or MIP).
Moreover, virus lacking gp120 failed to cross this biological
membrane, reinforcing the idea of a CD4 independent bind-
ing of gp120 to HSPGs. In support to this, previous studies
reported that syndecans greatly enhanced HIV binding on
both CD4+ cells, such as macrophages or T-lymphocytes,
and CD4- cells, including HuVEC and human genital
epithelial cells [Bobardt et al., 2003; Patel et al., 1993; Sa-
phire et al., 2001; Wu et al., 2003] . The adaptation of viral
vectors to the use of a HS mediated BBB cross-over pathway
would represent a major step forward for the delivery of neu-
rotrophic factors in neurodegenerative diseases.
2.2. Detargeting HSPGs: How to Increase Specificity
For gene therapy applications aiming specific tissues
such as metastasis, interaction with HS could represent a
major drawback, as viral vectors may be diverted from their
targets and trapped within HS rich organs, such as the liver.
To overcome this, HS detargeting strategies have been de-
veloped, mainly for adenovirus and AAV based vectors. To
target Ad5 derived vectors to a specific receptor, the invali-
dation of both CAR and integrin tropism is not sufficient. It
has been demonstrated that this vector still displayed a very
pronounced hepatic tropism [Martin et al., 2003] and thus,
that the abolition of Ad5 HS binding properties was required
to enable efficient targeting of specific markers. To do this,
the basic sequence found in the shaft of Ad5 fibre was first
mutated. Resulting RAds showed a 50% transduction reduc-
tion in rat liver [Nicol et al., 2004] . Combining this fibre-
shaft mutation to fibre-head mutations that prevented CAR
recognition resulted in a dramatic decrease (95%) of adeno-
virus transfer to the liver. A 99% reduction of rat liver trans-
duction could even be achieved by a further deletion of the
RGD motif required for integrin binding [Nicol et al., 2004] .
Altogether, these data show that HS is one of the major fac-
tor responsible for Rad hepatic tropism, but also that other
receptors are involved in this process. These results have
been further supported by in vivo trials in non-human pri-
mates that demonstrated the importance of HS binding on
tissue targeting. Indeed, while RAds harbouring mutations
for CAR recognition displayed no significant modifications
of their bio-distribution (mostly in liver and spleen), a dra-
matic change was observed for RAds lacking HS binding
motifs, with a significant decrease in delivery for all exam-
ined organs [Smith et al.,  2003] . Hence, the design of new
vectors may require appropriate modifications to achieve HS
detargeting and allow efficient “retargeting” towards specific
markers.
Abrogation of HS binding properties has also been con-
sidered for AAV-2 based vectors. One interesting property of
AAV-2 lies on the fact that its genome is integrated at a spe-
cific site into human chromosome 19 [Kotin et al., 1990;
Samulski et al., 1991]. Although this feature is lost in AAVs
vectors their non-immunogenic properties have made of this
virus one of the most promising viral vectors for gene ther-
apy.
The broad range of cells permissive to AAV-2 is another
advantage for gene transfer applications, such as ex-vivo
DNA delivery or direct injection into an organ or a tissue.
On the contrary, the low binding specificity of this vector is
a clear limitation for delivery through intravenous injections.
A number of studies aimed at redirecting AAV-2 to specific
target cells by inserting motifs in the VP capsid. AAV-2
vector with a VP protein harbouring an endothelial-specific
peptide inserted at the level of residue 587 was able to enter
HuVEC, using a HS-independent pathway, as addition of
soluble heparin had no effect on transduction efficiency
[Nicklin et al.,  2001] . In contrast to wt-AAV-2, such modi-
fied virus was not retained on a heparin column, indicating
that the peptide insertion had induced structural modifica-
tions that altered the heparin binding site. Another work re-
ported that the deletion of six residues at position 586-591
(GNRQAA) of the VP protein resulted in the loss of HSPG
recognition. Interestingly, the insertion of a peptide
(NGRAHA) identified by phage display to specifically target
CD13, a receptor expressed in the angiogenic vasculature
and many tumour cell lines, restored binding to HSPG inter-
action and thus, demonstrated the involvement of R588 in
the interaction [Grifman et al.,  2001] . Several studies have
also reported the insertion of a RGD peptide into the VP
protein, at different positions, without impairing the virus
titre. This addition of a RGD motif increased only moder-
ately the transduction of cells expressing both integrins and
HSPGs, including HeLa cells, but dramatically enhanced
transduction in cells that expressed low levels of HSPG, such
as Raji cells. Interestingly, Ovarian carcinoma cell (SKOV-
3) that are poorly transduced by wt-AAV-2 are permissive to
RGD-AAV vectors [Shi et al., 2003] . Surprisingly, contrary
to wt-AAV, RGD-AAVs were not susceptible to addition of
soluble heparin, indicating that the “RGD pathway” was
completely independent from HSPG. Such strategy is prom-
ising, especially for the targeting of tumours that overexpress
integrins [Albelda et al., 1990; Gladson et al., 1991; Lessey
et al., 1995] . Recently, the HS binding site on AAV-2 cap-
sid has been fully characterised [Kern et al., 2003; Opie et
al., 2003] . In correctly assembled VP trimers, a number of
basic residues (R484, R487, K532 in one site and R585,
R588 in another site of the VP capsid proteins) are gathered
in clusters that form the HS binding domain (Fig. 4). Inter-
estingly, mutation of residue R475 that is not exposed at the
capsid surface strongly reduced binding of AAV-2 to hepa-
rin, this being most likely due to an indirect structural effect
that disturbs the correct assembly of VP subunits and the
subsequent formation of the HS binding clusters. Mutations
on residues of the HS binding site have been performed to
alter AAV tropism for the polysaccharide. An in vivo ex-
periment was undertaken in immuno-competent mice by
injection in the tail vein of a wild-type or a double mutated
(R484E, R585E) recombinant AAV-2 encoding for lu-
ciferase. Three weeks after injection, luciferase activity was
detected predominantly in the liver, heart and to a lesser ex-
tent in kidney of mice treated with wild type vector, whereas
the luciferase activity was only detected in the heart, for
animals injected with the mutated vector. For these animals,
luciferase activity detected in the heart was fifteen times
higher than for wild type AAV-2 treated mice [Kern et al.,
2003].
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Fig. (4). Clustering of basic residues forms HS binding sites on
the AAV capsid.
(a) The amino acids involved in heparin binding are grouped in
three clusters at the threefold spike region of the capsid: R585 (or-
ange), R588 (red), R484 (purple), R487 (green), K532 (blue) and
R475 (yellow). (b) A side view of a VP trimer shows the surface
exposure of the basic clusters at the inner shoulder of the threefold
spikes and along a channel-like structure between the threefold
spikes.
(Reproduced from Kern et al., 2003 with permission).
A last interesting example on how HS can constitute an
obstacle in gene therapy is that of retrovirus vectors. Retrovi-
ruses are the most utilised vectors in gene therapy. Their
success is mainly based on their ability to integrate the gene
of interest in the cellular genome, this providing a hereditary
correction of the phenotype to daughter cells. Such feature is
particularly used for ex vivo correction of cells before re-
implantation [Cavazzana-Calvo et al., 2000]. Binding of
retroviruses to widely express receptors, such as HS, is thus
critical for both in vivo  and ex vivo applications. It has been
shown that the envelope of retroviruses can feature HSPGs
that were recovered from the plasma membrane of the in-
fected cell during the budding process of the progeny viri-
ons. These negatively charged molecules embedded in the
virion could have a negative effect on cell attachment, as
they generate small electrostatic forces that may repel the
virus from the cell surface. To overcome this problem, retro-
viral vectors have been treated with positively charged mole-
cule like polybrene [Davis et al., 2002]. This treatment
clearly improved direct interaction of the virus with the tar-
geted cell. In another approach designed for ex vivo applica-
tions, the retrovirus vector was complexed with HS and al-
lowed to bind to fibronectin (FN) coated plates. The HS-
fibronectin interaction resulted in neutralisation of the mole-
cule charges and contributed to immobilising the vector at
the surface of the plate. As the traction force that cell exerts
on the substrate was considerably larger than the repulsive
force of the virion, retroviral vector penetration would then
occur [Lei et al., 2002] . This two step mechanism showed
more efficiency than the direct interaction of polybrene-
treated retroviral vectors with cells.
2.3. HSPGs and Protein/Peptide Vectors
Recently, a series of virus-encoded and regulatory pro-
teins showed the ability to cross biological membranes. For
example, peptides derived from the Drosophila Anten-
napedia homeodomain are internalised by cells in culture
[Derossi et al., 1994] and transferred to the cell nucleus
where they can directly and specifically interfere with the
transcription [Derossi et al., 1996; Le Roux et al., 1995] .
HIV-1 Tat protein is rapidly taken up by the cell in vitro and
can specifically transactivate the HIV-LTR [Frankel et al.,
1988; Green et al.,1988] . The Tat protein is composed of
about one hundred amino acids including a highly basic re-
gion and a cysteine-rich region. It was shown that Tat-
derived peptides as short as 11 amino acids are sufficient for
transduction of proteins [Fawell et al., 1994; Nagahara et al.,
1998] . A Tat-galactosidase fusion protein could be effi-
ciently delivered into brain tissue and skeletal muscle in vivo
[Schwartz et al.,, 2000] . For a long time, the precise mecha-
nism by which the 11-amino acid transduction domain could
cross lipid bilayers was poorly understood, but a recent study
demonstrated that Tat or Antenapedia peptide endocytosis
was promoted by interaction with cellular glycosaminogly-
cans [Console et al., 2003] . This has also been described for
other viral trans-activators. The Zebra protein of the Epstein
Barr Virus (EBV), has recently been shown to enter lym-
phoid cells through a HS dependant pathway [Mahot et al.,
2005]. Similarly, the Rep68 protein of AAV-2 has been re-
ported to enter cells, through clathrin-dependent endocytosis
mediated by HS, and to reach the nucleus where it regulates
viral promoters [Awedikian et al.,  2005] . Altogether, these
results show that HS mediated cell entry is a mechanism
shared by several viral proteins.
Beside these viral peptides, a virus-like particle derived
from adenovirus called dodecahedron (Dd) has been devel-
oped for protein delivery into cells. A clear advantage of this
sub-viral particle is that it retains adenovirus endocytotic
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features but is devoid of genetic material. The proof of con-
cept of Dd use for protein delivery has been made for large
multimeric proteins, such as a monoclonal antibody [Fender
et al.,  2003] . Recently, a universal adaptor has been devel-
oped to make of Dd a versatile vector for protein transduc-
tion [Garcel et al., in press]. The efficiency of this new sys-
tem is surprisingly high, with an average of 107 proteins of
interest imported per cell. This efficacy can be explained, in
part, by the ability of Dd to bind with high affinity to cellular
HS, this interaction mediating cell entry through a fibre in-
dependent internalisation pathway [Vives et al., 2004b] .
This confers to Dd the ability to enter a wide range of cell
lines, including cells that are not permissive to adenovirus.
CONCLUSION
Understanding the mechanisms by which HS participates
to viral infection has become a critical issue for gene therapy
applications, as increasing evidence show that the binding of
viral vectors to HS can dramatically influence cell entry effi-
ciency, tropism and biodistribution. On one hand, this inter-
action can be beneficial, as the broad expression of HS by a
variety of cells enables ubiquitous delivery of the therapeutic
genes. With this respect, efforts have been made to engineer
viral vectors with increased affinity for this polysaccharide.
Addition of polybasic sequences in their capsid protein
yielded promising results, with a dramatic increase in trans-
duction efficiency for cells that would normally be poorly
permissive to the virus. On the other hand, for in vivo appli-
cations, injection of viral vectors in the bloodstream often
results in the accumulation of the virus in HS rich organs,
such as the liver, which thus prevents efficient delivery to a
specific target tissue. Hence, new strategies were developed
to “detarget” the vectors from their natural receptors, in-
cluding HS, and retarget them for the recognition of specific
ligand. With the recent finding that HSV-1 entry into cells
could be mediated by rare HS motifs of precise sulphation
pattern, a new view has emerged on the role of this polysac-
charide during viral infection. Binding to HS can also be
highly specific and may be used to drive infection towards
the only tissues expressing particular saccharide epitopes at
their surface. Further insights into the structural basis of vi-
rus-HS recognition will be crucial for the design of viral
vectors with improved specificity and efficiency.
ABBREVIATIONS
AAV =  Adenovirus-Associated Virus
Ad =  Adenovirus
Bs-Dd =  Base-Dodecahedron
CAR =  Coxsackie and Adenovirus Receptor
Dd =  Dodecahedron
EBV =  Epstein Barr Virus
FMDV =  Foot and Mouth Virus
GAGs =  Glycosaminoglycans
HIV =  Human Immunodeficiency Virus
HS =  Heparan Sulphate
HSPGs =  Heparan Sulphate Proteoglycans
HSV =  Herpes Simplex Virus
LTR =  Long Terminal Repeat
PGs =  Proteoglycans
Pt-Dd =  Penton-Dodecahedron
RAd =  Recombinant Adenovirus
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Adenoviruses are a large family of non-enveloped
DNA viruses that infect a wide range of human and
animal cell types, most commonly causing respira-
tory disease but also gastroenteritis or conjunctivitis.
Their characteristic morphology includes an icosahe-
dral capsid with a diameter of 900–1000 A˚, penta-
meric capsomers (penton bases) at the vertices and
hexavalent trimers (hexons) populating the facets in a
pseudo-TZ25 arrangement.1 A trimeric fiber protein
extends 100–300 A˚ (according to serotype) from the
outer capsid surface and is attached non-covalently to
each penton base forming the penton. Several other
minor structural proteins are involved in stabilizingd.
Figure 1. Schematics of adenovirus and its dodecahedron. (a) Diagram of adenovirus, including the major structural
proteins: hexon (light blue), penton base (grey) and the trimeric fiber (gold) that extends outwards ending in a knob.
Additional minor capsid proteins include the hexon “cementing” proteins IIIa (red bars), IX (yellow triangles), protein
VIII associated with the hexons (green oval) and protein VI associated with the penton base (blue ovals). DNA is
represented as an extended string (although in reality it is more compact than indicated here) and coated with associated
proteins. Beneath is a negative-stain EM image of a viral particle. (b) Representation of the sub-viral dodecahedral
particle with fiber bound (Pt-Dd) viewed down a 5-fold axis and a negative stain EM image from expressed penton base
and fiber proteins where some fibers are visible, particularly the distal knobs. (b) The dodecahedral particle without fiber
(Bs-Dd) and corresponding EM image. The bars represent 200 A˚.
Structure of the Ad3 Dodecahedral Particle 511the capsid (Figure 1). The distal knob-domain of the
fiber is necessary for cell recognition. Most subgroups
(A–F, excluding B) bind the Coxsackie and adeno-
virus receptor (CAR),2,3 an integral membrane
protein of the tight junction in epithelial cells.4 The
interaction between the fiber and CAR is implicated
both in viral entry and egress.5 Several subgroup B
adeno-viruses utilize another cell surface receptor,
CD46,6,7 but the primary receptor for another
subgroup B member, adenovirus serotype 3 (Ad3),
is still not known. Cell entry is gained by endocytosis,
in most serotypes through RGD-loops extending
from the penton base that bind to the avb3 or b5
integrins.8,9 The penton base also has a role in release
from endosomes and decapsidation.10,11
Models of the adenovirus capsid have been built
by combining available crystallographic structures
of the capsomers with lower resolution density
maps of the entire capsid from cryo-electron
microscopy (cryoEM). A model of the subgroup C
Ad2 capsid was partially built from the trimeric
hexon12 and capsid reconstruction.1 This model
accounted for w60% of the protein in the virion and
offered insights into hexon–hexon and hexon–penton base interfaces, as well as indicating
potential locations for some of the minor proteins.
More recent updates include cryo-electron
microscopy density maps of the Ad2 and Ad12
capsids to 21 A˚ resolution where surface features
such as the RGD receptor binding loops were
localized through binding MAbs or small receptor
fragments.13,14 However, much detail was lacking,
including the structure of the penton base, its
interaction with the fiber and the role of the
symmetry-mismatch between these two components.
Our recent cryoEM study on the Ad5 capsid has
extended the resolution to 10 A˚, allowing more
detailed modeling of the capsomer interfaces and
localization of minor structural proteins by compari-
son of native and deletion mutant capsids.15
For certain adenovirus serotypes, penton bases
can self-assemble into a sub-viral particle called
dodecahedron that comprises 12 copies of the
penton arranged on a TZ1 icosahedral lattice16,17
and may include fiber molecules (penton dodeca-
hedron, Pt-Dd) or not (base dodecahedron, Bs-Dd)
(Figure 1). Analysis of the dodecahedral particle of
Ad3 by cryoEM to a resolution of w30 A˚ revealed
512 Structure of the Ad3 Dodecahedral Particlethe overall shape of the particle and allowed an
estimation of the dimensions of the internal cavity.18
Comparison between particles including the fiber
molecule (Pt-Dd) and those without (Bs-Dd)
revealed apparent redistribution of density at the
outermost surface of the penton at the presumed
location of the mobile integrin-binding RGD loops.
The fiber itself, however, was poorly resolved,
possibly as a consequence of intrinsic flexibility,
limited number of particles included in the
reconstruction (30) or from bending imposed by a
restricted depth of ice formed during preparation
for microscopy. Subsequently, the dodecahedron
was shown to enter cells efficiently using the same
mechanism as adenovirus,19,20 confirming the
localization of the infection mechanisms to the
penton’s two constituent proteins, penton base and
fiber. We have previously proposed the dodeca-
hedron as an alternative to adenovirus for therapeutic
delivery.19,20 One of the potential advantages over
the intact virus particle is that it cannot provoke
infection directly or through recombination, as it
harbors none of the viral genome. A second is the
possibility of a weaker immune response compared
to adenovirus because of its reduced protein
content, thereby enhancing the success of multiple
applications. In addition, recent work has shown
that dodecahedra can penetrate a wider range of
cells than the virus by entering through a heparin
sulfate pathway.21 However, the internal cavity of
the dodecahedron is too small to accommodate
more than w100 bp of DNA and is thus too small to
carry a gene, although it could accommodate drugs.
Specific targeting to non-native receptors is possible
through modification of the cell-recognition
domains on the fiber, or combining fibers and
penton bases from different adenovirus serotypes.22
Recently, a crystallographic model of the Ad2
penton base was reported. An expressed 48
N-terminal truncated form of the penton exposed
to crystallization conditions lead to formation of
dodecahedral particles in the crystal.23 Interes-
tingly, the full-length Ad2 penton base did not
spontaneously form dodecahedra. The core of the
structure is a jellyroll motif, an eight-stranded
antiparallel b-barrel that is common to capsid
proteins of certain virus families, with an extensive
insertion of 308 residues (54% of the protein)
between two b-strands of the jellyroll, and a second
insertion of 54 residues between another pair of
strands. The first insertion includes two external
loops, one of which (the RGD loop) contains the
integrin-binding RGD domain and is highly vari-
able between serotypes in sequence and length. It is
also flexible and none of the 74 residues of the loop
were modeled in the crystal structure. The second
loop (variable loop) is shorter, also variable between
serotypes, and projects from the outer surface of the
penton base into solvent. The binding pattern of
the Ad2 fiber was revealed in a second
dodecahedron structure including residues 11–21
from the N-terminal part of the fiber protein
as five monomers bound to the penton base, albeitin non-stoichiometric quantities since the fiber
molecule is a trimer.
The available adenovirus penton base protein
sequences are highly conserved outside these
external loops, suggesting that the bulk of the
penton base has a common fold. The Ad2 penton
protein differs in sequence from that of Ad3 at the
amino terminus and at the two external loops,
where the Ad3 protein is some 34 residues shorter
in the RGD loop and nine residues longer in the
variable loop. These three variable regions are
perhaps the most important outside of the con-
served interface residues that direct subunit and
penton–hexon organization. The amino terminus is
located internally to the capsid15 and holds two
conserved motifs of the form PPxY that may
potentially interact with host cell ubiquitine ligases
containing WW domains24 presumably before
incorporation into the capsid or after partial
decapsidation. The RGD loop is a co-receptor
binding site involved in endocytosis, and the
second loop has unknown function but is clearly
serotype specific.
Here we report on our work extending the
structural characterization of the Ad3 dodeca-
hedron by cryo-electron microscopy, including a
more detailed visualization of the fiber and its
interface with, and effects on, the penton base. We
model the cryoEM density with the atomic
coordinates of the Ad2 dodecahedron to compare
the core structures and to identify the location of
residues unique to the Ad3 penton sequence as well
as part of the 48 amino-terminal residues not
visualized by crystallography.Results and Discussion
Although we published previously that dodeca-
meric particles consisting of Ad3 penton base or
Ad3 penton base plus fiber formed spontaneously
upon expression,18,20 new purification methods of
recombinant protein produced in insect cells led to
assembly of few particles, some incomplete, and
with a much higher proportion of free penton bases
(Figure 2(a)). We explain this discrepancy by first
noting that the atomic structure of the Ad2 penton
base dodecahedron was derived from protein that
was N-terminally truncated, with the first 48 amino
acid residues missing.23 The internal space in this
dodecahedron may be approximated by a sphere
with diameter of 80 A˚, sufficient to accommodate
225 kDa of tightly packed protein but which is too
small to accommodate the 317 kDa of truncated
peptides (60 copies of 48 residues). Clearly,
dodecahedra cannot assemble from full-length
penton base protein. Secondly, we observed that
when full-length Ad3 penton base (Figure 2(c),
lane 1) was kept for two weeks at room tempera-
ture, almost all the protein had assembled into
dodecahedra (Figure 2(b)) and that the protein had
been spontaneously degraded to a smaller size
(Figure 2(c), lane 2). N-terminal sequencing showed
Figure 2. Negative stained images of expressed penton base. (a) Expressed penton base visualized immediately after
expression and purification. Mainly free pentameric bases are visible with also some more or less complete dodecahedra.
(b) Same sample as in (a) but visualized after two weeks at room temperature, having lost the first 37 residues. Most of
the particles are well-formed dodecahedra. Only a few free penton bases are visible in the background. The scale bar
represents 30 nm. (c) An SDS-PAGE gel of the two samples visualized in a, lane 1, and b, lane 2.
Structure of the Ad3 Dodecahedral Particle 513that the protein was N-terminally truncated
between residues 37 and 38 (Figure 3). This 11
residue extension over the truncated Ad2 protein
visualized by crystallography totals only 73 kDa
(i.e. 60 copies of 11 residues) and is well able to pack
into an 80 A˚ radius cavity. We conclude that
our previous work on the Ad3 dodecahedron
most probably involved N-terminally truncated
protein resulting from inadvertent and unsuspectedFigure 3. Sequence alignment of penton base proteins from
Ad2 penton base are denoted above the sequence by blue arro
(numbered 2, RGD is boxed into a black square) and the varia
the regions involved in particle dodecamerization are in gree
(one connection on the 2-fold axis). The black arrow indicates
The number 5 and the black line above indicate residues 38–4
Figure 2(b) but not in the Ad2 dodecahedron X-ray structureproteolysis. In the experiments shown here, all
penton base protein was cleaved at the same site
(residues 37–38), but in principle one would expect
that dodecahedra could be formed from a mixture
of cleaved and full-length protein.
The observation of dodecahedra in lysates of cells
infected by Ad325 but not from cells infected by Ad2
may be due to the fact that the cleaved site is not
conserved between the two serotypes (Figure 3) andhuman adenoviruses 2 and 3. Secondary structures in the
ws (b-strands) and red helices (a-helices). The RGD region
ble loop (numbered 1) are highlighted in orange whereas
n and numbered 3 (two 2-fold related connections) and 4
the site of proteolysis allowing dodecahedron formation.23
9 that are present in the Ad3 dodecahedron visualized in
. Regions 1–5 are also indicated in Figure 5.
514 Structure of the Ad3 Dodecahedral Particlethat the Ad3 penton base is more readily cleaved in
infected cells. During infection of cells by Ad2 there
is production of a large excess of soluble fiber that is
thought to be necessary to undo the tight junctions
between cells involving the Ad2 receptor CAR.5
Ad3 does not infect the same cells as Ad2 and uses a
different receptor from CAR.3 The fact that Ad3
dodecahedra are found in large quantities in Ad3-
infected cells most likely means that these struc-
tures also play an as yet unknown role in the
infection process.26
Electron cryo-microscopy and image analysis
yielded models of the dodecahedron made from
penton base only (Bs-Dd) and dodecahedron made
of complete pentons (Pt-Dd) (Figure 4). The Bs-Dd
particle was resolved at 9 A˚ but for the Pt-Dd
particle only 16.5 A˚ was achieved as a consequence
of both a smaller dataset of images as well as higher
background noise due to the larger diameter
particle being embedded in thicker ice. The Bs-Dd
density map (Figure 4(d) and (e)) reveals tight
packing of subunits in the penton bases but a looser
association between penton bases. Although at
lower resolution, the Pt-Dd map (Figure 4(f) and
(g)) shows very strong density for the fiber up to the
fiber head. Keeping in mind the improper impo-
sition of 5-fold symmetry on the trimeric fiber
molecule, several observations can be made. Firstly,
the density level in the fiber is similar to that in the
penton base, indicating that the fiber is coincident
with the icosahedral 5-fold axis and so does not lose
strength due to the imposed and inappropriate
averaging. This strength of the fiber density is
remarkable in comparison to that visualized in
previous work18 and likely results from embedding
the particles in thicker ice, thus avoiding bending of
the fibers, as well as correction of image distortions
generated by the microscope (contrast transfer
function).27 We note that the Quantifoil grids used
here appear to have rims of thick carbon around the
holes that leads to thicker ice than for the "lacy"
home made holey carbon films used previously.
Secondly, we observe that the extent of the fiber
is well delimited: small bridges of density connect
it to the penton base (arrows in Figure 4(g)), and
at the distal end the transition from strong to
smeared density is sudden. Extending the radius of
selection for the raw images does not result in any
further extension of the fiber density in the
reconstruction (results not shown), thus indicating
the onset of either flexibility or a kink at the visible
distal end. Such flexibility was observed before for
negatively stained fibers of Ad2 that were seen to
have a triangular shaped head with the fiber shaft
lying flat on the carbon support film.28 Flexibility of
the fiber near the head and near the base probably
assists in favorable positioning for receptor
binding.29 Finally, the fiber density shows an axial
banding pattern with a spacing of about 15 A˚. This
feature will be discussed below.
The atomic structure of the Ad2 penton base was
fit into the EM density maps of Ad3 Bs-Dd and
Pt-Dd (Figure 5(a)–(d)). The atomic model fits verywell (see Materials and Methods) apart from two
loop areas where the EM density is too wide, as
indicated in Figure 5(a) and (b) by 1 for the variable
loop15,23 and by 2 for the RGD loop (see also the
sequence in Figure 3). The extra EM density in loop
1 is about 950 A˚3 in volume and can accommodate
about 800 Da, slightly less than required for the
eight amino acid insertion in the Ad3 penton base
compared to that of Ad2. Less can be said about
loop 2, the RGD loop, since most of it is invisible in
the atomic structure of the Ad2 penton base23 and in
the 10 A˚ Ad5 structure.15 Consequently, extra
volume is visualized in the EM density maps
corresponding to the RGD loop despite its shorter
length than for Ad2 (Figure 3). This volume appears
further from the penton’s axis of symmetry in the
Pt-Dd structure than for Bs-Dd, presumably a
consequence of the fiber binding the penton base
(see below).
The Ad3 dodecahedron is stabilized by three
contacts between each pair of pentons. Two of these
(marked 3 in Figure 5(c)–(f)) are related by the
2-fold axis and one (marked 4 in Figure 5(d) and (f))
is situated on the 2-fold axis. The corresponding
positions in the Ad2 sequence are also marked by 3
and 4 in Figure 3. Because the quasi-atomic model
of the Ad3 dodecahedron is made using the Ad2
X-ray structure, it is difficult to say exactly which
amino acids interact across the Ad3 penton–penton
interface. However, the atomic structure of the Ad2
penton base falls exactly inside the Ad3 EM density,
implying that both types of penton base use the
same structural elements to form the dodeca-
hedron. Further, the high degree of homology
between the sequences in these regions suggests
that many of the same contacts may be made.
The EM structure shows additional density
attached to the inside surface of the dodecahedron
at the position of the N-terminal residue 49 of the
Ad2 atomic structure (Figure 5(g) and (h); the
N-terminal residue 49 is marked by an asterisk (*)
and the extra density is marked by the number 5).
We attribute this to the presence of 11 additional
N-terminal residues present in the Ad3 penton base
protein used for the cryoEM reconstructions, and it
is a further indication that the N terminus of the
penton base is sequestered inside the dodeca-
hedron, and by inference inside the virus particle as
well. Data obtained by cryoEM for the Ad5 capsid
also showed extra density present under the penton
and was likewise attributed to the N-terminal 48
residues of the penton base.15 A corollary of these
observations is that the N-terminal PPxY sequences
that interact with cellular ubiquitine protein
ligases24,30 are not accessible in intact particles nor
after assembly of new virus particles.
Model for the fiber density and its attachment
to the base
The penton base is a pentamer but the fiber
molecule that binds it is a trimer. There are five
binding sites on the penton base for the N-terminal
Figure 4. Structures of the Ad3 penton base dodecahedron with and without fiber. cryoEM images of Bs-Dd (a) and
Pt-Dd (b), where arrowheads indicate fiber knobs. Several particles indicated by arrows are inset at double scale. The
scale bar represents 250 A˚. Surface representations of the Bs-Dd particle reconstruction viewed down a 2-fold axis and
calculated from the cryoEM images are shown in (c), exterior view, and (d), interior view where the front half has been
computationally removed. The penton bases are symmetrically identical, but colorized differently by a simple
segmentation across the icosahedral 2-fold axes to aid in interpretation. The most peripheral density appears to be
partially complete loops that may lose visibility due to flexibility. Gaps between penton bases are about 20 A˚ across and
would allow solvent access to the interior. The interior cavity is about 80 A˚ in diameter and lined by the inwardly
protruding loops of the penton bases. The central section corresponding to the sectioning plane in (d) is shown in grey-
scale (protein is black) in (e). Densities 3 and 4 on the icosahedral 2-fold axis, and near or on the interface between penton
bases, are marked with arrows and an arrowhead, respectively. These bridges are visualized in more detail in Figure 5.
Equivalent views of the Pt-Dd particle are shown in (f), exterior view, and (g), central section, where density connections
between the strong fiber density and the penton base are indicated with arrows. Also note the banding pattern along the
axis of the fiber density, with a spacing of about 15 A˚ (yellow arrow heads). The boxed region is reproduced in Figure 6.
An animation of the surface views is available on-line (Supplementary Data). The scale bar represents 50 A˚.
Structure of the Ad3 Dodecahedral Particle 515tail of the fiber.23 Therefore, when the fiber binds
to the base, the fiber N termini will occupy at
most three of the five available sites, an interesting
example of symmetry mismatch but with unknownpurpose. Because icosahedral symmetry is imposed
upon the dodecahedron during the image recon-
struction process, the density at the vertices,
including that of the trimeric fiber, is 5-fold
Figure 5. Quasi-atomic model of the Ad3 dodeca-
hedron using the atomic structure of the Ad2 penton base.
(a) Fit of the Ad2 penton base X-ray structure (PDB
accession number 1X9P) into the Ad3 penton base EM
density. The fit is nearly perfect at this resolution with
only two unoccupied regions visible in the EM map. The
first, marked 1, corresponds to the variable loop (see
Figure 3) while the second, 2, is the RGD loop. (b) Fit of
the fiber peptide, Ad2 penton base complex X-ray
structure (PDB accession number 1X9T), into the Ad3
penton EM density. Extra densities are marked as in (a).
The peptide that mimics the N terminus of the fiber
(amino acid residues 10–20) is drawn in black. (c) and (d)
Visualization of the contacts between two penton bases
across the 2-fold axis. (c) Top-view along the icosahedral
2-fold axis, and (d) a perpendicular side view. The
sequences involved in the different contacts are marked
3 and 4 as in Figure 3. Extra densities compared to the
Ad2 X-ray structure are marked 1 and 2 as in (a) and (b).
(e) and (f) The contact densities between penton bases are
indicated in these surface views that have been rendered
from a density map limited to 11 A˚ and contoured at a
stringent level to highlight stronger densities. Arrows and
numbers indicate features corresponding to those of (c)
and (d) and in Figure 3. The boundaries between penton
bases have been slightly adjusted from the simple 2-fold
positions of Figure 4 by inspection of the density and
respecting the 2-fold axis. The lower connection (4) is
apparently weaker and is not quite continuous at this
stringent contour level. (g) Same view of the Ad2 penton
base X-ray data fitted into the Ad3 penton base as in (d)
but the EM map is contoured at a lower threshold
(i.e. more density is visible). It is then possible to see that
the N-terminal part of the X-ray data (represented by an
516 Structure of the Ad3 Dodecahedral Particleaveraged. When the EM density for Bs-Dd is
subtracted from the density for Pt-Dd, several
regions remain (colored light blue in Figure 6(a)),
corresponding to the fiber as well as any penton
base densities that are flexible in Bs-Dd but more
rigid in Pt-Dd. On the top of the base, five spokes of
density radiate azimuthally outwards, each consis-
ting of three blobs. The center-most two blobs
correspond to the density observed in the complete
Ad5 capsid and also in the crystal structure of the
Ad2 penton base plus an N-terminal fiber peptide,
and are likely made up of Ad3 fiber residues
10-SFNPVYPYEDE-21.15,23 The third blob is situated
towards the outside of the penton base against the
RGD loop and is either due to a stabilizing effect of
the fiber N terminus on the flexible loop or
comprises the nine N-terminal residues of the
fiber tail. The volume of this blob of density,
1000 A˚,3 can contain 850 Da of protein, enough for
most of the nine N-terminal Ad3 fiber tail residues
(1-MAKRARLST-9). In a previous analysis18 we
interpreted the volume difference between Bs-Dd
and Pt-Dd near the RGD loop as movement by this
loop because at the low resolution of that analysis
we could only see that the midpoint of the mass of
this loop changed position. Only higher resolution
data would confirm our hypothesis about the
identity of the outer-most blue blobs.
The cross-section of the EM density of the fiber in
Figure 4(g) shows a series of striations along its
length. The distances between these striations is
15(G2) A˚ and thus could correspond to the 15
amino acid pseudo-repeats in the fiber shaft.28,31–33
Indeed, when the atomic structure of the distal shaft
and knob region of the trimeric Ad2 fiber31 is 5-fold
averaged, a similar pattern of striations is observed
from averaging of the repeating three pairs of
antiparallel b-strands that are close to the fiber axis
(Figure 6(b); b-strands and corresponding striations
are arrowed). Analysis of the sequence of the Ad2
and Ad3 fibers shows that they have N-terminal
tails of similar length (45 residues for Ad3 and 46
for Ad2) followed by three shaft repeats in
common.32 Although the short Ad3 fiber has only
six repeats in total compared to the 22 for the longer
Ad2 fiber,32,34 the regular spacing of repeats can be
directly compared with those of Ad2 that are
present in the crystal structure of the fiber
(Figure 6(b)). The cross-section of the fiber density
of Ad3 Pt-Dd shows five clear bands, with the sixth
striation from the last repeat being smeared out, as
is the density for the knob, implying some flexibility
is likely between the fifth and sixth repeat. The
distance between the first striation and the inner-
most blob of blue density shown in Figure 6(a) is
about 15 A˚ and is evidently made up of the prolineasterisk (*)) is now connected to a small cylindrical
density inside the dodecahedron. We attribute this
density to residues 38–49 (region 5 in Figure 3).
(h) Same view as in (g) but for the entire dodecahedron.
The cutting slice is colored in beige and region 5 and * are
indicated under one penton base. The bars represent 25 A˚.
Figure 6. (a) The fiber of adenovirus. Difference
mapping between Pt-Dd and Bs-Dd structures filtered
at 18 A˚ resolution. Bs-Dd is in grey and the difference
density is in blue. One half of the central penton shows
the same fit as in Figure 5(b). The N-terminal fiber peptide
(residues 11–21 of the Ad2 fiber23) is in black and
superposes exactly with extra density visible in Pt-Dd
(the two radially oriented cylinders of blue density). We
interpret a third blue density localized on the outside
part of the RGD loop (region 2 in Figures 3 and 5) as the
N-terminal part of the fiber (Ad3 fiber residues 1–9) that is
modeled by a red line connected to the black line (Ad2
fiber residues 11–21 seen in the crystal structure;
Figure 5(b)). The sequence alignment of the first 20
amino acid residues of the Ad2 and Ad3 fibers indicates
in black the amino acids that were modeled in the Ad2
crystallographic structure of the penton base with the
bound fiber peptide, and in red those that were
disordered. (b) Comparison of fiber density from the
crystallographic structure of the Ad2 fiber head domain
(residues 312–582)31 as indicated, and from the Ad3 Pt-Dd
density map. The Ad2 atomic model is averaged to mimic
the Ad3 icosahedral reconstruction by filtering to 16 A˚
followed by imposition of 5-fold symmetry about an axis
Structure of the Ad3 Dodecahedral Particle 517and glycine-rich sequence 21-SSSQHPFINPG
FISPDGFTQSPNGV-45 that must form the well-
defined link visible in the cross-section (Figure 4(g),
arrows).
The loose packing between penton bases and the
accessibility of the dodecahedron interior to solvent
are features of the subviral particle that contrast
sharply with the adenovirus capsid, where penton
bases interact with hexon and other minor structural
proteins to form a closed capsid. In addition, the
insight into the need for truncation of the N-terminal
37 residues (48 for Ad2) in order to form dodecamers
highlights another difference with the in situ penton
base and has been crucial to understanding how to
optimize particle production. These factors are
important for our goal of developing the dodecahe-
dron as a therapeutic vector (P.F. et al, unpublished
results). Loose packing is more likely to allow our
manipulation of the assembly status for the purpose
of encapsidating a drug or other "cargo", although
maintaining assembly buffer conditions will be
crucial for particle stability. The large trefoil perfo-
rations also present an interesting challenge for
retaining any packaged molecules, and clearly the
size of the molecule must be sufficient to avoid
diffusion through the pores. This may be achieved by
polymerization of the molecules, thus increasing the
diameter of the payload, or by modifying the interior
surface of the dodecahedron cavity to attract the
molecules but without affecting assembly. Finally, the
need for truncation is essential for assembling
particles in the first place, but also suggests that the
amino termini might be suitable sites to introduce
modifications for enhancing recruitment and reten-
tion of specific drugs and in sufficient quantity to be
useful. Clearly much needs to be done to develop this
system, but the structural work presented here gives
some clear directions for future work.Materials and Methods
Protein preparation
Adenovirus 3 dodecahedra were prepared using the
baculovirus expression system as described.20 Briefly, a
double expression vector pAcUW31 (Clontech, Palo Alto,
CA) was used for cloning the Ad3 penton base protein
(60 kDa) and fiber protein (35 kDa) genes into the
baculovirus genome. Infectivity titres were determined
on monolayers of Spodoptera frugiperda (Sf21) cells byparallel with the fiber shaft. The section view shows four
parallel striations corresponding to b-sheet crossovers, as
indicated by arrows, and large loops between the lowest
sets of b-sheet crossovers correspond to wisps of density
between the lowest two striations in the section. At right
is a corresponding section through the Ad3 fiber density
of the Pt-Dd structure (boxed region from Figure 4(g)) and
in approximate alignment by the distal ends presents
similar striations. In the Ad3 fiber five striations are
visible corresponding to five N-terminal motifs32 while
that for the distal sixth crossover is too smeared out to be
clearly defined (broken arrow).
518 Structure of the Ad3 Dodecahedral Particlestandard procedures. Trichoplusia ni moth cells (High
Five; Invitrogen) were infected with the recombinant
baculovirus isolates at a multiplicity of infection of 5
plaque-forming units/cell. Lysates of infected High Five
cells were separated on a 15%–40% (w/w) sucrose
gradient containing 10 mM Tris–HCl, 150 mM NaCl,
10% glycerol, 2 mM EDTA (pH 6.6) for 18 h in a Beckman
SW41 rotor at 40,000 rpm. Expressed protein was
visualized by SDS-PAGE and Coomassie stain of the
collected fractions at weights of 60 kDa and 35 kDa
corresponding to the penton base protein and fiber
protein, respectively. After the gradient, the protein-
containing fractions localized in 38%–40% sucrose were
dialyzed against 25 mM phosphate buffer (pH 6.6) and
further purified by anionic exchange chromatography
(Econo-Pac High Q Cartridge; BioRad) using a linear 0 to
1 M NaCl gradient in the phosphate buffer.
Electron microscopy
Particles were visualized by negative-stain EM to assess
their assembly status using 1%(w/v) sodium silicotung-
state (pH 7.0) as stain. cryoEM for structural analysis was
performed according to standard low-dose methods.
Bs-Dd particles were imaged on a JEOL JEM2010F
microscope equipped with an Oxford CT3500 cryoholder
operated at 200 kV and 50,000! nominal magnification.
Pt-Dd particles were imaged with an FEI CM200 micro-
scope with a Gatan 626 cryoholder operated at 200 kV and
38,000! nominal magnification. Quantifoil R2/1 grids
(Quantifoil Micro Tools GmbH, Germany) were loaded
with 4 ml of sample at 1 mg/ml, blotted and rapidly frozen
in liquid ethane within a liquid nitrogen bath using a Zeiss
cryo-plunger. Grids were maintained at liquid nitrogen
temperatures during transfer into the microscope and
imaged with low dose techniques on Kodak SO163
film. Fields were imaged twice at different defocus values
with the closer-to-focus exposure being made first.
Negatives were developed in full strength D19 for
12 min, screened by optical diffraction to reject those with
weak or astigmatic power spectra, and digitized at a 7 mm
sampling step on a Z/I Imaging PhotoScan (previously the
Zeiss SCAI).
Image analysis
Particle images were selected manually from the
digitized micrographs, corrected for contrast transfer
function effects and processed as described35 with several
modifications as noted. The Bs-Dd micrographs (seven
defocus pairs) yielded 5597 image pairs of which 1849 were
selected for the final reconstruction; for Pt-Dd, 2141 image
pairs were collected from six defocus pairs of micrographs,
and 1071 were included in the final density map. Particle
orientations were determined with the PFT protocol36
with modifications (D.M. Belnap, J.B. Heymann & J.F.C.,
unpublished results), and three-dimensional density maps
were calculated using Fourier–Bessel methods. Resolution
was estimated by Fourier Shell Correlation37 calculated
between independent half-dataset maps, and applying a
correlation limit of 0.3: for Bs-Dd this was at 9.3 A˚ and
for Pt-Dd, 16.5 A˚ (see Supplementary Data, Figure 1).
Density maps were manipulated with BSOFT utilities38
and visualized with ROBEM (Rob Ashmore, Purdue
University, Indiana), Amira (Mercury Computer Systems
Inc, Merignac, France), and the UCSF Chimera software†.† http://www.cgl.ucsf.edu/chimera/Density maps have been deposited in the Macromolecular
Structure Database‡ with accession numbers 1178 for Bs-
Dd and 1179 for Pt-Dd.Docking of the atomic structure of the Ad2 penton
base into the Ad3 penton base dodecahedron
The atomic structures of the Ad2 penton base alone
(PDB accession number 1X9P) and in complex with the
N-terminal fiber peptide (PDB accession number 1X9T)
were fit into the EM model for Ad3 Bs-Dd and Pt-Dd,
respectively. The atomic structures were placed manu-
ally into one penton base using the program O.39 The
optimization procedure was carried out using URO40
with the pentamer treated as a single molecule (i.e. only
applying icosahedral 2-fold and 3-fold symmetry). The
scale factor was also optimized to determine the real
magnification of the microscopes. For Bs-Dd the quality
of the final fit is given by a correlation coefficient of
80.4%, a crystallographic R factor of 44.5% and a
quadratic misfit of 17.9. The fitted scale factor was 0.98
of the original, corresponding to a calibrated pixel size in
the cryoEM images of 1.37 A˚. For Pt-Dd the quality of the
final fit after masking out the fiber shaft and head
domains is given by a correlation coefficient of 93%, a
crystallographic R factor of 41.9% and a quadratic misfit
of 14.9. The computed scale was 0.93 of the original, or
1.72 A˚/pixel.Difference imaging
Both the Bs-Dd and Pt-Dd maps were converted into
SPIDER format,41 adjusted to a common pixel size of
1.72 A˚ and subsequently filtered to 18 A˚ resolution. The
two maps were then normalized (same min/max and
standard deviation) and the correct threshold calculated
to include the expected molecular mass of the particle
(excluding the fiber for Pt-Dd). Pt-Dd was subtracted
from Bs-Dd but no significant positive densities were
visible (not shown). When Bs-Dd was subtracted from
Pt-Dd, positive difference density resulted as seen in
Figure 6(a).Five-fold averaging of the fiber
The PDB file corresponding to the distal region of the
Ad2 fiber (residues 319–582; PDB accession number
1QIU) was loaded into SPIDER and filtered to 16 A˚.
5-fold symmetry was imposed along the fiber shaft to
allow comparison with the corresponding density in the
cryoEM model. A central slice through the resulting
density is shown in Figure 6(b).Acknowledgements
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Abstract
Background Direct protein transduction is a recent technique that involves
use of peptide vectors. In this study, we demonstrate that adenovirus
dodecahedron (Dd), a virus-like particle devoid of DNA and able to penetrate
cells with high efficiency, can be used as a vector for protein delivery.
Methods Taking advantage of Dd interaction with structural domains called
WW, we have elaborated a universal adaptor to attach a protein of interest
to this vector.
Results A tandem of three WW structural domains derived from the Nedd4
protein enables the formation of stable complexes with Dd, without impairing
its endocytosis efficiency. Our protein of interest fused to the triple WW linker
is delivered by the dodecahedron in 100% of cells in culture with on average
more than ten million molecules per cell.
Conclusion These data demonstrate the great potential of adenovirus
dodecahedron in combination with WW domains as a protein transduction
vector. Copyright  2006 John Wiley & Sons, Ltd.
Keywords adenovirus; dodecahedron; WW domain; protein transduction;
vector; Nedd4
Introduction
Adenovirus penton is a non-covalent complex composed of the antenna-like
fibre protein attached to the capsid-embedded penton base protein. Pentons
are localised at the 12 vertices of the adenovirus capsid. It has been reported
for most human adenovirus serotypes including adenovirus of serotype 3
(Ad3) that the high affinity interaction of the fibre with its primary receptor
[1,2] triggers virus endocytosis through the subsequent interaction of the
penton base RGD motif with cellular integrin [3,4]. Remarkably, during the
Ad3 viral cycle, some pentons can self-assemble forming symmetric complexes
called penton-dodecahedron (Pt-Dd) [5–7]. The formation of dodecahedron
(Dd) is due solely to penton base interactions, as attested by the formation
in the baculovirus expression system of symmetric particles made of base
proteins only, called base-dodecahedron (Bs-Dd). Interestingly, both Bs-Dd
and Pt-Dd penetrate human cells albeit with a higher efficiency for the particle
containing the fibre. As these particles are devoid of genetic information, they
are potentially good tools for gene transfer or protein delivery [7,8].
Nedd4 is a protein belonging to the ubiquitin E3-ligase family. This modular
protein is composed of a C2 domain mediating calcium-dependent attach-
ment to the cellular membrane, four WW domains named WW1 to WW4,
Copyright  2006 John Wiley & Sons, Ltd.
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and the catalytic HECT domain (homologous to E6-AP
carboxy terminus) [9]. This catalytic domain mediates
ubiquitination of proteins that are structurally recognised
by the WW domains [10]. Target proteins recognised
by the WW domain often display short proline-rich lin-
ear sequences, such as PTAP or PPxP [11]. It has been
reported that interaction of Nedd4 with viral proteins is
required at a late stage of infection (i.e. budding) for
several enveloped viruses [12]. Surprisingly, it has been
recently demonstrated that the non-enveloped human
adenoviruses also interact with several WW-containing
proteins. This interaction occurs through the recogni-
tion of two PPxY motifs that are strictly conserved
in the N-terminus of the penton base protein [13,14].
Adenovirus dodecahedron is a good candidate for
intracellular protein delivery; however, in order to
attach proteins of interest to Dd, a module enabling
attachment to the base protein is necessary. As both
Bs-Dd and Pt-Dd contain 12 pentameric bases, they
exhibit 60 tandems of WW-interacting PPxY motifs.
In this study, the potential use of WW domains
for attaching proteins to these dodecameric vectors
has been evaluated. We report here that three WW
domains derived from Nedd4 are able to attach proteins
to Dds making these structural domains a universal
adaptor module for protein transduction by our subviral
particles.
Methods
Protein expression, purification and
detection
Both Pt-Bs and Bs-Dd were expressed in the baculovirus
system. Particles were purified by sucrose density gradi-
ent, as previously described [7]. The MBP-WW constructs
were expressed in E. coli and purified on amylose resin
(Biolabs), as previously described [15]. The maltose bind-
ing protein (MBP) tag was detected using anti-MBP
serum (Biolabs) at 1/40 000 for enhanced chemilumi-
nescence (ECL) and enzyme-linked immunosorbent assay
(ELISA) and a subsequent incubation with anti-rabbit
HRP 1/5000 (Jackson). Dds were detected using anti-Pt-
Dd serum recognising both the fibre and the penton base
protein at 1/40 000 and a subsequent incubation with
anti-rabbit HRP conjugated antibody at 1/5000 (Jack-
son).
In the immunofluorescence study, the anti-MBP serum
was used at 1/1000 for 1 h and was subsequently detected
with either anti-rabbit FITC-labelled or anti-rabbit Tex-
Red-labelled secondary antibody at 1/250 for 1 h. Pt-Dd
used in the co-localisation experiment was previously
FITC-labelled by incubating 300 nM of Pt-Dd with 1 mM
FITC (Sigma), in 20 mM HEPES, pH 8, for 3 h at 4 ◦C.
Free FITC was removed by dialysis against 20 mM HEPES,
150 mM NaCl, pH 8.
ELISA
Ninety-six multiwell plates were coated overnight at 4 ◦C
with 100 µl of Bs-Dd or Pt-Dd (1 µg/ml in carbonate
buffer, pH 9.6). Control wells were coated with buffer
alone. After washes with phosphate-buffered saline (PBS),
the plates were blocked with PBS/3% bovine serum
albumin (BSA) for 1 h at 37 ◦C. Different concentrations
of purified MBP-WW constructs ranging between 0 and
10 µg/ml were incubated for 1 h at room temperature
(RT) in triplicate. MBP detection was performed as
indicated above in PBS buffer containing 0.05% Tween
20 and 1% BSA. o-Phenylenediamine substrate (3 mg/ml,
Sigma) was added and the reaction was stopped with
0.5 N sulphuric acid. Absorption at 490 nm was measured
and the mean of the triplicate controls was subtracted
from the mean of the triplicate assays, for each point
tested.
Dd-MBP-WW complex formation
Purified Bs-Dd (100 µg), MBP-WW2,3,4 (200 µg), either
separately or pre-incubated together for 1 h at RT in
500 µl PBS, were ultra-centrifuged on sucrose gradient
density as previously described [7]. Fractions of 600 µl
were collected from the top of the gradient and 10 µl of
each were applied under vacuum on a PVDF membrane.
Detection was performed with either anti-MBP or anti-Pt-
Dd antibody as described above.
Immunofluorescence
HeLa cells were grown overnight on glass coverslips
(about 105 cell/cm2) in EMEM medium supplemented
with 10% fetal calf serum (FCS), at 37 ◦C under 5% CO2
atmosphere. Normal human astrocytes (NHA, clonetics)
were cultured in astrocyte basal medium (Clonetics)
following the supplier’ recommendations. The coverslips
were then incubated for 1 h at 37 ◦C with 50 µl of pre-
warmed PBS containing either MBP-WW2,3,4 protein
alone (2 µg) or in complex with Pt-Dd or Bs-Dd (1 µg).
After PBS washes, cells were permeabilised in cold
methanol for 10 min. Protein detection was performed
as described above. Cell nuclei were counterstained with
propidium iodide (5 µg/ml). Laser scanning confocal
microscopy was performed with a MRC600 (Bio-Rad).
Photographs shown in Figure 4a are the Z-serie projection
of eight 0.5 µm cell sections.
Dds and MBP-WW2,3,4 quantification
in transduced cells
HeLa cells grown on a 24-multiwell plate (105 cells/well)
were incubated at 37 ◦C with 200 µl PBS containing
various amounts of MBP-WW2,3,4 (0, 500, 1000, 3000,
5000 ng) either separately or pre-incubated for 1 h with
1000 ng of Pt-Dd. After 1 h, cells were washed and lysed
Copyright  2006 John Wiley & Sons, Ltd. J Gene Med 2006; 8: 524–531.
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in 100 µl of cell lysis buffer (Promega). Samples (10 µl)
were run on 12% sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE) with a range of purified
MBP-WW2,3,4 or Pt-Dd. After electrotransfer on PVDF
membrane, proteins were detected with anti-MBP or anti-
Pt-Dd antibody, as described above. The molecular weight
of MBP-WW2,3,4 (63 kDa) and of the Ad3 penton base
monomer (60 kDa, 60 monomers per Dd) make possible
the calculation of the amount of these proteins per well.
Results
Respective implication of the different
WW domains in binding to Dd
Three of the four WW domains derived from Nedd4
were cloned separately (WW2; WW3; WW4) or together
(WW2,3,4) in fusion with the maltose binding protein
(MBP) (Figure 1). In the present study, the MBP tag
(45 kDa) is not only used for protein purification, but will
also enable monitoring of these different constructs with
anti-MBP antibody.
Specific interaction of Nedd4 WW domains with Dd was
investigated using a modified ELISA method. A multiwell
plate coated with Pt-Dd or Bs-Dd was incubated with
different concentrations of purified WW proteins. Relative
amounts of bound WW proteins were assessed by MBP
tag detection, using anti-MBP antibody (Figure 2). All the
single Nedd4 WW domains can interact independently
with Pt-Dd with a slightly stronger interaction displayed
by WW3 (similar results were obtained with Bs-Dd, data
not plotted). However, for the construct expressing the
three WW domains together, a dramatic increase in
protein binding is observed with both Pt-Dd (full line) and
Bs-Dd (dashed line). The interaction reached saturation
at a concentration above 2 nM of MBP-WW2,3,4. These
observations suggest that, although the single WW
domains can independently recognise the penton base,
the three domains together likely interact in a cooperative
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Figure 2. Characterisation of WW construct interaction with
Dds by ELISA. Pt-Dd (full line) or Bs-Dd (dashed line) coated
on a 96-multiwell plate was incubated for 1 h with different
concentrations of WW constructs. Bound proteins were detected
with anti-MBP and their relative amounts were assessed with a
colorimetric substrate at 490 nm
Figure 1. Schematic representation of Dd and WW constructs. (a) Adenovirus penton (Pt) is a non-covalent complex involved in
Ad entry, composed of the trimeric fibre and the pentameric penton base (containing 2 PPxY motifs at the N-terminus of each
monomer). Expression of Ad3 penton base alone in the baculovirus system leads to the formation of a highly symmetric complex
termed base-dodecahedron (Bs-Dd). Co-expression with the Ad3 fibre gives a fibre-decorated particle termed penton-dodecahedron
(Pt-Dd). (b) Nedd4-derived constructs are expressed in E. coli in fusion with the maltose binding protein (MBP: 45 kDa). Three out
of the four Nedd4 WW domains (4 kDa) were expressed separately or together. Constructs containing WW1 domains were insoluble
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manner to both kinds of Dd. Moreover, since no difference
is observed for MBP-WW2,3,4 binding to Bs-Dd and Pt-
Dd, it shows that the fibre does not interfere with WW
domain binding to the penton base.
Purification of Dd/MBP-WW2,3,4 stable
complexes
Isolation of Dd/MBP-WW2,3,4 complex was performed
by sucrose gradient density centrifugation. Indeed, the
high molecular weight of Dds (3600 and 4800 kDa for
Bs-Dd and Pt-Dd, respectively) enables these particles to
migrate towards the bottom fractions of the sucrose gra-
dient density whereas MBP-WW2,3,4 (63 kDa) remains
in the upper fractions. In this experiment, Bs-Dd (1.7
nmol of monomeric penton base protein) was incubated
with MBP-WW2,3,4 protein (3.2 nmol) prior to ultracen-
trifugation on a 15–40% sucrose gradient density. After
fractionation, a portion of each of the 20 fractions was
analysed by dot-blot with either anti-MBP or anti-Pt-Dd
antibody. As expected, Bs-Dd alone migrated to the bot-
tom fractions of the gradient (Figure 3, top row, dots 12 to
20) while MBP-WW2,3,4 alone remained in the upper part
(Figure 3, middle row, dots 4 to 8). When these proteins
were pre-incubated together prior to centrifugation, a sig-
nificant part of the MBP signal was then detected in the
bottom fractions of the gradient density along with Bs-Dd
(Figure 3, bottom row). This demonstrates the formation
of a stable complex between Dd and MBP-WW2,3,4 that
can be separated from free MBP-WW2,3,4 remaining in
the upper fractions.
Protein delivery by Dd
Knowing that MBP-WW2,3,4 protein can form a stable
complex with Dd, the delivery of this protein into cells was
investigated using immunofluorescence. Pt-Dd or Bs-Dd
was mixed with MBP-WW2,3,4 protein prior to incubation
with HeLa cells. An equivalent amount of fusion protein
was used as a control, in the absence of Dd. After 1 h at
37 ◦C, cells were washed, fixed, and the presence of the
protein was detected in green using anti-MBP antibody
while the nuclei were counterstained in red. A very bright
and punctate signal was seen in the cytoplasm of HeLa
cells incubated with both Pt-Dd and Bs-Dd (Figure 4a,
middle and right panels). No detectable signal was seen
either in cells incubated with the MBP-WW2,3,4 alone
(data not shown), or for Pt-Dd incubated with MBP
protein not fused to WW domains (Figure 4a, left panel).
These data show that the protein delivery was specifically
mediated by Dd and through the WW adaptors.
In order to determine whether Dd and MBP-WW2,3,4
localise together in the cells at 1 h post-transduction, a co-
localisation experiment was performed. For this purpose,
FITC-labelled Pt-Dd was used and MBP-WW2,3,4 was
detected in red with a rhodamine-conjugated antibody
(Figure 4b). A pronounced yellow signal was obtained
by merging the green Pt-Dd signal with the red signal
of MBP-WW2,3,4. This shows that a large majority of
the transduced proteins is still in the same cellular
compartment as the vector.
Interestingly, the Dd-WW system enables a massive
transfer of MBP-WW2,3,4 not only in other transformed
cell lines like A549 (not shown), but also in human
primary cells, such as endothelial cells (HuVEC) or NHA
(Figure 4c).
Quantification of the protein of
interest delivered by Dd into the cells
The respective amounts of Pt-Dd and MBP-WW2,3,4
protein transduced into HeLa cells was assessed by
Western blot. Cells grown in a multiwell plate were
transduced for 1 h at 37 ◦C with different amounts
of MBP-WW2,3,4 protein (0 to 5000 ng), alone or in
complex with Pt-Dd. After several washes, cells were
lysed and analysed by Western blot using anti-MBP
or anti-Pt-Dd serum (Figure 5). The intensities of the
bands corresponding to the MBP-WW2,3,4 protein (upper
panel) or to the penton base protein (lower panel) were
compared to their respective range of purified proteins
(on the right). As expected, no WW-MBP signal was
seen for the control Pt-Dd alone or for the lowest
concentrations of MBP-WW2,3,4 in the absence of Pt-
Dd (Figure 5, upper panel, no Pt-Dd). Nevertheless,
for high concentrations of MBP-WW2,3,4 alone (2000
and 5000 ng), faint bands were visible, suggesting the
Figure 3. Isolation of Dd/WW2,3,4 complexes by sucrose gradient density. Bs-Dd and MBP-WW2,3,4 separately or incubated both
together for 1 h (noted ‘both’) were run on sucrose gradient density (15–40%). After gradient fractionation from the top to the
bottom, protein content in each fraction was analysed by dot-blot with αBs-Dd or αMBP, as indicated in the figure
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Figure 4. Detection and localisation by confocal microscopy of MBP-WW2,3,4 protein and Dd translocated in HeLa cell or human
primary cells. (a) HeLa cells were incubated for 1 h at 37 ◦C with MBP-WW2,3,4 in complex with Dds (middle and right panels) or
with a control MBP not fused to WW domains (left panel). After cell permeabilisation, MBP-WW2,3,4 protein was detected in green
with αMBP antibody while cell nuclei were counterstained by propidium iodide. Photographs are obtained by Z-serie projection
of eight 0.5 µm sections. (b) MBP-WW2,3,4 protein in complex with FITC-labelled Pt-Dd was incubated with HeLa cells for 1 h
before permeabilisation. Red signal reflects the MBP-WW2,3,4-transduced protein detected with anti-MBP and Texas-red secondary
antibody while green signal is raised by FITC-Pt-Dd. The photograph on the right-hand side of the panel was obtained by merging
the green Pt-Dd and the red MBP-WW2,3,4 signals demonstrating a significant co-localisation of the vector and the delivered
protein. (c) Human endothelial and astrocyte primary cells (HuVEC and NHA) are efficiently transduced by the MBP-WW2,3,4
protein delivered by Bs-Dd. The MBP-WW2,3,4 protein is detected in green with anti-MBP and FITC-labelled secondary antibody
and the nuclei are counterstained in red with propidium iodide
Figure 5. Quantification of the intracellular Pt-Dd and MBP-WW2,3,4 protein in HeLa cells. Cells grown in a multiwell plate were
incubated for 1 h at 37 ◦C with either MBP-WW2,3,4 alone (500, 1000, 2000, 5000 ng; noted ‘no Pt-Dd’ in the figure) or in complex
with a fixed amount of Pt-Dd (noted ‘with Pt-Dd’ in the figure). After washes, cells were lysed and analysed by Western blot with
anti-MBP (upper panel) or anti-Pt-Dd antibody (lower panel). Quantification of Pt-Dd and MBP-WW2,3,4 proteins per cell was
achieved by densitometry. For this purpose, the Pt-Dd and MPB-WW2,3,4 signals were compared to that of their respective range
of known amounts of purified protein (on the right)
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existence of a background internalisation of this protein
by HeLa cells. However, when this protein were pre-
incubated with Pt-Dd prior to addition to cells, a dramatic
increase in MBP-WW2,3,4 transduction was observed
for both low and high concentrations used (Figure 5,
upper panel, with Pt-Dd). Interestingly, revelation with
anti-Pt-Dd showed similar band intensity whatever the
concentration of MBP-WW2,3,4 used (Figure 5, lower
panel). This observation indicated that vector entry was
not affected by the WW domains bound to its surface,
thus showing that WW adaptors can be used with no
neutralising effect on the vector.
The amount of both Pt-Dd and MBP-WW2,3,4 present
in transduced cells was calculated by comparing signals
obtained for the different assays to that of the purified
protein ranges. It was estimated that on average 3.7 × 105
Pt-Dd are internalised into one cell. Under this condition,
Pt-Dd has directed the delivery of 4.7 × 106 MPB-
WW2,3,4 protein at the lowest concentration assayed and
up to 1.9 × 107 molecules for the highest concentration
tested without affecting cell viability, as determined
by trypan blue exclusion (not shown). Under this last
condition, 51 proteins of interest have been transduced by
one Pt-Dd. Interestingly, this ratio is close to the number
of penton base monomers constituting the dodecahedron
(12 pentamers = 60 monomers), which might signify
that one MBP-WW2,3,4 molecule is attached to each
penton monomer. Moreover, no proteolysis product was
observed for both the MBP-WW2,3,4 and the Pt-Dd
vectors, demonstrating that this system is not affected
during the internalisation process and the first hour after
delivery.
Discussion
The utility of the penton base protein has already been
described for gene delivery purposes [7,16–19]. In this
work, we demonstrate that adenovirus dodecahedron
(Dd) is also a valuable tool for direct protein delivery.
In order to attach the protein of interest to the
vector, we have taken advantage of the ability of
Dd to interact with WW-containing proteins [13,14].
Indeed, we have shown in this study that a protein
of interest fused to WW domains derived from the
human Nedd4 protein can form a stable complex with
Dd without impairing its endocytosis property. The
proof-of-concept has been made using a 63 kDa protein
(45 kDa for the protein of interest and 18 kDa for the
three WW domains). However, it can be speculated
that proteins of higher molecular weight could be
delivered using this system as we have previously
reported that a monoclonal antibody (160 kDa) directed
against Dd was efficiently co-internalised with the
vector [8]. Although the WW3 domain of Nedd4 seems
predominant for the interaction with Dd, as previously
reported for Nedd4 interaction with the VP40 protein
of Ebola virus [15] or with its natural target, the
epithelial sodium channel ENaC [20], this interaction
is greatly enhanced by the presence of WW2 and WW4,
suggesting a cooperative binding of these domains with
dodecahedron. In order to further improve the Dd
recognition by WW domains, it could be of interest
to artificially generate a tandem of WW3 domains of
Nedd4.
The confocal microscopy study shows that proteins
fused to the WW2,3,4 domains of Nedd4 are efficiently
and rapidly delivered into human cells. Importantly,
100% of the cells are transduced with the protein of
interest delivered by either Pt-Dd or Bs-Dd. This high
efficacy can be explained by the ability of both kinds of
Dd to interact with heparan sulfate (HS). HS is widely
expressed at the surface of most cell lines enabling Dd
to enter cells that are not even accessible to the virus
[21]. Furthermore, protein quantification revealed that,
on average, each HeLa cell is transduced with 3.7 × 105
Pt-Dd that have delivered 1.9 × 107 proteins after a 1-h
incubation period. This means an average ratio of 51
proteins of interest translocated per Dd, suggesting a
quasi molar-occupancy of Dd by the protein, as each Dd
is made of 60 monomers of penton base (12 pentamers).
Cooperative binding of the WW domains to the vector
observed in ELISA (Figure 2) might nevertheless take
place as two PPxY sequences are conserved in all the N-
terminal sequences of the adenovirus penton bases [13]
(see Figure 1). However, a further structural investigation
on Dd/WW is necessary to bring a detailed mechanism
for this interaction. Indeed, the recent Ad2 penton base
structure shows that the N-termini (deleted of the 50
first residues then of the two PPxY sequences) are buried
close to the Dd cavity [22]. As the size of the cavity is
too small to accommodate large proteins such as MBP-
WW2,3,4 [6], it could be envisaged in the full-length
penton base (i.e. with PPxY sequences) that the N-termini
are flexible, rendering them accessible to WW interaction
in the dodecameric structure.
To date, protein delivery has been described using
peptides like the drosophila Antennapedia homeodomain
[23] or viral peptides such as the Tat transactivator of
HIV-1 [24,25], its shorter form of only 11 amino acids
[26], or the VP22 protein from HSV-1 [27]. It is of interest
to note that these peptides mediate protein transduction
through interactions with glycosaminoglycans [28] and
that Dd also interacts with this cellular component with
an affinity in the nanomolar range [21]. This property
not only enables the Dd to be efficiently taken up by
Ad3 permissive cells (3.7 × 105 Dd per HeLa cells), but
also to target Ad3 non-permissive cells, as this virus
cannot exploit the glycosaminoglycan entry pathway
[21]. Even if Dd cannot be compared to short peptides
in terms of size, its use in protein delivery displays a
number of advantages. Indeed, this cargo uses the very
efficient adenovirus endocytosis pathway and it can be
envisaged to change its tropism. We have previously
demonstrated that the Ad2 long fibre can be inserted
in the Ad3 Bs-Dd [7]. The Ad2 fibre recognises the
CAR receptor [29], whereas the Ad3 fibre interacts
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with another primary receptor [30,31], possibly CD46
[1,2]. Addition of Ad2 fibre could not only direct the
vector to other cell types, but also change the fate of
the delivered proteins, as it has been demonstrated that
subgroup B (i.e. Ad3) and subgroup C (i.e. Ad5) fibres
induced different trafficking routes [32]. In particular,
it is known that adenovirus harbouring subgroup B
fibres follows an endosomal route whereas the Ad5
fibre induces rapid escape of the virion from early
endosomes [33]. From a targeting point of view, it might
be interesting to abolish the natural tropism of the penton
base for HS (work in progress) and specifically target
different cell lines by introducing into Dds the fibre of
different serotypes or by using modified recombinant
fibres, as has been done for recombinant adenoviruses
[34,35].
Direct protein delivery represents an alternative to
gene transfer technology when gene insertion into the
genome is not required [36,37]. Even though this strat-
egy may be appropriate only for restricted purposes,
this approach is of great interest for specific therapeu-
tic or biotechnological applications that do not require
a sustained protein activity like monogenic diseases but
rather need only a ‘hit’ effect of the therapeutic protein
that can take place either in the nucleus (i.e. trans-
activators) or in the cytoplasm (i.e. toxins). In this
study, we show the proof-of-concept that the Dd-WW
system might be of use in this restricted, but valuable
area.
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